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Hemoglobin (Hb) and hemocyanin (HMC) are oligomeric respiratory proteins 
found in the vertebrates and invertebrates, respectively.  Recent studies have revealed that 
hemocyanin (HMC) and hemoglobin (Hb) can generate cytotoxic ROS via 
prophenoloxidase (PPO) and pseudoperoxidase activity, respectively. However, in both 
cases, how the ROS production is regulated by the microbial virulence factors during 
infection and the significance of ROS-mediated antibacterial activity, are not fully 
understood.  The aim of the present study was to examine the potential roles of these 
respiratory proteins in innate immunity, with respect to their potency as producers of 
reactive oxygen species (ROS).  The ROS-mediated antimicrobial activity is a powerful 
host defense mechanism.   
Using various biochemical assays, real-time cell imaging, and in vivo bacterial 
clearance studies, we demonstrated that: (1) the PPO activity of the hemocyanin and the 
pseudoperoxidase activity of methemoglobin are efficiently triggered by microbial 
proteases and further enhanced by pathogen-associated molecular patterns (PAMPs), 
resulting in the production of more reactive oxygen species; (2) the ROS produced as 
quinone (by HMC) or as superoxide (by hemoglobin) could form a strong antimicrobial 
defense, particularly against protease-producing pathogens; (3) hemolytic virulent 
pathogens, which produce proteases as invasive factors, are more susceptible to this 
killing mechanism.  
 
                                                                                                                                         viii                                
We have further investigated the mechanism underlying how the described 
antimicrobial defense spares the host of self-destruction.  We found that (1) the ROS 
production is specifically activated/enhanced by microbial pathogenic factors, i.e. the 
microbial proteases and the PAMPs but not by the host protease or common cell 
membrane phospholipids from both the host and the microbial invaders; (2) as the 
HMC/Hb-PAMP interactions triggered the ROS production, ROS is localized at the 
immediate vicinity of the invader, thus sparing the host from self-destruction; (3) certain 
host protease inhibitor(s), such as CrSPI in the horseshoe crab plasma, may function as 
the “on-off” control of the ROS production during the acute-phase of infection via 
modulation of the protease activities.  
In contrast to previous work, this study has revealed a novel extracellular defense 
mechanism independent of host immune cells. Both the invertebrate and vertebrate hosts 
are capable of exploiting microbial virulence factors for the rapid conversion of their own 
respiratory proteins, from oxygen-carriers to potent ROS-producers, which in the 
vertebrates, only necessitates lysis of erythrocytes, but no prior transcriptional induction 
or translational upregulation.  Due to the localization effect, this ROS production 
specifically targets the invading microbes and spares the hosts from harm.  Our finding 
links the frontline recognition of the pathogen directly and immediately for the prompt 
killing of the invader, without the need for signaling cascades and antimicrobial peptide 
production.  Such a seminal shortcut immunosurveillance mechanism, which has been 
entrenched >500 million year ago, from horseshoe crab to human, probably represents 
another ancient form of innate immunity, being functionally conserved since prior to the 
split of protostomes and deuterostomes.    
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CHAPTER 1:     INTRODUCTION 
 
Throughout evolution, the host-pathogen relationship has existed as a series of 
invasive or defensive measures and countermeasures elicited by both players.  To survive 
in the hostile environment filled with disease-causing bacteria, fungi or parasites, human 
beings have developed potent defense mechanisms in the form of various immune 
responses.  Understanding of such defense mechanisms has established the foundation of 
infection treatment and disease control. 
Two arms of immune defenses have been developed: innate immunity and 
adaptive immunity.  In principle, innate immunity detects and eliminates a group of 
pathogenic invaders by recognizing the common structural features shared by the 
pathogens and not found in the hosts; in contrast, adaptive immunity has been specified 
to detect an individual pathogen by recognizing specific antigenic epitopes.  Existing in 
all multicellular organisms, including animals (both invertebrates and vertebrates) and 
plants, the origin of innate immunity can be tracked to early evolution; in contrast, 
adaptive immunity began late and, exists only in the vertebrate animals.  Although 
evolutionarily ancient, innate immunity is an indispensable defense mechanism due to 
several features.  For example, even in vertebrates which have developed the specific 
powerful adaptive immune system, in the first hours and days of infection by a novel 
pathogen, the host must rely on innate immunity as the first line of defense. Besides, 
adaptive immunity needs the innate immunity to process the pathogen molecules and 
provide signals necessary for its activation.  The importance of innate immunity can be 
reasoned from the fact that individuals having genetic defects in innate immunity suffer 
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from recurring infection although they have normal adaptive immunity (Albert et al., 
2000).  
The potency of the innate immune system is attributed to the cells and molecules 
it uses for defense.  In the following sections, the molecules and pathways in innate 
immunity will be first overviewed, using the horseshoe crab as an experimental model.  
Emphasis will be given to reactive oxygen species (ROS)-mediated innate immune 
responses, particularly on quinone and superoxide toxicity.  This is followed by an 
introduction to respiratory proteins, hemocyanin and hemoglobin, on their structure and 
activity as the oxygen carriers, and hence, to a description of their cryptic inducible 
activity to produce toxic ROS which kills bacteria.  After summarizing the role of 
hemocyanin and hemoglobin in innate immunity, the objectives and significance of this 
thesis will be addressed.  
 
1.1 Innate immunity: model organisms, molecules and pathways  
Throughout evolution, pathogenic microbes have developed numerous ways to 
invade the host and simultaneously evade the host immune defense (Maeda and 
Yamamoto, 1996).  These tactics include the secretion of virulence factors (Pollack, 
1984), the formation of biofilm (Hall-Stoodley and Stoodley, 2005; Kivisakk et al., 2003) 
and the employment of molecular mimicry (Damian, 1989).  Conversely, the host 
immune system has developed various countermeasures such as the release of 
antimicrobial peptides (Park and Hahm, 2005), the synthesis of highly toxic reactive 
oxygen species, ROS (Grisham, 2004), and the formation of the complement-mediated 
membrane-attack complex (Sunyer et al., 2003).  It is commonly accepted that the innate 
immune responses are multi-step processes initiated via the recognition of pathogen-
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associated molecular patterns (PAMPs) followed by successive signal transduction which 
leads to the action of downstream antimicrobial effectors (Medzhitov and Janeway, 
2000).  Over the last 2-3 decades, researchers have focused their attention on families of 
host receptors and signaling cascades.  Hereinafter, a review on the molecules and 
pathways in innate immunity in the horseshoe crab as the animal model will be provided.  
Wherever applicable, a comparison will be made with other well known invertebrate 
models.    
1.1.1 The horseshoe crab as a model organism for innate immunity study 
The horseshoe crab, an ancient protostome that has been dubbed a “living fossil”, 
belongs to the order Xiphosura.  Fossil evidence showed that Xiphosura existed in the 
form of the trilobites since around the Cambrian period (500 million years ago). Fossils 
that closely resemble the modern Limulus can be found in the Jurassic period (200 
million years ago), suggesting that the species had remained almost unchanged since then 
(Stormer, 1952) (Figure 1.1).    
 
 
Figure 1.1: Evolution of the horseshoe crab from the Cambrian period.  The time line 
indicates the approximate number of millions of years before present time.  Representations of 
horseshoe crabs during each time period are shown alongside.  Adapted from Stormer (1952).  
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There are four extant species of horseshoe crabs: Limulus polyphemus (in the 
eastern coast of North and Central America); Tachypleus tridentatus (in China and Japan) 
and Tachypleus gigas and Carcinoscorpius rotundicauda in Southeast Asia.  All four 
species are similar in terms of ecology, morphology, and serology 
(www.horseshoecrab.org).  
Sharing common innate immune mechanisms with the vertebrates, the 
invertebrate offers a useful model to study innate immunity. Among various invertebrate 
models, the horseshoe crab has its own advantages.  Firstly, it harbors a potent immune 
system.  As the estuarine mud-dwelling species, C. rotundicauda lives in an environment 
thriving with myriads of pathogenic microbes, including Gram-negative and Gram-
positive bacteria, and fungi.  Throughout evolution, it has developed a set of powerful 
innate immune mechanisms, which have protected it from the extremely challenging 
habitats and therefore provided an excellent model for innate immunity study.  Secondly, 
the horseshoe crab has a relatively large body size and therefore can provide substantial 
volume of tissues for biochemical and physiological studies.  This is less feasible when 
using small organisms like the fruit-fly and nematode.  Thirdly, although the genomic 
DNA sequences of the horseshoe crab is still unavailable, the recent launch of the 
expressed sequence tag (EST) clusters for frontline immune defense, cell signaling, 
apoptosis and stress response genes of the horseshoe crab has greatly facilitated the 
immune response study at the molecular level (Ding et al., 2005).  
1.1.2 The immune response molecules in the horseshoe crab 
In the past decades, the components of the innate immune system of the horseshoe 
crab have been extensively investigated at the level of individual proteins. These efforts 
have led to the elucidation of many unique frontline defense molecules in the hemocyte 
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and plasma of the horseshoe crab, such as lectins, serine proteases, protease inhibitors, 
and antimicrobial peptides. A summary of the innate immune molecules in the 
amebocytes and plasma of the horseshoe crab is provided in Table 1.1 (Iwanaga et al., 
2005).   
Besides efforts to individually characterize the immune response molecules, Ding 
et al. (2005) recently reported the spatial and temporal coordination of the expression of 
immune response genes during the acute phase of Pseudomonas infection.  Apart from 
amebocytes, which form the major blood cell type, they also examined the 
hepatopancreas, which is the immune-responsive functional equivalent to the insect fat 
bodies and the vertebrate liver.  As a result, in addition to 60 of the effector molecules at 
the frontline immunity, which have been examined individually, 208 non-redundant 
genes were identified to be involved in various putative functional groups, including cell 
signaling, apoptosis, stress response, cell cycle and development, cell structure, 
gene/protein expression, and metabolism.  Mapping the ensemble of immune-responsive 
genes represents the first and major step towards elucidating the pathways contributing to 
innate immunity.  
1.1.3 Cell-mediated immune responses in the invertebrates 
Figure 1.2 summarizes the principal cell-mediated host defense mechanisms in 
invertebrates (Iwanaga, 2002).   Some of the immune responses include coagulation, 
direct killing by antimicrobial peptides, encapsulation of the microbe, prophenoloxidase 
activation and melanization, complement-activation and phagocytosis.  Of this myriad of 
responses, the coagulation cascade, complement cascade and prophenoloxidase pathway 
are particularly pertinent to this thesis and therefore will be described in greater detail in 
the ensuing sections. 
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Table 1.1: Innate immune molecules in the amebocytes and plasma of the horseshoe crab 
 
Proteins and peptides  Mass (kDa)  Function/specificity  Localization  
Coagulation factors     
Factor C 123  Serine protease  L-granule  
Factor B 64  Serine protease  L-granule  
Factor G 110  Serine protease  L-granule  
Proclotting enzyme 54  Serine protease  L-granule  
Coagulogen 20  Gelation  L-granule  
Protease inhibitors     
LICI-1  48  Serpin/factor C  L-granule  
LICI-2 42  Serpin/clotting enzyme  L-granule  
LICI-3 53  Serpin/factor G  L-granule  
Trypsin inhibitor 6.8  Kunitz-type  ND  
Limulus trypsin inhibitor 16  New type  ND  
Limulus endotoxin-binding protein-
protease inhibitor 
12  New type  L-granule  
Limulus cystatin 12.6  Cystatin family 2  L-granule  
α2-Macroglobulin 180  Complement  Plasma & L-granule  
Chymotrypsin inhibitor 10  ND Plasma  
Antimicrobial substances     
Anti-LPS factor 12  GNB L-granule  
Tachyplesins 2.3  GNB, GPB, Fungus  S-granule  
Polyphemusins 2.3  GNB, GPB, Fungus S-granule  
Big defensin 8.6  GNB, GPB, Fungus L & S-granule  
Tachycitin 8.3  GNB, GPB, Fungus S-granule  
Tachystatins 6.5  GNB, GPB, Fungus S-granule  
Factor D 42  GNB  L-granule  
Lectins     
Tachylectin-1 27  LPS (KDO), LTA  L-granule  
Tachylectin-2 27  GlcNAc, LTA  L-granule  
Tachylectin-3 15  LPS (O-antigen)  L-granule  
Tachylectin-4 470  LPS (O-antigen), LTA  ND  
Tachylectin-5 380-440  N-acetyl group  Plasma  
Limunectin 54  PC  L-granule  
LAF 18  Hemocyte aggregation  L-granule  
Limulin 300  Hemolytic/PC, PE, SA, DDO  Plasma  
Limulus C-reactive protein (CRP) 300  PC, PE  Plasma  
Tachypleus CRP-1 300  PE  Plasma  
Tachypleus CRP-2 330  Hemolytic/PE, SA  Plasma  
Tachypleus CRP-3 340  Hemolytic/SA, KDO  Plasma  
Polyphemin ND  LTA, GlcNAc  Plasma  
Tachypleus tridentatus agglutinin ND  SA, GlcNAc, GalNAc  Plasma  
Liphemin 400-500  SA  Hemolymph  
Carcinoscorpin 420  SA, KDO  Hemolymph  
galactose-binding protein 40  Gal  Hemolymph  
Protein A binding protein 40  Protein A  Hemolymph  
(1 → 3)β-D-glucan binding protein 168  Pachyman, cardlan  Hemocyte  
Others     
Transglutaminase (TGase) 86  Cross-linking  Cytosol  
8.6 kDa protein 8.6  TGase substrate  L-granule  
Pro-rich proteins (Proxins) 80  TGase substrate  L-granule  
Limulus kexin 70  Precursor processing  ND  
Hemocyanin  3600  O2 transporter/ Phenoloxidase  Plasma  
Toll-like receptor (tToll) 110  ND Hemocyte  
L1 11  Unknown  L-granule  
L4 11  Unknown  L-granule  
LICI, Limulus intracellular coagulation inhibitor; GNB, Gram-negative bacteria; GPB, Gram-positive bacteria; LAF, 
Limulus 18-kDa agglutination-aggregation factor;  LPS, lipopolysaccharide; KDO, 2-keto-3-deoxyoctonic acid; PC, 
phosphorylcholine; PE, phosphorylethanolamine; SA, sialic acid;, LTA, lipoteichoic acid; ND, not determined.  Table 
was adapted from Iwanaga and Lee (2005).  
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Coagulation cascades  
The hemocyte of horseshoe crab is also called amebocyte, due to its capability to 
move towards a target and protrude its pseudopods toward it.  The hemocyte contains 
antimicrobial proteins in its large and small granules (Figure 1.3) (Murer et al., 1975).  
The large granules contain: (1) the coagulation factors, such as Factor C (Nakamura et al., 
1982), Factor G (Kawabata et al., 1996b), Factor B (Nakamura et al., 1986), proclotting 
enzyme (Muta et al., 1995) and coagulogen;  (2) the protease inhibitors, such as α2-
macroglobulin (Armstrong et al., 1993) and cystatin (Agarwala et al., 1996; Miura et al., 
1995); and (3) antimicrobial molecules such as Factor D, an azurocidin-like pseudo-
serine protease with antimicrobial activities (Kawabata et al., 1996b), and big defensin 
(Saito et al., 1991).  Small granules contain antimicrobial peptides, such as Tachycitin 
(Kawabata et al., 1996a) and big defensin.  Figure 1.3 illustrates the coagulation cascade 
triggered by Gram-negative bacteria (GNB).  Upon GNB infection, the amebocytes 
detect the lipopolysaccharides (LPS) on the out membrane of the bacteria via Factor C, 
the membrane-oriented LPS recognition receptor,  and initiates exocytosis to release the 
granular components to the vicinity of the invader (Ariki et al., 2004).  Binding to LPS 
promptly converts Factor C, the serine protease zymogen to its active form through self-
cleavage.  Then the activation of Factor C further triggers the whole serine protease 
cascade, which eventually results in the cleavage of soluble coagulogen into insoluble 
coagulin.  The resultant coagulin clot effectively entraps the invading microbes, thus 
preventing the intruders from further penetrating the host.   Immediately after coagulation, 
the pathogens which have been immobilized are killed by antimicrobial proteins and 
peptides from the small granules.  Due to the high sensitivity in detecting  
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LPS, the Limulus amebocyte lysate (LAL) was recognized by the FDA as the standard 
test for endotoxin contamination in pharmaceutical products (1977). Recently, the advent 
of new generation of endotoxin detection solution, using recombinant Factor C and 
synthetic fluorescence substrate greatly enhanced the sensitivity and specificity of the 
detection of LPS (Ding and Ho, 2001).   
The coagulation cascade plays an important role in host defense against GNB and 
fungi. However, this immune defense seems to be sacrificial of the host, since the host is 
deemed to “expend” some of its immune sensitive cells, which undergo degranulation to 
release the intracellular coagulation proteins.  Besides, it is unknown how Gram-positive 
bacteria, which lack LPS or (1→3) β-D-glucan, would be eliminated.   Therefore, there is 
a pertinent quest to examine whether an extracellular immune mechanism exists in the 
horseshoe crab, to spare the host cells while eliminating the invaders.   
Lectin/Complement pathways 
The complement system was first described as a biochemical cascade which helps 
clear pathogens from a vertebrate organism (Rosenberg, 1965).  It is composed of a 
number of small proteins found in the blood, which work together to kill target cells by 
disrupting the target cell's plasma membrane.  Deficiencies in the components of the 
complement system result in increased susceptibility to infections, indicating the 
importance of this system to host defense (Nusinow et al., 1985).  In the vertebrates, three 
complement activation pathways have been discovered: the classical, the lectin and the 
alternative pathways.  Each pathway is initiated by a different mechanism, but eventually 
converges at C3, towards a common downstream opsonization step or target cell lysis. 
Most recently, an opsonic complement system activated by lectin(s) has been identified 
                                                                                                                                      11           
in the invertebrates like the sea urchin (Smith et al., 2001) and the horseshoe crab (Zhu et 
al 2005), indicating the ancient origin of this powerful innate immune response.  Hitherto, 
little is known about how the complement pathway is activated in the invertebrates.  In 
horseshoe crab, evidence has shown that CRP, the LPS-recognition receptor, may play an 
important role in triggering this pathway (Ng et al., 2007; Zhu et al., 2005).  
Melanization: prophenoloxidase pathway 
Melanization, the formation of melanin, plays an important role in the innate 
immunity of invertebrates. Within minutes after infection, the microbial invader is 
encapsulated within an insoluble melanin capsule, and the generation of free radical 
byproducts during the melanin formation aid in killing the microbe.  Prophenoloxidase 
pathway in insect models has been well studied, and the cascade by which melanin is 
formed is illustrated in Figure 1.4.    
Upon infection, β-1,3-glucan, lipopolysacharide and peptidoglycan are recognized 
and bound by pattern-recognition receptors (PRRs) of the hosts, which then trigger a 
serine protease cascade leading to the activation of the prophenoloxidase-activating 
enzyme (ppA, or PPOA) from its pro-form.  The activated ppA which is also a serine 
protease then cleaves the prophenoloxidase into phenoloxidase.  The phenoloxidase 
enzyme then converts phenolic substrates, which in insects are diphenols derived from 
monophenols by hydroxylation,into quinones via oxygenation. Quinones are the 
intermediate compounds for melanin formation and are highly reactive and toxic to cells.  
The key enzyme in this pathway is the prophenoloxidase.  Tight regulation of this serine 
protease mediated pathway is carried out by the serine proteinase inhibitors (Serpins)  
(Cerenius and Söderhäll, 2004).           





Figure 1.4: The phenoloxidase pathway in invertebrates. Refer to the text for details.  
Modified from Cerenius and Söderhäll (2004).  
 
Quinones are highly redox active molecules which can create a variety of 
hazardous effects in vivo, including acute cytotoxicity, immunotoxicity, and 
carcinogenesis (Bolton et al., 2000).  As shown in Figure 1.5, through the redox cycle 
with their semi-quinone radicals, quinones lead to formation of reactive oxygen species 
(ROS), including superoxide (O2•-), hydrogen peroxide (H2O2), and ultimately the 
hydroxyl radical (•OH).  Production of these ROS can cause severe oxidative stress 
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within cells through the formation of oxidized cellular macromolecules, including lipids, 
proteins, and DNA. Lipid peroxidation, consumption of reducing equivalents, oxidation 
of DNA, and DNA strand breaks, together adversely affect the viability of cells.  Besides 
generating ROS that can oxidize macromolecules, quinones themselves can directly react 
with proteins, through amino and sulphydryl groups, His side chain, and perhaps Tyr side 
chain, to modify or cross-link proteins.  
 The excessive or untimely production of highly toxic compounds poses a threat 
to the host’s own safety.  Therefore, the activation of phenoloxidase must be tightly 
regulated.  Under physiological conditions, this process is controlled by specific protease 



















Figure 1.5: Alkylation and redox cycling of quinones generating adducts and ROS.  Through 
the redox cycle with their semiquinone radicals, quinones lead to formation of reactive oxygen 
species (ROS), including superoxide, hydrogen peroxide, and ultimately the hydroxyl radical.  
Adapted from Bolton and Trush et al. (2000). 
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1.1.4 Extracellular innate immune events 
Compared with the cell-mediated immune responses, extracellular immune events 
in the invertebrates remain poorly understood.  Although many innate immune-related 
proteins have been isolated from the extracellular milieu, their functions are relatively 
unknown.  It is commonly accepted that the invading pathogens are firstly recognized by 
pathogen recognition receptors (PRRs), and such recognition triggers an extracellular 
signaling system which subsequently summon the hemocytes in place (Medzhitov and 
Janeway, 2000).  This section summarizes the recent progresses in extracellular innate 
immune events.  
In Drosophila, PGRP-SA, the extracellular peptidoglycan recognition protein 
short form A, recognizes peptidoglycan (PGN), the common components from Gram-
positive and Gram-negative bacterial cell walls, and then triggers a signal transduction 
via a serine protease cascade.  At the end of the signaling cascade, cleavage of Späetzle, 
the extracellular protein, enables it to interact with Toll, the cell membrane receptor, thus 
transferring the signal into the immune cells for the synthesis of antimicrobial peptide  
(Michel et al., 2001).  The detailed composition of the protease cascade remains to be 
unraveled.   
Recently, using horseshoe crab as the experimental animal model, we have 
accumulated evidence on a complex pattern recognition system in the extracellular 
frontline innate immune defense in the invertebrates.  Parallel research in our lab have 
shown that the prominent plasma lectins, carcinolectin 5 (CL5) and C-reactive protein 
(CRP) display broad diversity, which enables the recognition and differentiation of wide 
spectrum of pathogens (Ng et al., 2004; Zhu et al., 2006).  The authors postulate that the 
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functional diversity of lectins in invertebrates appears to evolutionarily compensate for 
the lack of acquired immunity.  Most recently, Ng et al. (2007) found that 
lipopolysaccharide-affinity chromatography of the horseshoe crab hemolymph co-
purified CRP, galactose-binding protein (GBP) and carcinolectin-5 (CL5), revealing the 
existence of the pattern-recognition complex composed of various lectins.  It is believed 
that each lectin does not act alone but forms multiple protein complexes through which 
different populations of plasma lectins collaborate in frontline innate immune defense 
against disparate pathogens.  Serine proteases were found to play an important role in 
driving these PRR:PRR interaction and furthermore, stabilize the pattern-recognition 
complexes (Le Saux et al., 2008).  
Very interestingly, hemocyanin, the horseshoe crab respiratory protein was found 
to be involved in the dynamic pathogen recognition complex formed upon bacterial 
challenge (Li et al., 2008).   How hemocyanin is incorporated and what function it may 
play in this complex remains unknown.    
 
1.1.5 The serine protease cascade in the host: a common theme which promotes the 
innate immune response  
 
Many important immunological pathways have evolved to exploit a common 
organization of serine protease cascade.  These include the coagulation reaction in 
horseshoe crab blood (Iwanaga et al., 1992); fibrinogen clotting cascade in mammalian 
blood (Rosenmund et al., 1984); Späetzel-mediated Toll receptor activation in 
Drosophila (Michel et al 2001); and PPO pathway in insects (Cerenius and Soderhall 
2004).  An example is found with the coagulation reaction in the horseshoe crab (Figure 
1.6) (Ding and Ho, 2001).  The coagulation pathway in the horseshoe crab can be 
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triggered by lipopolysaccharide which causes the autocatalysis of Factor C zymogen into 
an active serine protease (Factor C’).  This then cleaves and activates the downstream 
serine protease Factor B which in turn does the same to the third serine protease, 
proclotting enzyme.  The active clotting enzyme then cleaves coagulogen into coagulin.  
The cross-linking of coagulin results in an insoluble clot.  Alternatively, formation of the 
clot can also be triggered by fungal toxin, (1-3)β-D-glucan, which acts via another serine 
protease zymogen, Factor G.  Activated Factor G then taps into the coagulation pathway 
via cleavage of proclotting enzyme.  Some of the significant advantages of the serine 
protease cascade organization are: (1) providing signal amplification to cause a powerful 
host response to the microbial invasion; (2) providing quick response to withhold the 
infection at the immediate vicinity; (3) to ensure tight regulation of the immune response 




Figure 1.6:  The coagulation cascade reaction in the horseshoe crab.  Refer to the text for 
details.  Adapted from Ding and Ho (2001). 
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Noted from the preceding sections, host proteases are commonly involved in the 
extracellular innate immune pathways.  In the next section, we will further examine the 
roles that microbial proteases play during host-pathogen interactions. 
 
1.1.6 Microbial extracellular proteases as virulence factors and potential immune 
response initiators 
 
Microbial proteases represent a major category of virulence factors of pathogenic 
microbes.  The Pseudomonas Elastase and Staphylococcal V8 protease are two of the best 
studied microbial proteases. In this section, we will first summarize the property and 
production of these two proteases, and then discuss the functional mechanisms of 
microbial proteases as virulence factors in pathogen-host interaction.   
P. aeruginosa produces a battery of extracellular proteases, two major ones of 
which are the elastolytic proteases, LasA (stapylolysin or LasA protease) and LasB 
(elastase) (Wretlind and Pavlovskis, 1983).  They are both extracellular zinc metallo-
endopeptidases and act synergistically to degrade their substrates, such as elastin and a 
variety of host immune defense proteins, including complement factors (Pollack, 1984), 
immunoglobulins (Heck et al., 1990), and antimicrobial peptides (Hoiby et al., 1990; 
Schmidtchen et al., 2002).   In vitro, the bacteria express elastase at the early exponential 
stage in a sub-aerobic culture condition (Nouwens et al., 2003).  In vivo, its expression is 
triggered by oxygen stress the bacterium encounters upon entry into the host (van Delden 
et al., 2001).    
The pathogenesis of S. aureus has been attributed to its potential to produce a 
diverse range of extracellular proteins, including hemolysins, toxic shock syndrome toxin  
and proteases (Shaw et al., 2004).  Four major types of extracellular proteases are 
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produced by S. aureus: a staphylococcal serine protease (SspA, also known as V8 
protease), a metalloprotease named aureolysin (Aur), a staphylococcal cysteine protease 
(Scp, also named staphopain) and a second cysteine protease (SspB) encoded within the 
same operon as SspA (Dubin, 2002).  All four proteases appear to be synthesized as 
preproenzymes, which are proteolytically cleaved to generate the mature enzymes.  In the 
case of the serine protease, the precursor form is enzymatically inactive and needs to be 
cleaved by aureolysin to become active (Oscarsson et al., 2006).  In vitro, the bacteria 
express V8 protease at the late exponential stage in a well-ventilated culture condition.  
In vivo, its expression is essential for the bacteria to disseminate from the infection loci. 
Microbial extracellular proteases play important roles in host-pathogen interaction. 
In vivo study demonstrated that strains of P. aeruginosa that produce less elastase have 
reduced virulence in animal models (Matsumoto, 2004).  In vitro, human colostral IgA 
and myeloma proteins of both IgA1 and IgA2 subclasses were susceptible to cleavage by 
Pseudomonas elastase (Heck et al., 1990).  This susceptibility of human IgA proteins to 
elastase suggests that P. aeruginosa might evade the potentially protective function of 
IgA by producing this enzyme. Besides, metalloprotease from P. aeruginosa degrades 
human RANTES, monocyte chemotactic protein-1 (MCP-1) and epithelial neutrophil-
activating protein-78 (ENA-78), and therefore alters the relative amounts of critical 
immunomodulatory cytokines in the infection site (Leidal et al., 2003). Furthermore, the 
neutral cysteine proteinase of Entamoeba histolytica degrades IgG and prevents its 
binding to antigens (Tran et al., 1998).  Proteases of the significant human pathogens 
such as Enterococcus faecalis, Proteus mirabilis and Streptococcus pyogenes, degrade 
the antibacterial peptide, LL-37 (Schmidtchen et al., 2002).  Taken together, by 
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extensively destroying the host immune responsive molecules, microbial proteases enable 
the pathogens to overcome the host immune defense.     
The host serine proteases have been examined in-depth regarding their roles in 
initiating and transducing the antimicrobial responses.  However, the probable roles of 
microbial proteases in triggering the host immune response have been long neglected.  
Compared to host serine proteases, the pathogen extracellular proteases normally harbor 
wider substrate spectrum (Prins et al., 1983) and are active by default at the site of 
pathogen invasion. Based on the understanding of the above-mentioned common 
organizational feature of immunological pathways (Section 1.1.5, Figure 1.6), this thesis 
hypothesizes that microbial extracellular proteases may function as potential immune 
response initiators.  In other words, microbial proteases could act on intermediate 
zymogen components without activating the initiator zymogen, thus activating the 
cascade directly.   Indeed, evidence supporting this hypothesis are accumulating recently.  
For example, P. aeruginosa elastase was found to stimulate the ERK signaling pathway 
and enhance IL-8 production by alveolar epithelial cell in culture (Azghani et al., 2002); 
the bacterium E. histolytica produces a neutral cysteine proteinase to cleave C3, and 
activate complement pathway directly (Reed et al., 1986).     
In this study, we will use the horseshoe crab PPO pathway as a model to examine 
whether or not microbial proteases can induce a direct and shortcut immune response in 
this ancient animal.  This work is further extended to test whether the hypothesis holds 
true for the human innate immune defense.  
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1.2  Respiratory proteins and their roles in innate immunity 
Hemoglobin (Hb) and hemocyanin (HMC) are oligomeric respiratory proteins 
found in the vertebrates and the invertebrates, respectively.  Under physiological 
conditions, both carry oxygen to the organs and tissues.  Recent research has revealed 
that these respiratory proteins also function in innate immunity.  For example, arthropod 
hemocyanin harbors prophenoloxidase activity (Cerenius and Soderhall, 2004; Nagai and 
Kawabata, 2000; Nagai et al., 2001); mammalian hemoglobin and chelicerate 
hemocyanin produce antimicrobial peptide (Destoumieux-Garzon et al., 2001; Lee et al., 
2003).  In this part, the structural characteristics of HMC and Hb as well as their function 
in innate immunity will be reviewed.  
1.2.1  Hemocyanin (HMC): the invertebrate respiratory protein 
HMC is the most abundant extracellular protein found in the plasma of both 
molluscs and arthropods (Mangum, 1985), mainly responsible for oxygen transport.   
Belonging to the hexamerin family, the arthropod HMC has a propensity to form 
multi-hexameric complexes with one, two, four, six or eight hexamers.  The HMC of 
Limulus polyphemus is the most complex, with eight hexamers (Martin et al., 2007).  
This complex quaternary structure is made up of seven immunologically distinct, 
although homologous subunit types, named I, II, IIIA, IIIB, IV, V and VI.  The molecular 
weight of each subunit is about 72 kDa and each is capable of binding one molecule of 
oxygen.  The oxygen binding complex of the holomolecule is co-operative and is further 
regulated by several allosteric effectors, of which protons, calcium and chloride ions are 
the most important.  Although the sequence identity of the seven subunits is very high, at 
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66 %, each subunit occupies a specific position in the 8 x 6 subunit complex (Figure 1. 7) 
(Martin et al., 2007).   
In the tertiary structure, each of the hemocyanin subunits folds into three domains: the N-
terminal α domain with seven to eight α−helices; the central copper-binding domain 
which is highly helical and where each copper is ligated by three histidine residues as 
well as the C-terminal  β domain with a seven-stranded β-barrel.  These domains are 
designated as in green, red and blue color respectively in Figure 1.8 a, the schematic 
domain structure of HMC (Hazes et al., 1993).  Functions of hemocyanin are highly 
related to this domain structure. As a respiratory protein, HMC carries oxygen by binding 
it to the two copper ions (as designated in orange color in Figure 1.8), which are chelated 
by six histidine residues from the central domain. The alpha domain harbors the binding 
sites for allosteric regulatory factors, while the C-terminal Ig-like domain is important for 
maintaining the hexamer structure (Hughes, 1999).  
 
Arthropod HMC accounts for over 90% of the total extracellular circulating 
proteins.  In contrast to hemoglobin, HMC uses a pair of copper ions for oxygen binding 
instead of ferrous ions (Figure 1.8) (Senozan, 1976).  In the absence of oxygen, these 
copper ions are in the copper (I) state, and are oxidized to copper (II) upon oxygenation.  
This accounts for the blue color of hemocyanin that develops upon oxygenation.  The 
sequences of the arthropod and molluscan HMC are very different.  The similarity 
between them is limited to the region which binds the second copper ion, Cu B in the 

























Figure 1.7: Views of the 3D reconstructed 8 x 6 mer of the limulus HMC. the eight subunit 
types as biochemically defined, and topologically localized, are indicated by different colours 
(red, type I; pink, type IIA; green, type II; yellow, type IIIA; blue, type IIIB; turquoise, type IV; 
white, type V; black, type VI). Note that the flop face of the upper 4 × 6mer is visible.  Adapted 
from Martin et al. (2007).  
 
 
Figure 1.8: The domain structure of a single HMC subunit and the view of the PO active 
site.  (A) shows the N-terminal α-domain (green), central copper binding domain (blue), and C-
terminal β-domain (red).  (B) shows the view of the oxygen binding active site of HMC. Shown 
are the two copper atoms (orange) binding one molecule oxygen (red) and the three pairs of 
histidines (grey) binding CuA and CuB. In addition, the orientation of the Phe49 (yellow) with an 
additional hydroxyl group is shown. Adapted from Decker and Rimke (2004).   
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Besides the well known function as a respiratory protein, recent studies have 
revealed that HMC may play an important role in innate immunity. The possible roles 
investigated hitherto are reviewed as follows.  
 
1.2.1.1 Hemocyanin as a pattern recognition receptor (PRR) 
Pattern recognition receptors (PRRs) are the host receptor proteins which can 
specifically recognize the pathogen associated molecular patterns (PAMPs) on invading 
microbes (Palaniyar et al., 2002). As biosensors, PRRs detect the microbe invasion and 
further transduce the signal to host effector molecules or cells which upon activation, will 
eventually eliminate the invading pathogen. Some well-studied PRRs include the Toll-
like receptors (TLRs) (Heine et al., 2005), the Galactose binding protein (GBP) and the 
C-reactive protein (CRP) (Ng et al, 2007; Zhu et al, 2006). 
The possible role of HMC as a PRR was first reported by Gilbride et al (1981).  In 
order to isolate lectins from horseshoe crab hemolymph, Gilbride et al chromatographed 
the horseshoe crab plasma through a Sepharose 4B column.  One of the eluted proteins 
had a high copper level under low pH condition, and was further identified as HMC.  
Based on this observation, Gilbride et al proposed that HMC may function as a lectin 
which could bind N-acetylglucosamine, a common chemical group on many PAMPs. 
Gilbride’s observation had long been ignored until after the crystal structure of HMC was 
resolved (Hazes et al., 1993). Based on the analysis of the crystal structure of HMC, 
Decker proposed that the hydrophilic and the hydrophobic pockets on the alpha domain 
of each HMC subunit form the binding sites for hydrophilic and hydrophobic ligand 
molecules, respectively. He also proposed that some amino acid residues in the alpha 
domain might orientate in such a way that they could bind N-acetylglucosamine.  
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Experimental evidence supporting Decker’s hypothesis was presented in 1999, when 
Jaenicke reported that spider HMC binds Ecdysone and 20-OH-Ecdysone with a 
relatively low affinity (Jaenicke et al., 1999). The hormone binding site was hence 
localized to an evolutionarily conserved hydrophobic pocket in the alpha domain. Most 
recently, parallel research in our lab revealed a pathogen-recognition receptor complex 
which involves HMC, re-awakening the theme of HMC as a PRR (Ng et al., 2007 and Li 
et al. 2008). Although structural analysis and some experimental evidence have suggested 
that HMC may function as a PRR, the direct interaction between HMC and PAMP 
molecules has not been examined; moreover, the significance of such interaction to 
innate immunity, if any, remains unknown.   
 
1.2.1.2  HMC as the prophenoloxidase (PPO) in the chelicerate 
The PPO pathway, as summarized in Figure 1.4 (Section 1.1.3), is important to 
prevent microbial invasion and to promote wound healing.  The controlling factor of the 
pathway is the enzyme PPO.  Both belonging to the hexamerin family, PPO and HMC 
from the arthropod share 30% amino acid sequence identity and have a similar domain 
structure (Hughes, 1999). Most of our knowledge on the PPO system comes from studies 
on insect models. Up till now 20 different PPOs have been isolated from different insects 
(Cerenius and Soderhall, 2004). Compared to the well-studied insect PPO system, the 
chelicerate PPO system remains elusive. Whether or not a PPO system exists in this 
ancient group of invertebrates remained an issue of doubt until 1996, when Nellaiappan 
first demonstrated that cationic detergents could bring about PO activity from the 
hemolymph of the horseshoe crab, Limulus polyphemus (Nellaiappan and Sugumaran, 
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1996). Later, Decker et al induced a PO activity with SDS from the HMC of Limulus 
polyphemus, Eurypelma californicum and Cancer magister (Decker et al., 2001).  This 
work shed the first light on the function of HMC as a PPO in chelicerates, the ancient 
invertebrates. Recently, Nagai et al. (2000, 2001) reported that molecules from the 
horseshoe crab hemocyte, such as Factor B, proclotting enzyme and antimicrobial peptide 
tachyplesin, could convert HMC to PO (Figure 1.9).  Taken together, these studies reveal 
that HMC is the functional substitute of PPO in chelicerae, solving the long term puzzle 
of the PPO identity in chelicerae.  These results also suggest HMC/PPO activation as a 
non-self recognition mechanism since HMC is converted to PO at the site of injury 
(Nagai et al. 2001). 
 
Figure 1.9: The link between the horseshoe crab clotting and prophenoloxidase-activating 
systems and a comparison between the insect and crustacean prophenoloxidase-activating 
systems.  Components of PPO system are framed.  Adapted from Nagai et al. (2000). 
 
Although researchers have identified HMC as the PPO in chelicerates, they failed 
to fully address the mechanism underlying how HMC is activated to PO under patho-
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physiological conditions.  Structural studies suggested that the PO active site may be 
blocked by Phe-49 from the α-domain of the same subunit (Figure 1.8) and thus binding 
of the phenolic substrates is inhibited (Decker and Rimke, 1998). It is known that 
proteolysis is essential for the insect PPO to be activated by PPOA, the PPO activating 
enzyme (Cerenius and Soderhall, 2004).  However, Nagai et al. (2001, 2002) did not 
detect any proteolytic fragments when they used the host proteases from the coagulation 
cascade to trigger PO activation.  Based on this observation, they proposed that horseshoe 
crab hemocyanin is activated through conformational change instead of proteolysis.  
They suggested that the specific binding of the activating factors, such as the clotting 
enzyme, Factor B or tachyplesin can induce a conformational change and therefore 
partially unfold the protein to shift the Phe-49 residue from the active site, thus opening 
an entrance for the phenolic substrates.  For the first time, Nagai et al identified the native 
activation factors of PPO in the chelicerate.  However, they only examined the host 
proteases, whereas the proteases from the pathogenic microbes were ignored.  
Furthermore, in their model, for the intracellular host protease to activate the extracellular 
HMC/PPO, the hemocyte degranulation is prerequisite.  It remains unknown whether or 
not hemocyanin, the chelicerate PPO, can be activated to PO by microbial proteases in 
the extracellular milieu upon microbial challenge.   
 
1.2.1.3  HMC as a precursor of antimicrobial peptide                  
Besides PPO activity, HMC also releases fragments that exhibit direct 
antimicrobial activity.  Recent studies have shown that peptides with antibacterial 
activities (Lee et al., 2003) were released from the C-terminus of crayfish HMCs, 








seemingly by cysteine protease.  Similarly, antifungal peptide correspondent to the C-
terminus of HMC were found in shrimp (Destoumieux-Garzon et al., 2001).  Interestingly, 
the levels of these peptides were regulated by the injection of LPS or β-glucan (Lee et al., 
2003). At this juncture, the production and functional mechanism of these antimicrobial 
peptides remains a mystery.   
The proposed functions of HMC in innate immunity are summarized in Figure 
1.10.   As the most abundant protein in circulation, HMC is arranged at the immediate 
frontline of the pathogenic microbe invasion.  However, compared to the intensive 
studies on other innate immune response molecules, investigation on HMC has been 
overlooked. Therefore, the possible role of HMC in the innate immune response, 
regarding (a) the direct evidence on HMC-PAMP interaction and (b) the actual activation 
pathway of HMC/PPO to PO during infection would be systematically examined in this 
study.  This information should provide a better understanding of the invertebrate innate 
immune mechanism, which will have functional implications on the vertebrate system.   










Figure 1.10: Summary of the roles of HMC under physiological condition and in host innate 
immune defense.   Adapted from Qiu Shijia, NUS BSc. Honor’s thesis (2006).   
Pathophysiological Role 
Physiological Role 
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1.2.2  Hemoglobin : the vertebrate respiratory protein  in the red blood cell 
Adult human hemoglobin (Hb) is made up typically of two α-chains and two β-
chains, with one prosthetic heme group embedded in a hydrophobic pocket formed by 
each chain (Figure 1.11).  Hb tetramer forms as a weak complex of two α-β dimers, each 
containing an α-subunit bound strongly to a β-subunit.  The heme group reversibly binds 





Figure 1.11:  The schematic structure of adult human hemoglobin.  Adapted from the website 
www.chem.purdue.edu/courses/chm333/hemoglobin.JPG.   
 
Unlike the invertebrate HMC which circulates as an extracellular protein, the 
vertebrate Hb is enclosed in the red blood cell (RBC) under physiological condition.  
Upon carrying oxygen, spontaneous oxidation of the ferrous heme iron (FeII) of 
hemoglobin to ferric iron (FeIII) produces superoxide radicals (O2 ˙ ) and hydrogen 
peroxide (H2O2), which exert oxidative stress to the host.  To catalyze the breakdown of 
the superoxide radicals and hydrogen peroxide thus formed, the RBC provides an 
abundance of antioxidant enzymes (catalase and superoxide dismutase).  These 
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antioxidant enzymes also catalyze the reduction of ferric iron (FeIII) back to the ferrous 
state, the only form that reversibly binds oxygen.  Therefore, the enclosure of Hb in RBC 
is important for Hb’s physiological function as well as the host homeostasis.  However, 
despite the existence of these protective mechanisms, approximately 1-3% of the 
hemoglobin within an RBC is oxidized at any given time (Bunn, 1995).  
 
1.2.2.1 Production of cytotoxic ROS by pseudoperoxidase cycle of metHb         
Recent studies on the hemoglobin-based blood substitutes has revealed that cell-
free Hb molecule has intrinsic toxicity to the host tissue since harmful reactive oxygen 
species (ROS) are readily produced during the auto-oxidation of Hb from ferrous state to 
the ferric state (Motterlini et al., 1995).  The ROS production is depicted as Figure 1.12.  
As hemoglobin (HbFeII) reversibly binds oxygen (koff/kon), it auto-oxidizes at a slow rate 
(kox) to ferric/metHb (HeFeIII), and superoxide ions (O2 ˙ ) are produced.  Superoxide will, 
by dismutation (kd), produce hydrogen peroxide (H2O2).  In the presence of this and/or 
exogenous H2O2, a catalytic cycle between the ferric (Hb FeIII) and the ferryl (Hb FeIV) 
hemes is initiated, in which H2O2 is eliminated in a peroxidase-like manner, and 
superoxide anion is generated (Giulivi and Davies, 1990; Giulivi et al., 1994).   
 
 
Figure 1.12: Correlation between 
oxygen affinity, auto-oxidation and 
oxidative modification reaction 
pathways of hemoglobin.  Refer to 
the text for details.  Adapted from 
Alayash (1999).  
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Superoxide anion occupies a critical position in the cycling of oxygen-dependent 
microbicidal agents in vivo.  This is because although superoxide is not itself considered 
to be cytotoxic (Fee, 1981), it is a direct precursor of the toxic derivatives it spawns, such 
as hydroxyl radical (HO·) and hypohalous acid (HOCl).  In addition, when iron 
concentrations are limiting, O2 ˙  is a vital reducing agent that regenerates Fe2+, thus 
facilitating the iron-catalyzed Haber-Weiss reaction, or the so-called superoxide driven 
Fenton reaction that produces HO· (Eqs. 1 and 2).  Therefore, processes that facilitate the 
generation of O2 ˙  will ultimately perpetuate and potentiate oxygen-dependent 
microbicidal action (Wentworth et al., 2000) .  
Fe 3+  + O2•-     Fe2+ +  O2                          [1] 
Fe2+  +  H2O2   Fe3+ +  -OH + HO•            [2] 
 
1.2.2.2 metHb is released from the RBC under infection condition 
Unlike the extracellular HMC counterpart, under physiological condition, 
vertebrate hemoglobin is sequestered inside the erythrocytes, probably to prevent host 
self-destruction from metHb-mediated ROS production. However, many bacterial 
pathogens, such as Escherichia coli (Cavalieri et al., 1984), Vibrio parahaemolyticus 
(Nishibuchi and Kaper, 1995), and Staphylococcus aureus (Menestrina et al., 2001) 
produce cytolytic toxins, the virulence factors capable of hemolysing erythrocytes to 
attack the host.  Figure 1.13 illustrates how S. aureus steals the heme by lysing RBC  to 
obtain iron needed for growth in mammalian hosts (Rouault, 2004).    
Considering the cytotoxic ROS production by the cell free hemoglobin, it is 
conceivable that while the microbial intruder seemingly usurp the RBC for the heme ion, 
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the host Hb countermeasures by producing ROS to kill the intruders.  Hitherto, whether 






Figure 1.13: A model to show how the S. aureus steals the heme by lysing RBC. S. aureus 
obtains most of the iron (Fe) needed for growth in mammalian hosts from the heme. To this end, 
S. aureus produces hemolysins that lyse RBC to release Hb containing heme. The heme is then 
catabolized by the heme oxygenase-like enzymes, with the release of iron which is used to fuel 
further bacterial growth. Adapted from Rouault et al. (2004).   
 
 
1.2.2.3  Hb as a precursor of antimicrobial peptides 
Besides producing ROS, a growing number of reports support a role of cell-free 
Hb as a precursor of peptides able to kill microorganisms.  Craig et al. (1976) found that 
the intact human hemoglobin tetramer, as well as the  α- and β- subunits exhibit 
considerable activity against gram-positive, and gram-negative bacteria and fungi (Craig 
and Kunin, 1976). Parish et al. (2001) further demonstrated that the carboxyl terminal 
thirty amino acids of the β subunit, which form a cationic α-helix based on the crystal 
structure of the intact tetramer, were active against E. coli, S. aureus and C. albicans.  
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(Mak et al., 2000) found that the approximately 50 amino acid long fragments, which 
were derived from enzymatically or chemically digested hemoglobin, were able to kill a 
variety of microorganisms at the half maximal lethal doses in the micromolar range.  
However, further fragmentation (e.g. by trypsin) to shorter peptides results in nearly 
complete abrogation of its antimicrobial properties.    
The term hemocidins was therefore proposed to name the bactericidal peptides 
derived from heme-containing proteins.  The evidence for the role of hemocidins in the 
innate defense against infection accumulated in many organisms. Interestingly, 
bactericidal fragments of bovine and rabbit hemoglobin were found in the gut of a tick, 
which might indicate that the parasite uses the host hemoglobin as a protective 
antimicrobial agent (Fogaca et al., 1999).  Most recently, (Mak et al., 2007) identified 
that menstrual hemocidin HbB115-146 is an acidophilic antibacterial peptide potentiating 
the activity of human defensins, cathelicidin and lysozyme. They proposed that 
hemocidins may act in a carpet-like manner characteristic for other α-helical antibacterial 
peptides (Oren and Shai, 1998).  Following electrostatically driven initial interaction with 
the membrane, the peptides form carpet-like cluster or plaques on the phospholipid 
bilayer, causing destabilization of the membrane and, finally, its disruption.  However, 
the exact mechanism underlying how hemocidins function in antimicrobial events 
remains elusive.   
 
1.2.2.4 Hb as a pathogen recognition receptor (PRR) 
Hb:LPS interaction has been examined by several studies.  Kaca et al. (1994)  
showed that native forms of Hb form stable complexes with LPS at a high affinity 
Jurgens et al. (2001) reported that the stoichiometry of Hb:LPS interaction is between 1:3 
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and 1:5,  using isothermal titration calorimetry.  Regarding the functional consequences, 
The LPS-induced TNF-α production of mononuclear cells is enhanced by Hb, whereas in 
the LAL assay an LPS concentration-dependent increase or decrease was observed 
(Jurgens et al., 2001). Howe et al. (2007) observed that the type and size of 
supramolecular aggregates of LPS change in the presence of Hb, thus allowing a better 
understanding of the change in bioactivity of LPS.  However, the functional significance 
of Hb-LPS interaction to host innate immunity remains poorly understood. 
 
1.3  The objectives and significance of this thesis 
Respiratory proteins exist in virtually all multi-cellular organisms.  Recent 
research has shown that hidden beneath the normally well-known and important function 
of oxygen carriage, the respiratory proteins harbor a cryptic function at the frontline of 
antimicrobial defense. Particularly, a close examination of ROS-production by the 
respiratory proteins showed that: (i) arthropod hemocyanin harbors prophenoloxidase 
activity to produce highly cytotoxic quinone; (ii) human hemoglobin, upon auto-
oxidation, gains pseudoperoxidase activity to release cytotoxic ROS via superoxide ions 
and (iii) virulent strains of S. aureus use hemolysin to rupture RBC and release 
hemoglobin in the microbe’s quest for iron.  These observations led us to hypothesize 
that hemocyanin and hemoglobin may perform a crucial fundamental role in immune 
defense through ROS-production.  
The aims of this study are to reveal the cryptic roles of respiratory proteins in 
innate immunity, mainly as ROS producers.  To achieve this, the following questions will 
be addressed:  
1. How is the ROS production activated upon microbial invasion?  
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2. How is the ROS production localized to the vicinity of the invading microbe?  
3. What is the functional significance of such respiratory protein mediated ROS 
production?  Does it elicit bactericidal activity?   
4. If the answer to question 3 is yes, then in humans, does a similar ROS-
mediated antimicrobial response of the respiratory protein exist, probably due 
to convergent evolution?  
Hitherto, the immune response is believed to require a series of modulated 
processes, involving the recognition of pathogen-associated molecular patterns (PAMPs) 
followed by signaling cascades and eventually, the antimicrobial effect.  However, recent 
research has provided clues that the innate immune system may contain a direct form of 
microbicidal action, such as the ROS producing antibodies (Wentworth et al., 2000).  We 
also intended to understand whether the ROS production by respiratory protein can be 
activated by microbial virulence factors directly, thus forming an immediate immune 
response at the front line of the antimicrobial defense.  In other words, we seek to 
examine the possibility of the microbial virulent protease as the microbes’ “Achilles 
heel” in their battle against the host, viz, the microbes apparent tool for victory ends up as 
its weak point for attack by the host.  
 
Theoretically, our findings will provoke the re-examination of the role of the 
well-examined respiratory proteins in innate immune responses.  Practically, the new 
physiological significance of the respiratory proteins should be important to clinicians 
and drug developers in view of the recent intensive developments on hemoglobin as a 
source of endogenous bioactive peptides, and as a blood substitute for the treatment of 
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CHAPTER 2:  MATERIALS AND METHODS  
 
2.1  Materials 
Unless otherwise stated, all materials were of molecular biology grade and 
handled under pyrogen-free conditions.  
 
2.1.1 Animals  
Adult horseshoe crabs, Carcinoscorpius rotundicauda, were collected from the 
Kranji estuary of Singapore and handled according to institutional guidelines of the 
“National Advisory Committee for Laboratory Animal Research” (NACLAR), Singapore. 
Before treatment, horseshoe crabs were washed to remove mud and kept in tanks to 
acclimatize with a minimal level of 30% (v/v) sea water/fresh water.  For experiments in 
which plasma from only one time point of infection (e.g. the 6 h post-infection) was 
studied against the naïve plasma, infection was performed on horseshoe crabs of the same 
gender so as to minimize gender-bias that may cause variations in the bacterial clearance. 
For establishing the cDNA libraries, the male animal was preferred due to our earlier 
observations of the prevalence of yolk precursor protein (vitellogenin) expression from 
female individuals (Wang J., personal communications). 
 
2.1.2 Bacteria 
To determine the specificity of the microbial proteases in driving the activation of 
PPO, the wild type strain of P. aeruginosa (PAO-Iglewski), which produces extracellular 
Pseudomonas aeruginosa elastase (PAE), and the mutant strain PAO-B1A1 (mutations at 
the LasA and LasB), which is PAE-deficient (Toder et al., 1994) were used. A Gram-
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positive bacterium, S. aureus, which lacks LPS, was used to preclude any LPS-mediated 
hemocyte degranulation and the consequential contribution of intracellular components to 
PPO activation. Thus, S. aureus strain PC1839 (a SarA mutant of wild-type 8325-4), 
which produces active V8 protease and strain AK3 (an Aur mutant of PC1839), which is 
active V8 protease-deficient (Karlsson et al., 2001), were used to confirm the specificity 
of bacterial protease on HMC/PPO activation and to examine the specific contribution of 
the extracellular PPO activation in in vivo antibacterial action.  Six naturally occurring 
Gram-positive bacterial species: Bacillus pumilus, B. aquimaris, B. subtilis, B. 
chandigarhensis, Enterococcus faecium and E. faecalis, which were isolated from the 
horseshoe crab habitat, as well as S. aureus ATCC49775, were also used in the in vivo 
antimicrobial test using horseshoe crab. The isolation of naturally occurring Gram-
positive bacteria as well as the labeling of the bacteria with GFP will be described in 
section 2.8.                    
 
2.1.3 Chemical reagents 
PAMPs and phosphatidyl lipids 
LPS of Pseudomonas aeruginosa, LPS of Escherichia coli 055:B5, both of gel-filtration 
chromatography grade; and LTA of Staphylococcus aureus and laminarin of Laminaria 
digitata were from Sigma.  Synthetic phosphatidyl lipids, POPC (1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine) and POPE (1-palmitoyl-2-oleoyl- phosphatidyl-
ethanolamine) were from Avanti Polar Lipids, Inc. (Alabaster, Alabama, USA). 
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Proteases 
Pseudomonas Elastase (PAE) of P. aeruginosa was from Elastin Product 
Company (Owensville, MO, USA).  Proteinase K of Tritirachium album, type XIV 
protease of Streptomyces griseus, subtilisin A of Bacillus licheniformis, trypsin of bovine 
pancreas, and collagenase of Clostridium histolyticum were from Sigma-Aldrich (St 
Louis, MO, USA).  Factor C was recombinantly expressed (Ding and Ho, 2001) and 
further activated by LPS. 
 
Other chemicals 
Azocoll reagent, 1,10-Phenanthroline monohydrate, reduced glutathione (GSH), 
phenylthiourea (PTU), PMSF, and 4-methylcatechol (4ME) were of the highest grade 
from Sigma.  HiTrap H-hyroxylsucinimide- (NHS) activated Sepharose High 
Performance columns, glutathione SepharoseTM 4B, CNBr-activated Sepharose® 4 Fast 
Flow slurry, Protein-A Sepharose 4 Fast Flow slurry, Superdex S200 gel filtration matrix, 
and Hybond-N+ nylon membrane were products of GE Healthcare.  Deoxynucleotide 
triphosphates (dNTPs) were from Promega.  X-α-gal was from BD Biosciences Clontech.  
Isopropyl-1-thio-β-D-galactopyranoside (IPTG) was from Invitrogen.  Sequencing grade-
modified trypsin (Porcine) was from Promega.  All restriction enzymes were from New 
England Biolabs or Fermentas.  The horseradish peroxidase substrate ABTS (2,2'-azino-
bis[3-ethylbenzthiazoline-6-sulfonic acid) was from Roche.  Sodium metaperiodate was 
from Merck.  Phenylmethylsufonylfluoride (PMSF), bovine serum albumin fraction V 
were from Sigma.  Anti-limulus hemocyanin goat antibody was from Abcam.  
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Immobilized pH gradient (IPG) strips for 2-dimensional electrophoresis were from Bio-
Rad. Common chemicals were from Sigma or Merck.  
 
2.1.4 Medium and agar  
 Luria Bertani (LB) broth was prepared with 1 % (w/v) Tryptone (Difco), 0.5 % 
(w/v) Yeast extract (Difco) and 0.5 % sodium chloride at pH 7.0.  For LB agar, 1.5 % 
(w/v) agar (Difco) was added.   
Tryptone soy broth (TSB) was a premixed formula of 1.7 % (w/v) pancreatic 
digest of casein, 0.3 % (w/v) papaic digest of soybean meal, 0.5 % (w/v) sodium chloride, 
0.25 % (w/v) di-potassium hydrogen phosphate and 0.25 % (w/v) glucose from Oxoid 
and was made by reconstituting the formula to 3 % (w/v) with deionised water.  For TSA 
(tryptic soy agar), 1.5 % (w/v) agar (Difco) was added. 
Marine broth from Oxoid was used to isolate naturally-occurring bacterial species 
from the estuarine water and mud collected from horseshoe crab habitat. 
SD medium was made with 0.67 % (w/v) Yeast nitrogen base without amino acid 
(Difco), 2 % (w/v) glucose and appropriate amino acid supplements, at pH 5.8.  
Depending on the nutritional selection that was used, one of the following supplements 
was added to the SD medium: 0.074 % (w/v) Trp Drop Out (DO) supplement, 0.069 % 
(w/v) Leu DO supplement, 0.064 % (w/v) Trp/Leu DO supplement, or 0.06 % (w/v) 
Trp/Leu/His/Ade DO supplement.  For medium whereby adenine was not the drop out 
supplement, an additional 0.003 % (w/v) adenine hemisulfate was also included.  For SD 
agar, 2 % (w/v) agar was added. 
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YPD medium was made with 2 % (w/v) peptone, 1 % (w/v) Yeast extract, 2 % 
(w/v) glucose at pH 6.5.  YPDA consist of the same nutrients as above but with 0.003 % 
(w/v) adenine hemisulfate.  For YPD and YPDA agar, 2 % (w/v) agar was added. 
 1806 broth was prepared according to the formula from ATCC website 
http://www.atcc.org/common/documents/mediapdfs/1806.pdf.  One liter of the medium 
contained yeast extract 30 g, casamino acid 20 g, Na2PO4 2.48 g, KH2PO4 0.41 g, 
MgSO4/7H2O 20 mg, MnSO4/H2O 7.5 mg, FeSO4/7H2O 6.4 mg, and citric acid 6.4 mg 
with 900 ml of distilled water, adjusted for final pH 7.3.  The medium was autoclaved at 
121 °C for 15 min, cooled to room temperature and aseptically supplemented with filter-
sterilized solution of sodium pyruvate 23.2 g in 100 ml distilled water.    
For the use of antibiotics, ampicillin was added at 100 µg/ml medium or agar, and 
kanamycin was added at 50 µg/ml medium or agar, unless otherwise stated.  For 
IPTG/X-gal plates, 0.05 % (w/v) IPTG and 0.04 % (w/v) X-gal were added.  For X-α-gal 
plates, 100 µl of a 2 µg/ml stock was spread per plate.  The X-α-gal stock was made by 
dissolving the powder in dimethylformamide.  Tetracycline was added at 100µg/ml, 
chloramphenicol was added at 10  µg/ml.  Kanamycin (50 µg/ml) was used to maintain S. 
aureus PC1839 strain and erythromycin (10 µg/ml) was used to culture S. aureus AK3 
strain.  
 
2.2  Purification of hemocyanin from horseshoe crab plasma 
2.2.1  Collection of cell-free hemolymph or plasma from the horseshoe crab  
The horseshoe crab has an open circulating system.  As shown in Figure 2.1, 
heart is the tubular vesicle along the dorsal side.  For work using cell free-hemolymph 
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(also called plasma), samples from naïve or infected horseshoe crabs were collected into 
pyrogen-free tube via a cardiac puncture.  To prevent contamination of the hemolymph, 
the site of puncture was cleaned off algae and dirt using detergent and water and then 
swabbed with 70 % ethanol.  The hemolymph was clarified from amebocytes by 
centrifugation at 150 x g for 15 min at 4 °C.  At this stage, to examine whether the animal 
was clear of microbial infection or not, a portion of 100 µl of the amebocytes-free 
hemolymph was applied on TSA agar or marine yeast agar and further incubated at 37 °C 
or 30 °C overnight.  Further clarification of amebocyte debris was achieved by 
centrifugation at 9000 x g for 10 min at 4°C. To distinguish whole hemolymph which 
contains hemocytes from cell-free-hemolymph, the latter will henceforth be referred to as 
plasma.  After preparation of the plasma, it was aliquoted into smaller volumes and 
quick-frozen in liquid nitrogen and stored at -80 °C until further use. Only plasma from 
individuals that showed sterile blood before treatment and no secondary infection from 
contaminating pathogen, following the injection were used for further experiments.   
Figure. 2.1:  Anatomy of the horseshoe crab. The hepatopancreas is the soft tissue that exist 
as ramifications arounds the intestinal tract of the horseshoe crab (left panel).  The intestinal 
tract is ventral to the heart, which is also tubular in structure (right panel).  Figure was taken and 
modified from http://www.lander.edu/rsfox/310limulusLab.html which had been adapted from 
(Owen, 1873).  
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The following sections describe the purification of hemocyanin hexamer from 
horseshoe crab plasma via gel-exclusion chromatography.  The hemocyanin subunits 
were further purified by ion-exchange chromatography. The purity of the protein was 
analyzed with SDS-PAGE.  
 
2.2.2 Purification of hemocyanin holo-molecule by gel filtration chromatography  
The cell-free hemolymph was collected under pyrogen-free condition from the 
horseshoe crab as described in Section 2.2.1.  Then the hemocyanin was purified from the 
plasma as described with modification (Decker et al., 2001).  Briefly, the plasma was first 
diluted 1:2 (v/v) with 0.2 M Tris/HCl, pH 8.0, 10 mM CaCl2, 10 mM MgCl2 to stabilize 
the protein.  Then it was purified by gel filtration through a Superdex S200 column (2.0 x 
150 cm) using 0.1 M Tris/HCl, pH 8.0, containing 5 mM CaCl2 and 5 mM MgCl2 as the 
equilibrium/elution buffer (4 °C, at the flow rate of 9 ml/h).  The peaks were collected for 
further analysis by SDS-PAGE. 
 
2.2.3  Purification of HMC subunits by ion-exchange chromatography  
The holo-HMC purified from the gel filtration was stripped, i.e. transformed to 
single subunit, by dialysis against 0.05 M Tris/HCl, pH 8.9, 10 mM EDTA (so called 
stripping buffer) at 4 °C overnight. Then the stripped hemocyanin was purified to 
individual subunits as described (Brenowitz and Moore, 1982).  Briefly, the DEAE-
Sepharose was packed in 1.6 x 10 cm column, and equilibrated with the stripping buffer. 
Then the stripped hemocyanin was applied to the column, and eluted with a NaCl 
                                                                                                                                      42           
gradient of 0.17-0.4 M in the stripping buffer).  The flow rate was 4 ml/min.  The peaks 
were collected for further analysis by SDS-PAGE and mass spectrometry.      
 
2.2.4  Analysis of purified HMC  
Protein fractions collected from the chromatography was analyzed on SDS-PAGE.  
Proteins of interest were then excised from the gel to be identified by mass spectrometry.  
The techniques used for these analyses are described below.   
 
2.2.4.1 SDS-PAGE  
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out to resolve the purified proteins according to their molecular weights.  Vertical 
mini-slab gel containing 12 % separating gel [12 % 29:1 Acrylamide:Bisacrylamide, 375 
mM Tris-HCl pH 8.8, 0.1 % (w/v) SDS, 0.1 % (w/v) APS, 0.08 (v/v) TEMED] and 5 % 
stacking gel [5% (w/v) of 29:1 acrylamide:bisacrylamide mix, 125 mM Tris-HCl pH 6.8, 
0.1 % (w/v) SDS, 0.1 % (w/v) APS, 0.125 % (v/v) TEMED) were routinely cast using 
the Mini-protean II system (BioRad).  Protein samples were reduced with SDS-PAGE 
sample loading buffer (50 mM Tris-HCl, pH 6.8, 2 % SDS, 10 % glycerol, 3 % β-
mercaptoethanol and trace amount of bromophenol blue) with 3 min water bath boiling 
before loading into the gel.  Electrophoresis was performed at room temperature in Tris-
glycine buffer (25 mM Tris, pH 8.3, 250 mM glycine, and 0.1 % SDS) at a constant 
current of 25 mA per gel.  
After electrophoresis, the gel was fixed and stained in Coomassie Blue staining 
solution (0.25 % Coomassie Brilliant Blue R-250, 40 % methanol, 10 % acetic acid) for 
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30 min.  Background staining was then removed by rinsing the gel in destaining solution 
[50 % (v/v) methanol, 5 % (v/v) acetic acid]. 
 
2.2.4.2 Mass spectrometry 
In-gel digestion of proteins and mass spectrometric analysis 
Protein bands of interest were excised from SDS-PAGE.  Care was taken to 
prevent keratin contamination by wearing a face mask.  The gel pieces were carefully 
rinsed with milliQ water after transferring it from the cutting plate to the Eppendorf tube.  
The gel pieces were further cut into small cubes of around 2 mm dimensions to facilitate 
permeation of solutions during the in-gel treatment.  Coomassie stain was removed from 
the gel pieces by a two-step process of rinsing in 50 mM ammonium bicarbonate/ 50 % 
(v/v) acetonitrile and dehydrating it with acetonitrile.  The two-step of “rinse and dry” 
treatment was repeated until the gel appears white and opaque.  The gel was then dried in 
a speed-vacuum to completely remove the acetonitrile before subjecting the in-gel protein 
to disulfide-reduction using 10 mM dithiothreitol in 100 mM ammonium bicarbonate at    
57°C for 1 h followed by S-alkylation with 55 mM iodoacetamide in 100 mM ammonium 
bicarbonate at room temperature for 1 h.  The gel was then rinsed three times in 100 mM 
ammonium bicarbonate, dehydrated with 2 rounds of acetonitrile treatment and then re-
rinsed once in 100 mM ammonium bicarbonate and dehydrated again with 2 rounds of 
acetonitrile treatment.  The gel pieces were centrifuged at 5,000 x g for 2 min and the 
acetonitrile was discarded.  Any remaining traces of acetonitrile were removed by 
applying speed-vacuum, before in-gel digestion was carried out with 12.5 ng/ml trypsin 
in 50 mM ammonium bicarbonate at 37 °C for 12 h.     
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After overnight in-gel digestion, the protein fragments were extracted from the gel 
with 20 mM ammonium bicarbonate, followed by 5 % formic acid in 50 % aqueous 
acetonitrile and with 100 % acetonitrile. The extracts were pooled and the solvent was 
allowed to vaporize in a speed-vacuum before mass spectrometric analysis.   
 
MALDI-TOF mass spectrometry 
Matrix-assisted laser desorption ionization-Time of flight (MALDI-TOF) analysis 
was performed at the Protein and Proteomics centre (Department of Biological Sciences, 
National University of Singapore) using Voyager-DE™ STR Biospectrometry™ 
Workstation (PerSpetive Biosystems) to obtain the peptide mass fingerprint.  The peptide 
mass fingerprint used to search for a protein match in the database using the Mascot 
website: http://www.matrixscience.com.  A match occurs if the protein has a significant 
number of peptide fragments with the same molecular weight after an in silico chemical 
modification (reduction and alkylation, in our case) and enzyme treatment (trypsin).  The 
probability that the match is random or significant is subsequently determined using the 
molecular weight search score (Mowse score) (Pappin et al., 1993).  
2.3 Cloning of HMC full-length cDNAs 
 
2.3.1  Amplification of HMC cDNA from the amebocyte and the hematopancreas 
cDNA libraries   
To investigate the function of HMC using molecular biology method, it was 
necessary to obtain the C. rotundicauda HMC cDNA sequences of all the different 
subunits.  To this end, total RNA was prepared from C. rotundicauda amebocyte and 
hepatopancreas, and then Oligo(dT)-primed cDNA libraries were established in phage 
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λgt10 (Ng, et al., unpublished data). Two degenerate oligonucleotides were designed 
according to the highly conserved amino acid sequences of CuA (HHWHWH)- and CuB 
(HNWGHV)-binding sites of known hemocyanin sequences.  Platinum® Taq DNA 
polymerase with lower misreading rate and higher amplification efficiency was used in 
place of Taq DNA polymerase Klenow.  The PCR product were cloned into the vector 
pGEMT-easy (Promega, WI, USA) and sequenced.  
 
2.3.2  5’- and 3’-RACE for the full length cDNA of each individual subunit  
Extensions to the 5’- and 3’-ends were obtained with 5'- and 3’- rapid 
amplification of cDNA ends (RACE) using the cDNA library as template.  For RACE 
PCR reactions, the gene specific primers were designed from sequences of the central 
part of each subunit; while the 5’- or 3’- universal primers designed from the phage λgt10 
vector were used.  A typical RACE PCR reaction was set up with 0.25 µM of each primer, 
1 µl of the cDNA, 0.2 mM dNTP and 2 U of Platinum® Taq DNA polymerase 
(Invitrogen) in a PCR buffer (20 mM Tris-HCl, 50 mM potassium chloride, pH 8.4) 
complemented with 1.5 mM magnesium chloride.  Tm, the annealing temperature of the 
3’- or 5’-RACE reaction for each individual subunit, was optimized by testing a series of 
PCR reactions with gradient annealing temperatures on the Applied Biosystem amplifier, 
in view of the various melting points of the gene specific primers.  The temperature at 
which the band at desired molecular weight is bright and sharp was used.   The PCR 
program used for 3’RACE was as follows: 1 cycle of 94 °C for 5 min, 32 cycles of 94 °C 
for 15 s, Tm °C for 30 s and 72 °C for 40 s, and finally 1 cycle of 7 min of 72 °C.  The 
resulting RACE product was cloned into pGEMT®-Easy vector and sequenced. 
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The gene specific primer sequences for 5’- and 3’- RACE of each subunit are 
listed in Table 2.1.    
 




HMC subunit 3’- / 5’-end 
 
Primer sequence 
1 I 3’- 5’- GGCTACGCACCACACCTTACGTCGAT   
2 I 5’- 5'-TCTTCGTGGA ACTTGCCCTC TGGGTC 
3 II 3’- 5’-TGGGTGATATCGCGATTTCGGACATGGT  
4 II 5’- 5’-TTCGTCCAGGTTCTTGTGGTTGCCTTCG    
5 IIIa 3’- 5’-AGACGTGCGCGCGATATGATTGTG-3’ 
6 IIIa 5’- 5’-GCCCTGGCTAACGGATTCGTAACTGG-3’ 
7 IIIb 3’- 5'-CCAGGTACGACTGCGAGCGACTTT  
8 IIIb 5’-  5’-GAACATTCCCTCGTTCACCACATCTTTT 
9 IV 3’- 5’-GGCGACCAGAGGTGATGGGTAAAGTCAA  
10 IV 5’- 5’-GCGTCGTGCAAGTGACCAGGATGAA  
11 V 3’- 5'-GTTTGTCCTA CCCATCACGA CCCGCA 
12 V 5’- 5’-GCGGGTCGTGATGGGTAGGACAAA 
13 IIIb 3’- 5'- CCTGCCACCTAGCGGCCAGAAGTGATA 
14 IIIb 5’- 5’-ACCTTCAGGCCGTGATGGATAGGGTAAG   
 
The complete cDNA sequence of each hemocyanin subunit was computationally 
constructed by combining the cDNA fragments from 3’- and 5’- RACE.    
Confirmation of the full-length cDNA of subunit IV was conducted by amplifying 
the cDNA template synthesized from hepatopancreas mRNA, using gene specific primer 
designed from the 5’- and 3’- end cDNA sequences.  The forward primer is: 5’-
ATGACCCTTAAGGAAAAACAGGATCG-3’, and the reverse primer is 5’- 
TCAGTGAACAAACTGGATCCTGATGTCG-3’.   The full length PCR product was 
purified by electrophoresis through the agarose gel and the desired band of interest was 
recovered for further cloning into pGEMT-Easy vector and sequenced.  
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2.3.3 Computational analysis of HMC subunits  
Analysis of the domain structure of HMC subunits  
The domain structure of each CrHMC subunit was analyzed by protein BLAST 
analysis (http://ncbi.nlm.nih.gov/blast/blastp) on the basis of the full length amino acid 
sequence.  
 
Phylogenetic analysis  
For computational analysis of C. rotundicauda HMC, homologues from different 
organisms were aligned to show the degree of conservation of the protein across the 
phylogenetic tree.  Gene sequences were also used for the prediction of gene or protein 
properties via tools from the EXPASY website.   
The programs provided by the Software Package 8.0 from the Genetics Computer 
Group (Madison, WI) were used for sequence analysis.  The 7 cDNA sequences 
corresponding to CrHMC subunits I to VI (Genbank Accession numbers:DQ 090484 to 
DQ 090490) were aligned using PILEUP and imported into GeneDoc 2.5 for further 
manipulation. The PHYLIP 3.6 software package was used for phylogenetic analyses. 
Distances between pairs of protein sequences were calculated and corrected for multiple 
changes according to Dayhoff's empirical PAM 001 matrix with the PROTDIST program. 
Phylogenetic trees were constructed either by neighbor joining or by maximum 
parsimony method implemented in the PROTPARS program. The reliability of the trees 
was tested by bootstrap analysis with 1000 replications (SEQBOOT program). To 
estimate the divergence times, the PAM matrix was imported into the Microsoft EXCEL 
97 spreadsheet program. A linearized tree that corresponds to the phylogeny of the 
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chelicerate HMCs was calculated on the basis that Merestomata and Arachnida split about 
450 million years ago (Dunlop et al, 1997).  The confidence limits were estimated using 
the observed standard deviation of the protein evolutionary distances.  
LpoHc-2, subunit II of L. polyphemus (P04253); EcaHc-a-g, E. californicum 
hemocyanin subunits, from a through to g (X16893, AJ290429, AJ277489, AJ290430, 
X16894, AJ277491, and AJ277492, respectively); AauHc6, Androctonus australis HMC 
6 (P80476); ScoHcA, S. coleoptrata HMC A (Q95P08) were included in the phylogenetic 
analysis. 
 
2.4 The PAMP binding-activity of HMC and Hb 
Figure 2.2 shows the structural diagram of LPS.  LPS is composed of Lipid A, 
which is buried in the outer membrane, a short carbohydrate core, and a long chain of 
polysaccharides that is made up of repeating sub-units (www.ratsteachmicro.com.).   Lipid 
A is the toxic component of the LPS (Takada and Kotani, 1989).  As the bacteria lyse, 
LPS is released, leading to inflammation and fever, and complement consumption.  It 
also interferes with coagulation, and eventually leads to shock.  To study the PAMP 
binding activity of HMC or Hb, two strategies were employed:  (i) ELISA with PAMP-
immobilized microplates and (ii) SPR analysis of real time PAMP binding using LPS 
immobilized HPA chip.   
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Figure 2.2:  The structure of LPS, the Gram-negative bacterial endotoxin.  Refer to the text 
for details.  Adapted from http://www.ratsteachmicro.com. 
 
2.4.1  ELISA-based endpoint protein-PAMP interaction assay  
The interaction between HMC or Hb with LPS or LTA were examined by ELISA.  
Aliquots of 100 µl LPS or LTA were incubated in a 96-well microtitre plate (Maxisorp®, 
NUNC, Denmark) at room temperature overnight.  The wells were rinsed three times 
with 100 µl of PBS and blocked with 150 µl of PBS with 2% (w/v) BSA at 37°C for 2 h.   
To measure the protein-PAMP interaction, the wells were again rinsed three times with 
PBS before 100 µl of serial dilutions of the protein (HMC/Hb) in 2% BSA in PBST (PBS 
containing 0.05% v/v Tween 20) was added and further incubated at 37°C for 1 h.  After 
rinsing the wells three times with PBST, 100 µl of primary rabbit antibody diluted to 
1:500 with 2% BSA in PBST, was added to the wells and incubated at 37°C for 30 min, 
followed by rinsing the wells three times with PBST.  Subsequently, horseradish 
peroxidase-conjugated goat-anti-rabbit antibodies (DAKO, Japan) were added in 1:1000 
dilution in 2% BSA in PBST and incubated at 37°C for 30 min. The wells were rinsed 
four times with PBST before addition of 50 µl of peroxidase substrate, ABTS (2,2’-
azino-bis[3-ethylbenzthiazoline-6-sulfonic acid], Roche).  After incubation for 10 min at 
room temperature, the OD was read at 405nm. 
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To test the specificity of the ELISA, we examined whether or not pre-incubation 
of HMC or Hb with LPS or LTA could reduce the ELISA-readout in a dose-dependent 
manner.  To this end, HMC or Hb, at a concentration that shows an ELISA-readout A405
 
at the linear range, was first incubated with 0-200 µg/ml LPS or LTA, at 37°C for 1 h.  
Then the incubation mixture, containing both HMC or Hb and LPS or LTA, was 
transferred to the LPS- or LTA- immobilized microtitre plate and the ELISA was 
performed as described above.  The reduction of the interaction between preincubated 
HMC or Hb and the immobilized LPS or LTA, respectively, would demonstrate the 
specificity of such a protein-PAMP interaction.   
 
2.4.2  SPR-based real time protein-PAMP interaction assay  
To study the binding affinity between HMC and LPS via a solid phase assay, we 
immobilized the LPS on a BIAcore Hydrophobic Affinity (HPA) sensor chip.  HMC 
purified from cell-free hemolymph via ion-exchange (see section 2.2.3) was injected 
over the chip surface to allow its binding to LPS on-chip. The affinity of HMC and Hb to 
lipid A was determined by using BIA evaluation software version 3.2. 
 
Immobilisation of LPS on HPA sensor chip  
The lyophilized LPS from Sigma was dissolved in pyrogen-free water to the stock 
concentration of 5 mg/ml.   The LPS solution was then sonicated at room temperature for 
10 min and vortexed vigorously for 2 min.   Then the LPS solution was centrifuged at 
13,000 x g for 2 min at room temperature to remove particles.   Immediately before 
immobilization, the LPS was further diluted to 0.25 mg/ml in phosphate-buffered saline 
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(PBS) pH 7.4, containing 10 mM EDTA.  Again, the solution was sonicated at 32 °C for 
10 min and then vortexed for 10 min and centrifuged at 13,000 × g for 2 min at room 
temperature. One hundred µl of LPS solution was injected onto the HPA sensor chip 
(BIAcore) in BIAcore 2000 system using water as running phase at the flow rate of 2 
µl/min. Fifty µl 100 mg/ml skimmed milk (Difco) was injected to coat the nonspecific 
binding sites, followed by 20 µl 0.1M NaOH to remove the multiple layers of lipids and 
proteins until, theoretically, a monolayer of LPS was immobilized on the chip.  
 
Investigation of the affinity between LPS and HMC or Hb 
All the protein samples were diluted into desired concentrations with PBS.  The 
LPS-HPA chip was also equilibrated with PBS. Each sample was injected in a volume of 
50 µl at the flow rate of 30 µl/min, and then dissociated for 180 s. The protein was 
washed off by 10 mM EDTA in 50 mM Tris, 150 mM NaCl, pH 7.4 to regenerate the 
chip for the next experiment. The data was later analyzed by BIAevaluation (Version 3.2) 
 
2.5 The protein-protein interaction between PRRs and HMC  
The protein-protein interaction between HMC and CRP or HMC and GBP were 
investigated through four independent methods: yeast-2-hybrid, recombinant protein 
pulldown assay, ELISA and protein-copurification.  
 
 2.5.1 Yeast-2-hybrid analysis 
The yeast-2-hybrid (Y2H) analysis is a powerful strategy for identification of 
interacting protein partners.  Unlike in vitro pull-down assay, this method allows the 
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cDNA of the interacting partner to be easily isolated and identified.  The method is not 
restricted by proteins that are in lower abundance and can overcome the problems 
associated with a lack of glycosylation when compared to pull down assays involving 
recombinant proteins made from the bacteria.  Thus, yeast-2-hybrid is an appropriate 
complement for biochemical analysis.  However, proteins that show interaction in the 
nucleus of the yeast may or may not be reflective of a physiological interaction in the 
native situation.  Therefore, identified interacting partners should be further verified by 
other methods.  For yeast-2-hybrid assay, a cDNA library constructed from horseshoe 
crab hemocyte mRNA in pGADT7 vector and transformed into yeast strain AH109 was 
screened.  To this end, HMCIIIB β was cloned into pGBKT7, which was further 
transformed into yeast, Saccharomyces cerevisiae, strain Y184.  Then the AH109 library 
was mated with Y184, and clones showing protein-protein interaction was selected on 
nutrient agar, QDO and verified by blue-white selection on QDO with X-α-gal.  The 
pGADT7-cDNA plasmid was extracted for sequencing in order to identify the cDNA by 
searching for identical or homologous sequence in the database. 
 
2.5.2 Pulldown assay with recombinant proteins 
His-tagged recombinant HMC7β and GST-fusions with CRP1 or CRP2 or GBP 
were expressed and purified for use in interaction assays.  
 
Expression and purification of His-tagged recombinant HMCIIIB β 
 The beta domain of HMC subunit 7 was cloned into the pETH vector (Figure 
2.3) and expressed by Escherichia coli as a His- tagged HMC7β protein.  Optimization of 
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the expression and purification conditions for this protein was carried out according to 
the user manual of the pET expression system by Invitrogen.  
 
Figure 2.3: Cloning of HMC IIIb into pETH for expression with His-tag. The mature 
HMCIIIB b sequence was amplified from the pGEMT-HMCIIIB plasmid and ligated into pETH 
at the EcoRI and BamHI restriction sites.  
 
Expression and purification of GST-fusion CRP1 or CRP2 or GBP 
Full length of CRP1, CRP2 and GBP were cloned into the pGEX vector and 
expressed by E. coli as GST-CRP1, GST-CRP2 and GST-GBP fusion protein 
respectively. Purification of the fusion protein was carried out using reduced GSH-
affinity chromatography according to the user manual on GST-fusion protein by GE 
healthcare.   
1. PCR of HMC 7β clone with primers containing 













2. Recombinant CRP2 clone  digested 









3. Resultant plasmids express His-tagged 
HMC 7β fusion proteins 
BamH Eco 
                                                                                                                                      54           
Interaction assays using recombinant proteins 
HMC interactions with CRP1 and CRP2 were investigated by pull down assay 
and ELISA using recombinant HMC7β-His, GST-CRP1 and GST-CRP2; while 
interaction between HMC and GBP was investigated by ELISA using recombinant 
HMC7β-His and recombinant GST-GBP. 
 
a. Pull down assay 
HMC7β-His conjugated to the beads pre-charged with Co2+ was used in this 
assay. To obtain this, the bacteria colony containing the recombinant plasmid was 
cultured and protein expression was induced. The cell lysate containing His-tagged fusion 
protein was then incubated with 1 ml of 50% slurry at 4 °C for 3 h with slight agitation 
on a platform shaker. The unbound proteins were then removed and the beads were 
washed by re-suspending with 20 bed volumes of 1 x Equilibration/Wash buffer. Instead 
of eluting the bound protein, 20 µg of recombinant GST-CRP1 or GST-CRP2 was added 
to the beads and incubated at 4°C overnight with slight agitation. The next day, the beads 
were washed ten times with 1 x Equilibration/Wash buffer before the bound proteins 
were eluted with the Elution buffer. Proteins pulled down were resolved on 12% SDS-
PAGE and Western Blot using anti-CRP antibodies was performed to investigate the co-
elution of CRPs.  
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b. ELISA assay 
For ELISA, polyclonal goat anti-GST antibody  was coated onto 96-well plates 
(NUNC) by incubating 50 µl of polyclonal goat anti-GST antibodies (1:500 titer) in 50 
mM carbonate-bicarbonate buffer (50 mM sodium carbonate, 50 mM sodium 
bicarbonate, adjusted with either the carbonate or bicarbonate to pH 9.6) at 4°C 
overnight. The next day, the wells were rinsed three times with 100 µl of PBS and 
blocked with 150 µl of PBS with 1.5% (w/v) BSA at 37°C for 2 h.  The wells were rinsed 
three times with PBS before 0.04 mM of either GST-CRP1, -CRP2 or -GBP in PBS was 
added. The proteins were incubated at 37°C for 2 h and then rinsed three times with 
PBST (PBS containing 0.05% v/v Tween 20). 0.04 mM of His-tagged recombinant 
HMC7β was then added to the wells and incubated at 37°C for 2 h, after which, the wells 
were rinsed three times with PBST.  Subsequently, horseradish conjugated anti-His 
antibodies were added in 1:500 dilution in PBS and incubated at 37°C for 1 h. The wells 
were rinsed four times with PBST before 50 µl of peroxidase substrate ABTS (2,2’-
azino-bis[3-ethylbenzthiazoline-6-sulfonic acid], Roche) was added. The OD was then 
read at 405nm after incubation for 10 min at room temperature. 
 
c. Determination of dissociation constant (KD) by ELISA assay  
The purified recombinant proteins, HMC7β-His, GST-CRP1, GST-CRP2 and 
GST-GBP were used to determine the dissociation constants of the interactions.  
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To determine the KD, ELISA was conducted as described above, except that 
different amount of HMC7β-His was added to the wells to allow the interaction at 
different level.  The actual amount of His-HMC7β protein bound was calculated from the 
standard curve, which links the ELISA readout and the His-HMC7β immobilized in each 
well.  The KD was determined by the software, SigmaPlot (version 8).  
 
2.5.3 Co-purification of native GBP and its interaction partners by Sepharose 4B 
bead from the horseshoe crab cell free hemolymph 
Native GBP was purified from the Limulus plasma with the use of a Sepharose 4B 
column as GBP is a lectin which could bind tightly to the sugar moiety on the Sepharose 
(Chiou et al., 2000).  To this end, CNBr-activated Sepharose beads were packed into 
column, washed with ice-cold 0.1 M HCl and incubated with TBS for 1 h.  Then the 
column was blocked with ethanolamine-HCl for 2 h before washed with TBS.  The 
plasma was applied to the blocked column and incubated for 1 h at 4 °C before washed 
with 20 x bed volume of TBS.  Finally, GBP, together with its interaction partner was 
eluted by 0.4 M N-Acetylglucosamine (GlcNAc) from the column and collected for 
further analysis by 12 % SDS-PAGE gel to visualise the protein profile. 
 
2. 6  Conversion of HMC/PPO to PO and the PO activity assay using chromogenesis 
of phenolic substrate 
The PO activity was measured as described (Jiang et al., 2007) with modifications 
(Figure 2.4).  In a reaction volume of 125 µl, purified HMC/PPO (holo-molecule) was 
incubated with proteases in the 50 mM Tris-HCl, pH 8.3, containing 0.05 M NaCl, at    
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20 ºC for 10 min, followed by the addition of the PAMP dissolved in the same 
buffer.  Then, 1 mM 4-methylcatechol (4ME) in 0.1 M potassium phosphate, pH 6.0, was 
added as substrate.  The absorbance at 405nm was monitored continuously using a 
microplate reader (Molecular Devices, USA).    
        
 
 
Figure 2.4:  The illustration of the chemical reconstitution of PO activation by microbial 
protease and PAMPs.  CFH is the cell-free hemolymph, also known as plasma, obtained as 
described in section 2.2.1.  Chromogenenic phenolic substrates were used to monitor the PO 
activity.  For 4-methylcatehol, optical absorbance at 405nm were monitored.  
In order to confirm that the chromogenic reaction is catalyzed by PO, PO specific 
inhibitors, Phenylthiourea (PTU) and kojic acid, were applied to the reaction.  The PO 
activity was presented as A405 at 5 min after the addition of substrate; or as the 
A405/0.001/min.    
 
2.7   Measurement of superoxide production by metHb using chemiluminescence (CL) 
The generation of O2 ˙  by metHb was monitored by CL of Cypridina luciferin 
analog (CLA) as described (Kawano et al., 2002) using the Sirius luminometer (Berthold 








      
PO activity:  
OD405nm at 5min 
OD405nm/0.001/min 
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per second (RLU/s).  CLA-CL specifically indicates the generation of O2 ˙  and singlet 
oxygen, but not that of ozone, hydroxyl radicals or H2O2.   The superoxide dismutase 
(SOD) was further applied to the CLA-CL assay in order to determine that the ROS 
produced is superoxide anion.    
The pseudoperoxidase activity of the metHb is presented as the maximum speed 
of O2 ˙  production in the presence of excessive amount of H2O2 and CLA.  
  
2.8  Establishment of the bacterial model for antimicrobial activity assay 
2.8.1  Isolation and identification of naturally occurring Gram-positive bacteria 
          from the habitat of the horseshoe crab 
 
In order to isolate and identify the naturally occurring Gram-positive bacteria 
species from the habitat of the horseshoe crab, estuarine water and mud were sampled 
from the horseshoe crab habitat, Kranji Estuary, Singapore.  The estuarine water and mud 
samples were inoculated to marine agar and cultured at room temperature for 4 days.  
Then single colonies were selected and purified by sub-culturing on marine agar.  Gram-
positive bacteria as confirmed by Gram staining were cultured for further use.  
The isolated Gram-positive sporing rod-shaped bacteria were identified by two 
independent methods: (i) biochemical assays using API 20 Strep and API 50 CHB 
microtest kits (Biomerieux, France) and (ii) sequencing of the 16s rDNA.  For 
sequencing the 16s rDNA, PCR amplification was performed with the highly conserved 
16s rDNA primer pair, BacU518 (5’-CCAGCAGCCGCGGTAATACG-3’) and 
BacU1513 (5’-ATCGGYTACCTTGTTA CGACTTC-3’), as described (McCabe et al., 
1995). The sequencing primer was BacF880 (5’-GGTGGTGCATGGTTGTCG-3’).  The 
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sequences were analyzed using the NCBI nucleotide-nucleotide (blastn) engine 
(http://www.ncbi.nlm.nih.gov/BLAST/) and the highest hits were adopted.  
 
2.8.2  Cloning the bacteria with GFP for real-time fluorescence microscopy 
To perform the real-time observation of the antimicrobial action by fluorescence 
microscopy, the bacterial strains were transformed with GFP- or EGFP-carrying plasmid.  
Electroporation was applied to increase the transformation efficiency.  For P. aeruginosa, 
pDSK-GFP were transformed and selected on the LB agar with 250 ug/ml kanamycin. 
For S. aureus, pALC1420 was transformed and selected on 10 µg/ml chloramphenicol.  
Single colonies of the transformants were tested for their viability, growth profile, GFP 
expression and protease-producing ability.  Transformants which do not change 
significantly were selected and kept for further antimicrobial assay.   
  
2.8.3 Pyrogen-free culture of Gram-positive bacteria: verification by hemocyte 
         degranulation and Factor C assays 
 
Lipopolysaccharide (LPS), also known as the pyrogen, resides on the outer 
membrane of the Gram-negative bacteria but not on the Gram-positive bacteria.  Upon 
injection of the Gram-negative bacteria into the horseshoe crab, the LPS is necessary and 
sufficient to trigger the degranulation of the host hemocytes, which subsequently releases 
the intracellular factors to kill the invader effectively (Ariki et al., 2004; Iwanaga, 2002). 
Previous study demonstrated that the intracellular serine proteases, such as Factor B, pro-
clotting enzyme, and clotting enzyme can activate the prophenoloxidase activity of the 
hemocyanin (HMC/PPO) to phenoloxidase (PO) (Nagai et al., 2000, 2001).  To verify 
that the microbial extracellular protease could activate HMC/PPO to PO and further 
                                                                                                                                      60           
mediate the antimicrobial response in the extracellular milieu, Gram-positive bacteria 
which lack LPS and therefore do not trigger hemocyte degranulation are used in the in 
vivo antimicrobial assay.  Being ubiquitous and chemically very stable, LPS may 
contaminate the Gram-positive bacterial culture.  In order to avoid the interference from 
the inadvertent introduction of exogenous LPS, every precaution must be taken to prepare 
the Gram-positive bacterial culture under pyrogen-free condition.   
 The culture media was prepared using pyrogen-free water and containers which 
have been depyrogenised by baking at 200 oC for 4 h.  After sterilization of the media, 
LPS was assayed using the PyroGeneTM Endotoxin Diagnostic Kit (Cambrex Inc., USA), 
and only use the medium when the LPS level was negligible.  As a quality control index, 
the Gram-positive bacteria harvest, at 108 cfu/ml, should not cause significant activation 
of Factor C, the serine protease zymogen which is sensitively activated by LPS.  To 
verify the pyrogen-free status of the Gram-positive bacterial culture, we incubated the 
culture with the horseshoe crab hemocyte, and three examinations were conducted:  
(1) Morphological observations of the hemocytes under light microscopy.  To this 
end, the hemolymph was collected via the cardiac chamber under pyrogen-free 
condition.  Then 1 µl of the bacterial culture under test, at a density of 107cfu/ml, was 
mixed with 1 µl hemolymph on a glass slide.  The mixture of hemocytes and bacteria was 
immediately examined under bright-field and fluorescence microscopy with Zeiss 
fluorescence microscope.  Time-lapse microscopy image of the hemocytes were taken at 
30 s intervals over a period of 30 min and a movie was made.  As a positive control of 
host degranulation, morphological observation of hemocytes in contact with P. 
aeruginosa, a Gram-negative bacterium, was performed under the same condition.  
                                                                                                                                      61           
(2) Factor C activity assay in the cell free hemolymph.  The principle of this test 
is that under physiological condition, Factor C resides in the large granules of the 
hemocytes in a zymogen form.  It is only released into the cell free hemolymph upon 
hemocyte exocytosis/degranulation triggered by LPS.  To detect Factor C, LPS is applied 
to convert it from zymogen to active serine protease, which can be indicated by 
fluorescent substrates.    
(3) Intact hemocytes sediment at the bottom of the test tube during incubation.  
The principle is as follows:  the presence of LPS causes the hemocytes to degranulate and 
no intact cells would settle to the bottom of the glass tube, thereby presenting a 
translucent-to-clear ‘tube bottom’.  In contrast, in the absence of LPS, Gram-positive 
bacteria alone will not cause hemocyte degranulation.  After standing incubation, the 
hemocytes will aggregate into a dense button at the bottom of the borosilicate tube.  
 
2.9   Antimicrobial assay of ROS production from HMC  
2.9.1  In vitro antimicrobial assay  
The end point antimicrobial activity assay 
As shown in Figure 2.5, the end-point measurement of the ROS-mediated 
antimicrobial activity was chemically reconstituted using an initial bacterial population of 
106 cfu/ml.   For HMC/PPO, the bacteria under test were incubated with 60 µg purified 
HMC plus 100 nmol 4ME in 100 µl PBS at 37 ºC for 1 h.  To evaluate the impact of PO 
activity, 10 nmol of PTU was added to the above reactions.  Controls were also set up by 
incubating bacteria with HMC/PPO or 4ME or PTU separately, or in combinations.  Each 
condition was tested in triplicate.    
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The real time observation of the antimicrobial effect  
The real-time imaging of the bacterial clearance elicited by PO-catalyzed 
production of quinone was conducted with PAE-producing and non-producing strains 
of P. aeruginosa.  Each bacterial strain at 107 cfu was mixed with 60 µg HMC/PPO and 
100 nmol 4ME in 100 µl PBS.  One µl of the mixture was examined by fluorescence 
microscopy.  Images were taken at intervals of 30 s for 1 h, at a magnification of 63 x 1.6, 














Figure 2.5: Illustration of the in vitro antimicrobial activity assay of the microbial 
components mediated PO activation.  Refer to the text for details.  rt, room temperature.   
 
2.9.2  In vivo antimicrobial activity assay 
In order to demonstrate the ability of microbial factor-activated PPO activity in 
clearing the invading pathogen in vivo, we infected horseshoe crabs in the presence or 
absence of PO-specific inhibitor, PTU or kojic acid (Figure 2.6).  A comparison of the 
remnant bacterial load under these conditions should help to clarify the specific 
contribution of PO, if any, to the antimicrobial activity.   Previously, it was reported that 
HMC/PPO is activated by host intracellular factors released through LPS-dependent 
degranulation of hemocytes.  To avoid provocation of PPO by such cellular components 













37°C, O/N +/- 
PO inhibitor 
and to unequivocally demonstrate that the microbial factor-activated PPO contributes to 
the antimicrobial defense, Gram-positive bacteria lacking LPS were used to avoid LPS-
induced hemocyte lysis.   
Culture the Gram-positive bacterial strains under pyrogen-free condition was as 
described in section 2.8.3.  Then the bacterial population was adjusted to 106-107 cfu/ml 
with pyrogen free 3% NaCl (isotonic to the horseshoe crab hemolymph).   The horseshoe 
crab was injected intracardially with 100 µl bacteria/100 gram body, using guage #23 
needle.  At 30 min post injection, hemolymph was collected from the horseshoe crab by 
cardiac puncture using guage #18 needle.  Immediately after collection, the hemocytes 
were removed by centrifuging the hemolymph at 150 x g for 10 min at room temperature.  
The remnant bacterial load was quantified in the extracellular milieu by applying 100 µl 
of the resultant cell-free hemolymph to nutrient agar plate and incubating at 37 °C 
overnight.  In order to confirm the contribution of PO activity in the bacterial clearance, 5 
mM PTU or 5 mM kojic acid was included in the bacterial injection to block in vivo PO 
activity, if any.  








Figure 2.6:  Illustration of the in vivo antimicrobial activity assay of the extracellular PO 
activity induced by microbial protease.   
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2.9.3 Examination of the exocytosis or degranulation of the Horseshoe crab 
hemocyte upon challenge of the Gram-positive bacteria 
 
The hemolymph was collected via the cardiac chamber under pyrogen-free 
condition.  To confirm that the hemocytes were not degranulated during the process of 
humoral PPO activation by exogenous microbial elicitors, morphological examination of 
the hemocytes was performed as described in section 2.8.3.   
To further validate the absence of hemocyte degranulation or lysis, and hence, 
precluding the involvement of host intracellular factors in the humoral PPO activation 
under examination, biochemical analysis of Factor C activity was performed.  To this end, 
aliquots of 500 µl of freshly collected hemolymph contained in pyrogen-free borosilicate 
glass test tubes were incubated with 100 µl of serially diluted bacteria (from 108 cfu/ml 
to 105 cfu/ml) at room temperature.  After 90 min, the supernatants were collected and 
the Factor C activity was measured.  Ten µl supernatant was mixed with 90 µl fluorescent 
substrate from the PyroGeneTM Endotoxin Diagnostic Kit (Cambrex Inc., USA), and the 
fluorescence emission at 440 nm was monitored upon excitation at 380 nm.  The 
supernatant samples were also tested with the addition of 10 µg/ml LPS to activate the 
Factor C if any, in case it was exocytosed in its inactive precursor form.  For the negative 
control, pyrogen-free saline was used in place of bacteria.  
 
2.10 In vitro antimicrobial assay of metHb-mediated ROS production using a         
chemically reconstituted system  
 
The end-point measurement of the ROS-mediated antimicrobial activity was 
chemically reconstituted using an initial bacterial population of 106 cfu/ml.  For metHb, 
the bacteria under test were incubated with 36 µg metHb, 1.6 µmol H2O2 in 200 µl PBS 
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at 37 ºC for 1 h.  The remnant bacterial population in the reaction mixture was 
enumerated by plating 100 µl of serially diluted samples on nutrient agar plates and 
incubating at 37 ºC overnight.  To further prove that the antibacterial activity was indeed 
attributable to ROS, the superoxide ions were quenched using 2 µmol GSH.  Controls 
were also set up by incubating bacteria with metHb, H2O2 and GSH separately or in 
combinations.  Each condition was tested in triplicate.    
 
2.11 In vitro antimicrobial assay using mammalian RBC  
The metHb-mediated antimicrobial activity was also evaluated using mammalian 
red blood cells (RBC).  Both the rabbit and human RBCs were collected into heparinized 
tubes, washed with pyrogen free saline (0.9 % NaCl), and diluted to 0.4% (v/v).  Then the 
bacteria under test were incubated with the washed RBC.  Pyrogen-free saline was used 
as a negative control.  The bacterial population was monitored up to 30 min.  Protease 
inhibitor Mix G (Serva Chemical Co., Westbury, NY) was used to investigate the 
necessity of microbial protease in triggering the ROS production, if any.  Superoxide 
dismutase (SOD, from Sigma), at 10 Units/ml was used to determine the specificity of 
ROS in the antimicrobial action.  
 
2.12 Azocoll protease activity assay 
The proteases produced by different strains of bacteria were assayed by using 
Azocoll as a chromogenic substrate which was prepared as described in the product 
specification (Sigma-Aldrich).  Briefly, 75 mg of Azocoll reagent was resuspended with 
10 ml of 50 mM Tris-HCl (pH 7.4), and swirled end-to-end for 2 h, before the insoluble 
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part was spin down by centrifugation at 10,000 x g for 5 min.  Then the pellet was 
resuspended in 5 ml of the same Tris-HCl, and ready to use.  For the protease activity 
assay, an aliquot of 100 µl of sample was incubated with 400 µl of Azocoll reagent for 2 
h at 37 ºC.  The undigested Azocoll reagent was precipitated by centrifugation at 15,000 
x g for 10 min.  The supernatant was transferred to a microplate and absorbance at 550 
nm was read.  Each sample was tested in triplicate. 
 
2.13 Immunoblotting analysis 
The sample was resolved by SDS-PAGE and electro-transferred from the gel to a 
PVDF membrane (Millipore) in the mini Trans-Blot Electrophoretic Transfer Cell 
(BioRad) at a constant voltage of 50 V for 1 h while immersed in transfer buffer (25 mM 
Tris-base, 192 mM glycine, 20 % methanol).  The PVDF membrane was pre-wet with 
methanol before using for transfer.  After transfer, the membranes were blocked with 3% 
(w/v) skimmed milk in 0.05% Tween 20 in Tris-buffered saline, pH 7.6 (TBST) for 1 h 
and washed four times (15 min each) with TBST. Following overnight incubation with 
the primary antibody (1:1~2000), four-15 min washes in TBST, 1 h incubation with 
HRP-conjugated secondary antibody (1:10,000), and again four-15 min washes in TBST, 
the blot was developed with SuperSignal® West Pico Chemiluminescent Substrate 
(Pierce) and exposed to X-ray film (Kodak) for 5-10 s. 
 
2.14  Measurement of the red blood cell lysis 
The hemolysis assay was adapted with modifications, from the method of Shin et 
al. (2005). Briefly, 0.4 % (v/v) of saline-washed rabbit or human blood cells were 
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incubated with 107 cfu/ml bacteria at room temperature under steady rotation (6 rpm).   
Pyrogen-free saline was used as the negative control and 1% Triton-X100 in saline was 
used as the positive control.  The samples retrieved at timed intervals were centrifuged at 
1000 x g, at room temperature for 10 min to allow the RBC to settle.   Absorbance at 404 
nm was monitored as an indication of the hemoglobin released into the supernatant.   
 
2.15  Monitoring the conformational change of protein by partial proteolysis profile 
The conformational change of protein induced by ligand can be readily 
demonstrated by the partial proteolytic profiles (Wang et al, 2002).  In order to examine 
the human metHb for its structural alteration in the presence of LPS, we compared the 
proteolytic profile by subtilisin in the presence and absence of LPS.  Human metHb (72 
µg) was incubated with 90 µg of LPS, in 180 µl of pH7.4 PBS, at 37 °C for 10 min, 
followed by the addition of 72 ng (10 U/mg) of subtilisin in 7.2 µl of PBS.  The control 
contained subtilisin without LPS. At the indicated time points, a 40 µl aliquot of the 
incubation mixture was collected and the proteolysis was stopped with 5 mM PMSF.  
15% reducing Tricine-SDS-PAGE (15%) was used to examine the proteolytic profile.  
For each lane, 2 µg of metHb was loaded.  Western analysis was performed using 
polyclonal rabbit anti-human Hb antibody.  Unique bands which occur only in the 
presence of LPS indicate that the presence of LPS changes the pattern of cleavage sites of 
Hb available to subtilisin A, as an evidence of the altered tertiary structure of the 
hemoglobin.        
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2.16   Measurement of the total phenolic substrate level in cell free hemolymph         
Besides using the exogenous substrate 4-ME, a well-appreciated synthetic 
substrate for PO, which generates cytotoxic quinones that in high enough concentrations 
lead to microbicidal actions, we also explored the existence of the endogenous substrate 
for PO in the extracellular milieu as well as examined the phenolic substrate level in the 
plasma, especially on the dynamic profile of the substrate level during infection.   To this 
end, horseshoe crab cell free hemolymph (plasma) was collected as described in section 
2.2.1.  Then the hemocyanin was removed by ultracentrifugation at 40,000 rpm, 4 h at 4 
°C.  The supernatant was collected and further removed off protein/peptide by 
ultrafiltration through Vivaspin column with molecular weight cut off (MWCO) of 3 kDa.  
The sample prepared, referred as to protein-free plasma, was appropriate for further 
phenolic substrate level assay with Folin-Ciocalteau reagent (Sigma).  An aliquot of 1.5 
ml of the protein-free plasma and 0.25 ml of the Folin-Ciocalteau reagent were mixed.  
After 3 min, 2 ml 20% sodium carbonate solution was mixed thoroughly.  The mixture 
was placed in a boiling water bath for exactly 1 min before leaving the tube at room 
temperature for 1 h.  Then the absorbance was measured with a Beckman 
spectrophotometer (DU 50) at 650 nm, against a blank containing only water.  A standard 
curve was prepared using different concentrations of catechol (10-60 µg) for intrapolation 
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CHAPTER 3: RESULTS  
 
3.1 Purification and characterization of HMC from horseshoe crab cell free hemolymph 
3.1.1 Purification of HMC holoprotein by gel-filtration chromatography  
The hemolymph was collected from horseshoe crabs which were confirmed clear 
of microbial infection.  The clarified cell-free hemolymph was applied to gel filtration.  
Three major peaks were obtained (Figure 3.1).  The SDS-PAGE shows that the first peak 
was composed of a protein of 70-72 kDa, while the second 200 kDa and the third 28 kDa.  
Consistent with previous report, these three peaks may represent the three major plasma 
proteins, which are hemocyanin, alpha-2-macroglobulin and C-reactive protein (CRP).  
HMC was eluted first due to its high molecular weight, presumably 3,500 kDa, as a large 
polymer constituting 48 subunits (Martin et al., 2007).  Further analysis of the first peak 
showed that the first half portion of the peak was the pure form of hemocyanin (Figure 
3.1a, b), but the second half contained other proteins (Figure 3.1a).  
 
3.1.2 Isolation of HMC subunits by ion-exchange chromatography  
Further isolation of the individual subunits was performed with DEAE-sepharose 
ion-exchange (Figure 3.2). The first portion of peak I, exhibited as a single band on SDS-
PAGE (Figure 3.3), was retrieved for identification with MALDI mass-spectrometry 
(Figure 3.4).  The peptide fingerprint was matched to subunit IV of C. rotundicauda 
HMC, showing a significant match (26.7% coverage, i.e.167 aa matched over a total of 
624 aa) with the trypsin digested profile of the putative amino acid sequences derived 
from cDNA cloning of HMC subunits (GenBank accession number: DQ090488). 

























































































































































































































































































































































































































Figure 3.2: Elution profile of hemocyanin subunits from DEAE-sepharose chromatography 
column. The column was equilibrated with 0.05 M Tris/HCl, pH8.9, 10 mM EDTA. The NaCl 
gradient applied was from 0.17-0.4 M based on the equilibrium buffer.  The flow rate was 4 






















Figure 3.3: SDS-PAGE of the hemocyanin subunits purified by ion-exchange. Holo- 
hemocyanin loaded at the column is shown at the last lane. 
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3.2 Full length cDNA clones of the seven HMC subunits from the horseshoe crab  
3.2.1 Full length sequences and the derived amino acid sequences of HMC subunits 
As shown in Figure 1.8, each of the seven HMC subunit shares the same domain 
organization. The central copper binding domain harbors two copper binding sites, 
representing the most conserved part among all the known HMC sequences.   
To identify HMC-specific cDNAs, degenerate oligonucleotides derived from the 
amino acid sequence of the CuA- and CuB-binding sites were used for amplifying the 
most conserved part of HMC cDNAs, using a cDNA library prepared from two immune 
responsive tissues, hemocyte and hepatopancreas as the template. Thirty nine individual 
sequences were obtained, coding for seven different polypeptides each encompassing the 
CuA- and CuB-binding sites. Based on the sequences obtained, we further designed the 
gene-specific primers for cloning the 3’- and 5’- end of each subunit from the cDNA 
library (Refer to Table 2.1).  Finally, fragmented sequences, representing the central part, 
the 5’- and the 3’- ends respectively, were combined in silico to attain the full length 
sequences of each subunit.  The sequences of the full-length C. rotundicauda HMC 
(CrHMC or CrHc) cDNAs have been deposited in the GenBankTM database.  The 
accession numbers of all subunit are listed in Table 3.1.    
To confirm the full-length cDNA sequences obtained, we amplified from 
hepatopancreas mRNA, the full-length PCR product of subunit IV using gene specific 
primers designed from the 5’- and 3’- end cDNA sequences.  The forward and reverse 
primers were: 5’-ATGACCCTTAAGGAAAAACAGGATCG-3’, and 5’- 
TCAGTGAACAAACTGGATCCTGATGTCG-3’, respectively.  The sequence of the 
full length PCR product was consistent with that obtained by RACE method.   
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The full length cDNA sequence of CrHMC subunit IV (CrHMC IV or CrHc IV 
for short), including the 5’- and 3’- non-translational regions and the derived amino acid 
sequence is shown in Figure 3.5.  
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Figure 3.5: cDNA sequence and the derived amino acid sequence of C. rotundicauda 
hemocyanin subunit IV. The 5’- and 3’- non-translational regions are shown.  Blue colored is 
one of the primer sequences corresponding to the conserved copper binding site.  GenBank 
accession number. DQ090488.   
 
 
3.2.2  Pairwise comparison of the seven HMC subunits 
Full-length cDNAs cover the complete coding regions for the different HMC 
subunits, together with 11-77 bp of the respective 5'-untranslated regions and the 
complete 3'-untranslated regions comprising the polyadenylation signal, AATAAA, and 
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the poly(A) tail.  The open reading frames translate into polypeptides of 624 to 
638 amino acids with calculated molecular masses ranging from 71.6 to 74.0 kDa. These 
values correspond well with the apparent molecular mass of 71-74 kDa.  In total, the 48-
subunit HMC would have a total molecular mass of ~3,500 kDa.  The identity of each 
subunit was defined according to a homology alignment of the first 30 amino acids, 
between the amino acid sequences derived from the cDNA with those amino acid 
sequences obtained from actual N-terminal sequencing of isolated hemocyanin subunits 




















Figrue 3.6: A homology alignment of the first 30 amino acids, between the amino acid 
sequences derived from the cDNA of C. rotoundicauda, with the amino acid sequences 
obtained from actual N-terminal sequencing of isolated hemocyanin subunits of L. 
polyphemus (Lp).  LpI: L. polyphemus hemocyanin subunit I; LpII: L. polyphemus hemocyanin 
subunit II (CAJ910997) ; LpIIIa: L. polyphemus hemocyanin subunit IIIa (CAJ91098); LpIIIb: L. 
polyphemus hemocyanin subunit IIIb; LpIV: L. polyphemus hemocyanin subunit IV(CAJ91099); 
LpV: L. polyphemus hemocyanin subunit V (CAJ91100); LpVI: L. polyphemus hemocyanin 
subunit VI.  
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The pairwise comparison of the seven subunits is presented in Table. 3.1. The 
aligned complete amino acid sequences are presented in Figure 3.7.  Pairwise sequence 
comparison of single subunits revealed that 53-79% of amino acid positions are identical 
(Table 3.1).  The full length protein sequence alignment shows that 202 amino acids 
(32%) are strictly conserved throughout the seven subunits. Among the three structural 
domains, most sequence variation is found in the N-terminal domain 1 and in the C-
terminal domain 3, showing 21 and 27% identity, respectively.  In contrast, the central 
domain 2, which contains the copper-binding sites A and B, is strikingly conserved, 
exhibiting 45% sequence identity (Figure 3.7).  
 
 Table 3. 1. Comparison of the C. rotundicauda HMC subunits. Molecular properties of the      
 CrHMC subunits and their pairwise sequence identities are below the diagonal.  
     subunit           GenBankTM       cDNA      Protein       MW              pI       Pairwise sequences identities of the subunits %                         
                      Accession number     bp          aa           kDa                                I          II           IIIa       IIIb        IV       V          
    
    CrHMCI           DQ090484          2175       624         71.6            5.96        
    CrHMCII          DQ090485          2240       629         72.5            5.81          57.8       
    CrHMCIIIa       DQ090486          2054       631         72.8            5.74          70.5     60.0 
    CrHMCIIIb       DQ090487          2220       628         72.8            5.86          61.6     53.4      63.4 
    CrHMCIV         DQ090488          2188       624         72.1            5.97          63.9     58.3      65.4     68.5 
    CrHMCV          DQ090489          2581       638         74.0            5.74          59.8     55.9      59.6     58.4     59.3    
    CrHMCVI         DQ090490          2266       631         72.8            5.74          60.3     55.1      59.3     57.1     59.0     79.3       
 
Although the HMC is extracellular proteins, no signal peptides for transmembrane 
transport have been found in the subunit sequences. This is consistent with the 
observation made by Siggens et al (1983).  They studied the in vitro translation products 
of the mRNA isolated from the limulus cyanoblast (the tissue for HMC synthesis) using 
Xenopus oocyte systems, and drew the conclusion that the HMC polypeptides are 
unlikely to undergo significant post-translational modification or to possess cleavable 
signal sequences; instead, the release of haemocyanin into the haemolymph in vivo may 
involve rupture of the cyanoblasts.  Furthermore, they proposed that HMC proteins do  
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domain 1 
CrHcI           --MTIKEKQASILALFEHLTSVPKQHIPEKE-RDNRLHDVGHLSRGKLFSLFHREHLEEA 57 
CrHcII          --MTLHDNQVRVCHLFEQLSSATVTGNGEKHKHSDRLKNVSKLQPGAIFSCFHPEHLEEA 58 
CrHcIIIa        --MTVKEKQSRLLPLFKHLTSLTRDQPPVSQ-RDDRLKDVGHLPRGTLFSLFHSKHLEEA 57 
CrHcIIIb        --MTIQEKQNKILSLLEHLNNLTKHQLPVDE-RDPRLKDVGHLLRGGLFSLFHMEHLTEA 57 
CrHcIV          --MTLKEKQDRILALFEHLTSLTKHQLPEEQ-RDARLHDLGHLLRGELSSCFHKEHLEEA 57 
CrHcV           MVLSVLQKQLRVLPLFECATVPTKEKFALKAYRDHKFEGVGILGRGQLFSLFHAEHLAEA 60 
CrHcVI          MVLDTVEKQLRVLPLFEYASISTKEKFALKVHRDPKLQGLGVLGRGQLFSLFHAEHLAEA 60 
LpHcII          ---TLHDKQIRICHLFEQLSSATVIGDGDKHKHSDRLKNVGKLQPGAIFSCFHPDHLEEA 57 
                     AAAAAAAAAAA  AAA              AAAA              AAAAAAA 
                        α1.1      α1.2             α1.3                α1.4 
 
CrHcI           THLYEILHAAKNFDDFLLLCKQARDFVNEGMFAYAVSVALLHRDDCRGLIIPPVEEVFPD 117 
CrHcII          RHLYEVFWEAGDFDDFIEVAKEARTFVNEGLFAFACEVAVLHRDDCKGLHVPPVQEIFPD 118 
CrHcIIIa        THLYEILYGAKDFDDLIHLLEQARDTVNEGMFVYAATVAVLHRDDCRGVTVPPIEEVFPD 117 
CrHcIIIb        THLYETLYNAEDFDDFIHLCEQAKDVVNEGMFAYAISVAVLHRNDCKGLALPPIQEIFPD 117 
CrHcIV          THLYEALYKAKNFDDFIHLCEEARQIVNEGMFVYAVSVAILHRDDCKGLAVPPIQEIFPD 117 
CrHcV           TKLYEVLIAADTFEEFLDLCHQVRDFVNESLYVYALSVALLHRPDCKGITLPPIQEIFPD 120 
CrHcVI          TKLYEVLIGAKTFEEFLDLCHQVRDFVSEGLYVYAVSVAILHRPDCKGVSLPPIQEIFPD 120 
LpHcII          RHLYEVFWEAGDFNDFIEIAKEARTFVNEGLFAFAAEVAVLHRDDCKGLYVPPVQEIFPD 117 
                AAAAAAAA    AAAAAAAAAAA      AAAAAAAAAAAAA           AAAA 
                  α1.4        α1.5                α1.6                
 
                                                     domain 2   #      *   * 
CrHcI           RFIPVETIREAQKEVELHPGKD---IVVEVENTGNILDPEYRLCYFREDLGVNAHHWHWH 174 
CrHcII          KFIPSIAINEAFKKAHIRPEFDESPILVDVHDTGNILDPEYRLAYYREDVGINAHHWHWH 178 
CrHcIIIa        RFIPAETIRHADKEVTAHPDKD---IVVEFEETGNILDPEYRLAYYREDVSINRHHWHWH 174 
CrHcIIIb        RFIPAETITEAIKDDHNRHDHEV--LTVEARDTGNILNPEQHLAYFREDIETNAHHWHWH 175 
CrHcIV          RFIPAETITQAMKDDHHRKEHEA--LVVDMEETGNILNPEQRLAYFREDIEINAHHWHWH 175 
CrHcV           KFVPVQTFNNALKEAFTEPDKEKE-MIVNMQATGNIHDPEYNIAYYREDIGINAHHWHWH 179 
CrHcVI          KFMPVQTMYDAYKEAWLNPNKEED-IIVDMQSTGNILDPEYNLAYYREDIGINAHHWHWH 179 
LpHcII          KFIPSAAINEAFKKAHVRPEFDESPILVDVQDTGNILDPEYRLAYYREDVGINAHHWHWH 177 
                    AAAAAAAAA            BBBB          AAAAAAAA  AAAAAAAAAAA        
                     α1.7                β1B                        α2.1   
              
                                          *     #    #         
CrHcI           IVYPATWRSEVMGKTKDRKGELFFYMHQQMCARYDCERLSNHMHRMSPFSNLHEELEGYA 234 
CrHcII          LVYPSTWDPKYFSKKKDRKGELFYYMHQQMCARYDCERLSNGMHRMLPFHNFDEPLAGYA 238 
CrHcIIIa        IVYPATWRPEVMHKEKDRKGELFYYMHQQMCARYDCERLSNGMHRMYPFNNFHEDLEGYS 234 
CrHcIIIb        IVYPATRNSKVMHKVKDRKGELFFYMHQQMCARYDCERLSVGLQRMLPFQNFEEELEGYS 235 
CrHcIV          LVFPATWRPEVMGKVKDRKGELFYYMHQQMCARYDCDRMSVGLQRMIPFQNFEETLEGYS 235 
CrHcV           LVYPATWRPEVTGKVKDRKGELFYYMHQQMCARYDCERLSNDMPRMEPFHNFHSPLEGYS 239 
CrHcVI          IVYPATWRPEVIGKIKDRKGELFYYMHQQMCARYDCERLSNGMPRMEPFRNFHDTLEGYS 239 
LpHcII          LVYPSTWNPKYFGKKKDRKGELFYYMHQQMCARYDCERLSNGMHRMLPFNNFDEPLAGYA 237 
                        AAAA      AAAAAAAAAAAAAAAAAAAAAA       
                                         α2.2  
 
                              # 
CrHcI           PHLTSMISGLHYGVRPSGMKLHDID-VVTIQDMERWVQRIMEAIDIHMVNDTHGNKLKLD 293 
CrHcII          PHLSHIASGKYYSPRPDGLSLRDLG-DIAISDMVRMRERISDSIHLGYVIDSEGNHKNLD 297 
CrHcIIIa        PHLTSLISGLNYGTRPDGLKLHDLH-DVTIQDRERWRERIHNAIDLKMVHDHDGKEIAIH 293 
CrHcIIIb        AHLTSLVSGLHYASRPEGMHLHDLKGVVNLYEMERWRERIMDAIERGLVFDDDNHEHKLE 295 
CrHcIV          AHLTSLISGLHYASRPEGLHIRDLN-DISLQEMERWRGRILDAIHPGHLHDAHGNEVKLD 294 
CrHcV           SHLTSLINGLSYPSRPAGLKLQDLK-DVSIQDMERWRSRISDAIHIGHVQDENNHEYLLD 298 
CrHcVI          SHLSSSINGLPYPSRPEGMTLQDLK-EVSIQDLERWRDRISDAIHIGHVEDENGSHVPLD 298 
LpHcII          PHLTHVASGKYYSPRPDGLKLRDLG-DIEISEMVRMRERILDSIHLGYVISEDGSHKTLD 296 
                   BB    BB                AAAAAAAAAAAAAAAAAAA BBB     BBB 
                   β2B   β2C                         α2.3       β2D    β2E 
 
                                           *   *                      #     
CrHcI           ETTGIDVLGALVEASHDSINPEYYGSLHNWGHVITARAHDPEGKFHEDPGVMSDTSTSLR 353 
CrHcII          EHHGIDILGALVESSHESVNKEYYGNLHNWGHVTMARIHDPDGRFHEEPGVMSDTSTSLR 357 
CrHcIIIa        EENGIDILGALVESSYESVNQGFYGSLHNWGHVLTARAHDPEGKFYENPGVMSDTSTSLR 353 
CrHcIIIb        EPHGIDMLGAIIEASHDSVKHDFYGSIHNWGHVMFARLHDPDGRYHDNPGVMSDTATSLR 355 
CrHcIV          EEHGIDTLGSLIEASHESKNEEYYGNLHNWGHVMLARVHDHDGRFHENPGVMSDTSTSLR 354 
CrHcV           ETHGIDILGAIIEASHESINQHFYGSIHNWGHVITARVLDPDGRFHLNPGVMSDTATSLR 358 
CrHcVI          EARGIDVLGALVEASYESINQAFYGSIHNWGHVITARVQDPDGRYHLNPGVMSDTATSLR 358 
LpHcII          ELHGTDILGALVESSYESVNHEYYGNLHNWGHVTMARIHDPDGRFHEEPGVMSDTSTSLR 356 
                   AAAAAAAAAA       AAAA  AAAAAAAAAA                      
                      α2.4                  α2.5 
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                ##     *                # domain 3                 # 
CrHcI           DPIFYRWHRFIDNVFQDYKESLHPYTKDELSFTGIKVVNVSVNAKVKNVITTFIKKNELE 413 
CrHcII          DPLFYNWHGFIDDLFQEYKNTLKPYDHGMLNFTDIQIQNVTLHARVDNVIHTFMRENELE 417   
CrHcIIIa        DPIFYRWHRTLDNLFQEYKESLSPYTKEELSFPGIEVLSASVKTKTNNVITTSMVESELE 413 
CrHcIIIb        DPIFYRFHRYIDNMFQTYKATLHSHEHHQLTFSGVQIDNVTVKAKQPNVINTYTTESELE 415 
CrHcIV          DPIFYRYHRFIDNMFQEYKASLHHYTKKELTFPEISVSHVTVKAXVPNIIHTXMATDELE 414 
CrHcV           DPIFYRWHRFIDNLFQDYKETLPHYRKDELEFPGVEITNVIVSAEHANNINTFKENALLN 418 
CrHcVI          DPIFYRWHRFIDNMFQNYKETLPHYNHSDLEFAGVEITKVLVRAKHTNNIDTFKSNSLLD 418 
LpHcII          DPIFYNWHRFIDNIFHEYKNTLKPYDHDVLNFPDIQVQDVTLHARVDNVVHTFMREQELE 416 
                 AAAAAAAAAAAAAAAAAA       AAAA    BBBBBBBBB     BBBBBBBBBBBB 
                       α2.6               α3.1       β3A             β3B  
  
                                                                # 
CrHcI           LTHGMDFGTTNSVKVKYPHLEHEPFSFQITVENTSGAKKDATVRIFLAPKFDELGNELPA 473 
CrHcII          LKYGVNLGHARSVKARYYHLDHEPFSYAVDVQNNSASDKHATVRIFLSPKYDELGNEIKA 477 
CrHcIIIa        LSHGINFGTDHSVKVKYHHPDHEPFSYHINVSNNSGSPKHATVRIFLAPKYDELGNLLHP 473 
CrHcIIIb        LSHGIHMKG--PTKVKYHHLDHDKFDYSISVNNTSGLAKNATFRIFLGPKYDELGNLLTP 473 
CrHcIV          LSHGIHLNG--PTKVKYHHLNHEXFTYEIHVENKSDSVKHGTFRIFLAPKYDELGNRLIL 472 
CrHcV           LSHAYEFGRTGNVKVRYNHLSHESFDYNIEVENHSNRTKPSTVRIFMAPKYDELGNELQT 478 
CrHcVI          LSHAYEFGRTGAVKVRFNHLNHEEFDYKIQVENHTSKTKPATVRIFMAPKYDELGNELNT 478 
LpHcII          LKHGINPGNARSIKARYYHLDHEPFSYAVNVQNNSASDKHATVRIFLAPKYDELGNEIKA 476 
                            BBBBBBBBBB   BBBBBBBB     BBBBBBBBBBB          A 
                                β3C        β3D           β3E 
 
                                   #                                     c c 
CrHcI           NIQRRLFIELDKFHRELISGQNIITHNAADSSVTVSTLRSFEDLKAGKGVSEDATEYCSC 533 
CrHcII          NDLRHTAIELDKFKTDLHPGKNTVVRHSLDSSVTLSHQPTFEDLLHGIGLNDNKSEFCSC 537 
CrHcIIIa        NEQRRFCIELDKFHKELNAGKTEITRNSVDSSVTISTLRTFNELNDGVGVSENADEYCSC 533 
CrHcIIIb        EQQRRFFIELDKFHREVPTGKSVITRSSADSSVTISHVPTFEELRNGKGVDVNNSEFCSC 533 
CrHcIV          NEQRRLFIELDKFHHGIHKGSNTIVRNSTESSVTISKVHTFNELKAGVGVKESNTEYCSC 532 
CrHcV           KDLRRLMIEMDKFHHDLHPGRNTIIRHSKDSSVTLSSERTFDELAHGEGINEHANEYCSC 538 
CrHcVI          KNLRRLMIEMDKFHAEFYPGHNYIVRHSKNSSVTISSARSFGQLAHGEGVNEHANEYCSC 538 
LpHcII          DELRRTAIELDKFKTDLHPGKNTVVRHSLDSSVTLSHQPTFEDLLHGVGLNEHKSEYCSC 536 
                AAAAAA BBBBBBBBBB  BBBBBBBBAAA   BB     AAAAA                 
                           β3G         β3H      β3I      α3.3 
 
                        #     #                          c      c   
CrHcI           GWPQNMLIPRGNRKGMVFELFVMLTDWEKDNVNG---SVGFCSDAVSYCGAKDHKYPDKK 590 
CrHcII          GWPSHPLVPKGNVKGMEFHLFVMLTDWDKDKVDG--SESVACVDAVSYCGARDHKYPDMK 595 
CrHcIIIa        GWPKNMLIPRGNHKGMVFELFVMLTDWEHDNVSGKGQESPMCDDAVSYCGAKDSKYPDKK 593 
CrHcIIIb        GWPQHMLIPRGNYLGMEFQLFVMLTDWEQDKAGK-DLEHLTCADAVSYCGARDHLYPDKK 592 
CrHcIV          GWPQHMLVPRGNEKGMDFQLFVMVTDWEDDNVNG-ALS-LICADAVSYCGARDHKYPDKR 590 
CrHcV           GWPDHLLVPRGNEKGMPFHSFVMLTDWLHDQVGD-HGKTSICVDAVSYCGAKDQLYPDRR 597 
CrHcVI          GWPDHLLVPRGNENGMPFHLFVMLTDWLQDQVGD-HGKTGMCTDAVSYCGAKDQLYPDRR 597 
LpHcII          GWPSHLLVPKGNIKGMEYHLFVMLTDWDKDKVDG--SESVACVDAVSYCGARDHKYPDKK 594 
                 BBAAA         BBBBBBBBBBBBAAAA              AAAA 
                 α3.4                β3J   α3.5 
 
                    #  
CrHcI           PMGFPFARKIKNEPLEDFLTTNMGVSAIKIQFMG------- 624 
CrHcII          PMGFLFDRPILTEHISDFLTNNMFIKDIHIKFHE------- 629 
CrHcIIIa        HMGFPFDRRIDAPDIEEFLXPNMTLTDIKIKFEGKKPK--- 631 
CrHcIIIb        PMGYPFDRPIKAHTVEEFLTPNMSLTDVKIQYKGNI----- 628 
CrHcIV          PMGFPFDRPIDARTPSQFATPNMSFTDIRIQFVH------- 624 
CrHcV           AMGFPFDRAIESDHLEEWILPNMRNTVITVTYHEEVHSEHH 638 
CrHcVI          PMGFPFDRDIEEEHLSDWLLPNMKDVLITVTHHE------- 631 
LpHcII          PMGFPFDRPIHTEHISDFLTNNMFIKDIKIKFHE------- 628 
                                                                         AAA          BBBBBBBBB 
                                                                         α3.6                       β3L 
 
 
Figure 3.7:  Amino acid alignment of the C. rotoundicauda hemocyanin subunits.  The 
positions that are strictly conserved are shaded. At the bottom, the secondary structure elements 
derived from the analysis of L. polyphemus subunit II (pdb1LLA) are indicated: A: α-helices; B: 
β-sheets. The nomenclature has been adapted from the NCBI Entrez Protein. Other features are 
given in the top row: *, copper ligand; c, disulfide bridges.  
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not need to pass through the Golgi apparatus and therefore no carbohydrate moiety was 
detected in the native horseshoe crab HMC, despite the presence of several putative N-
glycosylation sites (NX(T/S)) in the primary structure of all seven subunits (Siggens and 
Wood, 1983).  By contrast, the signaling peptide was found in the prophenoloxidase 
(PPO) from the giant fresh water prawn, Macrobrachium rosenbergii  (Liu et al., 1998).   
 
3.2.3  Phylogenetic analysis of the horseshoe crab hemocyanin 
The sequences of the 7 subunits of the C. rotundicauda hemocyanin (CrHMC) were 
aligned with the known HMC subunit II sequences of L. polyphemus, those of the 
American Tarantula (also a Chelicerate) and those from Crustaceans (Figure 3.8). Non-
rooted phylogenetic tree suggests that the HMC subunit II is the least homologous to 
other subunits, and this is consistent with the unique PPO activity shown by Decker et al. 
(Decker et al., 2001).  In their study, submicellar concentrations of SDS were used to 
exhibit the O-diphenoloxidase activity of the HMCs from Limulus polyphemus, 
Eurypelma californicum, and Cancer magister.  The enzymatic activity seems to be 
restricted to only a few of the heterogeneous subunits, with similar topological positions 
in the quaternary structures as linkers of the two tightly connected 2 x 6-mers (Figure 
1.7).  In Figure 3.8, for phylogenetic inference, a few of the available PPO sequences of 
Crustacean and insects were included into the alignment.  PPO-like proteins are the most 
likely ancestors of arthropod HMCs, and thus the contemporary arthropod PPO was 
considered as the outgroup. Phylogenetic trees were constructed assuming maximum 
parsimony or with the neighbor joining method. In all types of analysis, the HMC 
subunits of the Chelicerata form a single well supported clade that is strictly separated 
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from that of the Crustacean proteins (Figure 3.8a). This indicates that the subunits 
individually diversified in the subphyla after the Crustacea and Chelicerata diverged in 
the Cambrian or in an earlier period. 
Figure 3.8 a: Evolutionary implication of hemocyanin sequences: phylogenetic relationship 
among the Chelicerate HMCs.  The simplified trees were deduced by a neighbour-joining 
analysis based on the alignment of the amino acid sequences. The crustacean HMCs and PPO are 
considered as the outgroup. Abbreviations and sequence anotations are as in legend to Fig. 3.8b.  
a 
































Figure 3.8 b: Evolutionary implication of hemocyanin sequences: an approximate time scale 
of the evolution in the chelicerate hemocyanins. The linearized tree was obtained on the basis 
of corrected protein distance data (PAM 001 matrix). The divergent times were estimated as 
descrived. At the bottom of the figure, the arrow indictates the Merestomata-Arachnida split.  
CrHc_I-IV, hemocyanin subunits I to IV of C. rotundicauda (DQ090484, DQ090485, DQ090486, 
DQ090487, DQ090488, DQ090489 and DQ090490, respectively);  EcaHc_a-g, hemocyanin 
subunits, from a to g, of E. californicum (X16893, AJ290429, AJ277489, AJ290430, X16894, 
AJ277491, and AJ277492, respectively); AauHc6, Androctonus australis HMC 6 (P80476); 
LpoHcII, subunit II of L. polyphemus (P04253);  ScoHcA, S.coleoptrata HMC A (Q95P08); 
CmaHc6, hemocyanin subunit 6 of C. magister (AAA96966); DmePPO, prophenoloxidase of D. 
melanogaster (BAB17671).  
 
 
3.2.4 Interpretation of the functional features of HMC in innate immunity from its 
molecular structure 
 
With the cDNA and the amino acid sequences available, the possible role(s) of 
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hemocyanin in innate immunity can be predicted based on the understanding of structure-
activity relationship.  The pairwise homology amongst the seven subunits is as high as 
53-79%, suggesting that each subunit play similar or related functions.  Figure 3.9 shows 
the Kyte-Doolittle hydropathy plots for the alpha domains of CrHc subunit I.  Alpha 
domain is the most diversified domain, with homology of only 21% among the AAs. 
However, this domain of each HMC subunit harbors a conserved hydrophilic pocket and 
a conserved hydrophobic pocket respectively, which are supposed to be the ligand 
binding sites responsible for the allosteric regulatory role of HMC’s oxygen-binding 


























Figure 3.9: Hydrophobicity plot for the α domains of C. rotundicauda hemocyanin subunit I.  
The prominent hydrophobic and hydrophilic regions in the α-domain are conserved among all the 
subunits. (Plotted using DNAMAN) 
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The active site for oxygen binding and PPO activity resides in the central copper-
binding domain.  Figure 1.9 highlights how a Phe49 is supposed to block the entrance for 
phenolic substrate to the active site. A proteolysis or conformational change that removes 
the blockage will activate the PPO to PO.    
Table 3.2 shows the comparison of the C-terminal 16-peptide sequences of 
CrHMC subunits, with reference to the known antimicrobial peptides from other 
chelicerate HMCs (Destoumieux-Garzon et al., 2001; Lee et al., 2003).  It is notable that 
CrHcIIIa harbors a highly positively charged C-terminus, with considerable similarity to 
the 16-mer PleH antimicrobial peptide isolated from P. leniusculus, which is believed to 
be released from hemocyanin by some serine protease cleavage during microbial 
infection.  Whether or not similar mechanism works for the horseshoe crab immune 
response needs to be further investigated.  
 
Table 3.2: Comparison of CrHMC C-terminal peptides and the antimicrobial peptides 
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3.3 The extracellular antimicrobial effect is elicited through activation of PO by 
microbial proteases and PAMPs  
 
 
The ROS-mediated antimicrobial activity is a powerful host defense mechanism. 
Recent studies have revealed that HMC and Hb, the respiratory proteins from 
invertebrates and vertebrates, respectively, can produce ROS (Nagai and Kawabata, 2000; 
Nagai et al., 2001; Alayash, 1999; Kawano et al., 2002).  However, in both cases, (i) how 
the ROS production is regulated by the microbial virulence factors during infection and 
(ii) the contribution of the ROS in antibacterial actions are not fully understood. 
To address these questions, in this section, we will (1) reconstitute the microbial 
proteases- mediated ROS production by HMC and Hb, respectively;  (2) evaluate the 
antimicrobial activity of the ROS production in vitro and in vivo;  (3) study the 
mechanism underlying how the ROS production is tightly regulated to avoid host self-
destruction.   
 
3.3.1 Activation of HMC-PPO to PO by microbial proteases and PAMPs  
Seeing that the horseshoe crab HMC harbors PPO activity, in this thesis, native 
form of HMC purified from the animal plasma is addressed as HMC/PPO.  To test the 
hypothesis that microbial proteases can trigger the PPO activation independent of host 
proteases, purified HMC/PPO was reacted with several microbial proteases and the PO 
activity was determined.  
As shown in Figure 3.10, the subtilisin A and proteinase K from Gram-positive 
bacteria; Pseudomonas elastase (PAE) from Gram-negative bacteria; and the type XIV 
protease from fungi efficiently activated HMC/PPO.  However, the activated host 
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protease Factor C or mammalian digestive protease trypsin did not (Jiang et al., 2007).  
Nagai et al (2000, 2001) reported that activated serine proteases from the clotting cascade 
converted the horseshoe crab hemocyanin to PO, however, non-proteolysis was observed 
during the activation, and therefore they suggested that these serine proteases activated 
PPO through conformational change in the hemocyanin molecule.  To understand 
whether or not the proteolysis is essential for the microbial protease-mediated PO 
activation, we used protease inhibitors to inactivate the proteases prior to their action on 
HMC/PPO (Figure 3.11). When subtilisin A, proteinase K, and type XIV protease (of 
microbial origin) were inhibited by PMSF, or when PAE, a metalloprotease from P. 
aeruginosa, was inhibited by 1,10-phenanthroline monohydrate, we observed only <20% 
PO activity, clearly indicating that proteolysis of the HMC/PPO is specific and 






Figure 3.10: Activation of the horseshoe crab HMC/PPO to PO by microbial proteases.  PO 
activity triggered from HMC/PPO by various microbial proteases: subtilisin (♦), proteinase K (○), 
Pseudomonas Elastase (PAE, ▲) and type XIV protease (■); Negative control: BSA (∆).  
Purified HMC/PPO (60 µg) and protease (40 µg) were used  in each reaction containing 125 µl.   
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Figure 3.11:  PO activity triggered from HMC/PPO by various microbial proteases through 
conditional proteolysis.  One mM PMSF was used to inactivate subtilisin A, proteinase K and 
Type XIV protease while 1 mM of 1,10-phenanthroline monohydrate was used to inactivate 
PAE.   
 
PAMPs play important roles in triggering the innate immune response (Heine and 
Ulmer, 2005; Ingle et al., 2006; Kurata et al., 2006; Nurnberger and Brunner, 2002).  To 
understand their contribution in PPO activation, we tested two types of LPS, two types of 
LTA and one type of laminarin and found that none of the PAMPs on their own (at 
0.125-20 mg/ml) activated HMC/PPO substantially.  Considering the co-existence of 
PAMPs and the extracellular proteases at the vicinity of the microbe, we further tested 
PAMPs in combination with microbial proteases.  As shown in Figure 3.12, when   
HMC/PPO was pre-treated with PAE prior to adding LPS, the resulting PO activity was 
enhanced dose-dependently by LPS.  Similar observation was made with LTA-subtilisin 
A combination, but not with the laminarin-type XIV protease combination.  The 
enhancement of the microbial protease-induced PO activity by PAMPs strongly suggests 
that HMC/PPO activation is a non-self recognition mechanism.  This specificity of the 
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action of PAMPs is further confirmed when PAMPs and mammalian host membrane 




Figure 3.12: PAMP molecules further enhanced the PPO activation induced by microbial 
proteases in a dose-dependent manner.  10 µl of the HMC was first incubated with 10 µl of 
protease at room temperature for 10 min.  Then 10 µl of LTA or LPS were added into the reaction, 
immediately before 100 µl of 1mM 4ME were added.  PO activity was presented as the A405 at 
5min upon the addition of substrate.   
 
 
3.3.2  HMC/PPO activation by microbial components commonly occurs amongst 
horseshoe crab community  
 
In order to understand whether the activation of HMC/PPO to PO by microbial 
components is a universal immune response in the horseshoe crab species, or is simply a 
random observation in certain individual animals, a survey was conducted amongst the 
horseshoe crab community.  To this end, 16 horseshoe crabs were randomly selected 
from a collection of 80 individuals, including both genders and of various sizes.   Plasma 
was collected from each individual and the HMC was purified by gel-filtration for further 
PPO activity assay.  To measure the microbial components mediated PO activity, 
hemocyanin from each individual was treated with the same protocol: 60 µg of 































hemocyanin was incubated with 40 µg of PAE at room temperature in 10 µl 50mM, pH 
7.4 PBS for 10 min before 50 µg of LPS in 10 µl of the same buffer was added.  
Immediately afterwards, 100 nmol 4ME in 100 µl of 0.1 M, pH 6.9 potassium phosphate 
buffer were added.  The absorbance at 405nm was continuously monitored.  The PO 
activity was presented as the increment of A405 per min.  As control, 100 nmol 4ME in 
120 µl of 0.1M, pH6.9 potassium phosphate buffer was added to 60 µg untreated 
hemocyanin in 50 mM pH 7.4 PBS, and the A405 was monitored.   The result was shown 
in Figure 3.13.   Microbial component mediated PO activation was observed in all the 
individual replicates of horseshoe crabs investigated; indicating that the microbial 
protease and PAMP mediated PO activation is a universal immune response in the 














Figure 3.13: A survey among the horseshoe crab community demonstrated that the 
microbial protease-mediated PO activation is a universal immune response.   Plasma was 
collected from 16 randomly selected horseshoe crabs and hemocyanin was purified by gel-
filtration.  Synergism between PAE and LPS in PPO activation was observed in all the samples 
tested. Void bar: hemocyanin alone; Solid bar: hemocyanin treated with PAE and LPS.  
 
3.3.3 Tight control of quinone production to avoid host self-destruction  
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Highly reactive quinone produced from PPO activation is toxic to both the 
microbe and the host (Cerenius and Soderhall, 2004).  Therefore, to avoid undesirable 
self-destructive effect, the host seems to have evolved a fine thread in distinguishing non-
self from self to ensure that its PPO is only activated proximal to the invading microbes.  
For the microbial component-mediated PPO activation pathway in the horseshoe crab, we 
investigated the mechanisms underlying how the PO production was controlled in tightly 
regulated manner and found that no less than four fold mechanisms were involved.  
 
Mechanism #1:  The specificity of the PPO activation factors  
We have shown that PPO activation was induced by microbial components, such 
as extracellular protease and PAMPs.  Host proteases abundantly exist in the plasma, 
often as zymogens, and can be activated through a cascade of limited proteolysis.  In 
order to understand whether or not the host zymogen or activated proteases, can turn on 
HMC/PPO to PO, we tested the horseshoe crab Factor C, located on the surface of 
amebocyte, in both its zymogen form and the LPS activated serine protease form.  
Furthermore, we simultaneously tested a mammalian digestive protease, trypsin, as a 
control for host-microbe specificity.  As shown in Figure 3.12 and Figure 3.14, only the 
microbial protease but not the host extracellular proteases activated the PPO.  Besides, 
we also compared PAMPs, such as LPS and LTA from prokaryotic microbes, with POPG 
and POPE, which are phosphatidyl lipids commonly found in both prokaryotic microbes 
and eukaryotic host cell membrane.  As shown in Figure 3.15, only PAMPs, but not the 
phosphatidyl lipids, could further enhance PPO activation.  In summary, the specificity of 
the PPO-PO conversion assures that the PPO activation only happens in the presence of 
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invading microbes. At this juncture, only Factor C, which exists on the surface of 
hemocyte, was examined.  Future study may include other plasma proteases, such as the 
complement components, to further address the specificity issue. This self-nonself 
differentiation mechanism could have been an evolutionary advantage to confer immune 
protection to the host whilst preventing itself from the ultimate quinone toxicity (Jiang et 




Figure 3.14: Activation of the horseshoe crab HMC/PPO to PO by microbial proteases but 
not by host proteases Factor C. PO activity triggered from HMC/PPO by various microbial 
proteases: subtilisin (♦), proteinase K (○), Pseudomonas Elastase (PAE, ▲) and type XIV 
protease (■); but not by host protease Factor C (o). Negative control: BSA (∆).  Purified 
HMC/PPO (60 µg) and protease (40 µg) were used  in each reaction containing 125 µl.   
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Figure 3.15:  Microbial PAMPs but not the lipids common to host and bacteria further 
enhance the mircrobial protease-meidated PO activation. Phosphatidyl lipids POPE, 1-
palmitoyl-2-oleoyl-phosphatidylethanolamine and POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine are common to the host and the microbe.   
 
 
Mechanism #2: The limited availability of the endogenous PO substrate 
Besides the specificity of the PPO activation factors, the availability of a PO substrate in 
the host could be another check point of the toxic quinone production.  Without knowing 
the actual identity of phenolic substrate species present in the hemolymph, we examined 
the total phenolic substrate level in the plasma, especially on the dynamic profile of the 
substrate level during infection.  As shown in Figure 3.16, the total phenolic substrate 
level in the horseshoe crab plasma remained constantly low in all the individuals 
examined.  Moreover, such level was not significantly affected by bacterial infection.  
This observation revealed one more inherent property which may ensure the limitation of 
the quinone production under normal circumstances, viz, the low level of the phenolic 
substrate in circulation.  This low level of phenolic substrate may be attributable to the 
highly active PO that would immediately exhaust any phenolic substrate when it is 
available.  This scenario would effectively reduce any undesirable formation of the 
                                                                                                                                      94           
harmful quinone product. It is conceivable that the production/availability of phenolic 













Figure 3.16:  The total phenolic substrate level in the horseshoe crab plasma.  For each 
sample, 1.5 ml of the protein-free plasma was used.  
 
Mechanism #3:  Protease inhibitors act as the on-off control of the PPO activation  
Undoubtedly, the prevention of unfavorable activation of PPO under normal 
physiological conditions must be crucial to maintain homeostasis. Recent research has 
revealed at least two endogenous protease inhibitors related to PPO pathway in the 
hemolymph of insect Manduca sexta (Wang et al, 2004; Zhu et al, 2003).  Does such a 
protease inhibitor exist in the horseshoe crab?  Interestingly, CrSPI, a Kazal type serine 
protease inhibitor, was found in horseshoe crab hemolymph (Thangamani, Jiang et al, 
unpublished).  This CrSPI targets microbial protease such as subtilisin.  Moreover, in the 
acute phase (1-3 h of infection) of horseshoe crab immune response against sublethal 
dosage of Pseudomonas aeruginosa, the transcription of CrSPI was downregulated and 
the CrSPI activity in the plasma was also lowered. Since the microbial protease like 
subtilisin could activate host HMC/PPO to PO, we were interested to verify whether or 
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we added the recombinant CrSPI at increasing level to the subtilisin-triggered PPO 
activation reaction, and monitored the resultant PO activity.  As shown in Figure 3.17a, 
the increasing level of CrSPI effectively inhibits the PO activation mediated by subtilisin.  
Although the endogenous cognate protease of CrSPI remains to be identified, the protein 
and transcript levels of CrSPI display interesting temporal profile (Figure 3.17b, 
Thangamani, Jiang et al, unpublished), and it may reflect another level of homeostatic 
mechanism:  under naïve condition, CrSPI level is high, and this is presumably important 
to inhibit endogenous protease which possibly limits any random activation of PPO; 
however, soon after the bacterial challenge, during the acute phase of immune response 
(1-3 hpi), the CrSPI level was lowered, presumably to release the endogenous and 
exogenous cognate proteases, to allow them to activate immune responses, such as PPO 
activation.  By 6 hpi, the plasma CrSPI level recovered, which may again be important to 
restore homeostasis.  
 
Mechanism #4:  Localization of the PPO activation through HMC/PPO-pathogen 
interaction   (see section 3.3.4) 
With a large variety of proteases circulating in the plasma, and the extremely high level 
of HMC/PPO, the horseshoe crab is challenged with the potential risk of undesirable PO 
activity.  Thus, it appears pertinent to ask whether there is any mechanism to orientate or 
localize the PPO/PO directly at the microbe whilst sparing the host itself from the toxicity 
of the quinone.  As we will demonstrate later, PPO activation control also resides in the 
localization of HMC/PPO to the vicinity of invading microbial, which helps to prevent 
the activated PO from diffusing from the microbes.  This localization is probably 
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mediated by HMC-microbe interaction via two mechanisms: (1) direct HMC-PAMP 
interaction and (ii) the indirect HMC interaction through PRRs (pathogen recognition 
receptors).  In the following part, we will summarize the investigation on these two ways 
of HMC-microbe interactions.  
                          
 
Figure 3.17: Indirect control of PO activation by endogenous protease    
 inhibitors. (a) CrSPI inhibits the PO activation by subtilin in a dose dependent manner.  (b) Plasma 
CrSPI level remains low within the acute phase (1-3 hpi) of P. aeruginosa challenge, suggesting that 
protease inhibitors may form another level of regulatory mechanism to allow the PO activation at the 
acute phase of innate immune response. 
 
3.3.4 Localization of PO activity through HMC-PAMP and HMC-PRR interaction  
3.3.4.1 Evidence for the direct interaction between HMC and LPS 
It was reported that spider HMC binds Ecdysone and 20-OH-Ecdysone with a 
relatively low affinity and the binding site was localized to an evolutionarily conserved 
hydrophobic pocket in the α domain (Jaenicke et al., 1999).  The structure-activity 
relationship suggests that HMC may harbor LPS binding activity within the α domain of 
its subunits. Indeed, direct interaction between HMC and PAMPs were demonstrated 
with ELISA.  Figure 3.18 clearly shows that HMC binds to the immobilized LPS in a 
dose-dependent manner (solid line); moreover, pre-incubation of HMC with LPS 
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significantly blocked the HMC bound to the immobilized LPS (dashed line).  In other 














Figure 3.18: ELISA shows the direct interaction between HMC/PPO and LPS.  96 well 
microplates was immobilized with LPS (4µg/ml).  Solid line: HMC binds to the immobilized LPS 
in a dose dependent way.  Dash line: Pre-incubation of HMC with increasing amount of LPS 
reduced the ELISA signal in a dose-dependent manner, showing the specific interaction between 
HMC and LPS.   
 
SPR analysis revealed that the KD of Hemocyanin with immobilized LPS on HPA 
chip was (2.83±1.82) x 10 -7 M.   Compared with the KD of Ab-Ag interaction, which is 
from 10-7 M to 10-10 M, the HMC-LPS is relatively strong and therefore could localize 
the HMC/PPO at the vicinity of the Gram-negative bacteria during infection.    
 
3.3.4.2 Evidence for hemocyanin-PRR interaction 
In the plasma, horseshoe crab possesses an array of pattern recognition receptors 
(PRRs), which bind PAMPs with high affinity (Ng et al, 2007, Zhu et al, 2006).  The 
most abundant PRR is C-reactive protein, which binds to LPS.  Galactose binding protein 
(GBP) binds LPS through the GlcNAc motif.  The evidence on the interaction between 
HMC and these PRRs has been accumulated.   However, in this thesis, I will address only 
one of these observations, i.e. co-purification of HMC and GBP from the horseshoe crab 
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plasma.  Parallel studies in our lab on this issue have been reported by Ng and La Saux 
else where (Ng et al., 2007).    
Native GBP was purified from the naïve horseshoe crab plasma using affinity 
chromatography through the Sepharose 4B column, which carries GlcNAc suger moiety 
on it (Chiou et al., 2000).   The proteins eluted by GlcNAc solution were analyzed by 
SDS-PAGE gel.  As shown in Figure 3.19, the eluent showed different profiles under 
non-reducing and reducing conditions, suggesting a protein-protein interaction complex 
was eluted. Except for the common 72 kDa HMC doublets, a 250 kDa single band was 
observed under non-reducing condition while a 28 kDa doublet which was previously 
identified to be GBP (Ng, et al, 2007) appeared under reducing conditions.  Then the 250 
kDa band was retrieved for further identification by mass spectrometry (MALDI-TOF). 
Interestingly, the 250 kDa band shows a combined fingerprint profile of hemocyanin and 
GBP in the naïve plasma (Figure 3.20), indicating a possibile interaction between HMC 
and GBP which is independent of GlcNAc.  Further study in our lab verified the HMC-
GBP as well as the HMC-CRP interactions using recombinant proteins (Qiu, NUS 
Honor’s project, 2006).   
Our investigation on HMC-microbe interaction, through either HMC-PAMP 
interaction or HMC-PRR interaction has demonstrated how the PPO activation was 
controlled to avoid undesirable production of cytotoxic ROS.  In the ensuing section, the 
functional significance of the activated PO will be examined for its antimicrobial effect in 
vitro and in vivo.  To this end, the establishment of the bacterial models for the 
antimicrobial assay will be first presented.   
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Figure 3.19: GlcNAc elution profile of horseshoe crab hemolymph from CNBr-activated 
sepharose beads.  The 250 kDa band shown under non-reducing condition was further identified 
by mass-spectrometry, as shown in Figure 3.21.   
 
 
3.3.5 Bacterial models for the in vitro and in vivo antimicrobial studies  
To properly demonstrate the antimicrobial effect of the microbial protease-
mediated PO activation, the bacterial model should meet several criteria.  Firstly, 
representative Gram-positive and Gram-negative bacterial species should be examined.   
Secondly, to determine the specificity of the microbial proteases in driving the activation 
of PPO, bacterial strains which produce extracellular protease and those non-producing 
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Figure  3.20:  Mass spectrometry analysis of p250 complex.  The peptide fragments showed 
the co-existence of HMC and GBP in the complex. 
 
 
strains should be compared.  Thirdly, to avoid the interference from other microbial 
components, the protease-producing and non-producing strains should be of minimal 
genetic difference.  Fourthly, for real-time observation of the bactericidal effect, the 
bacteria should be labeled with a fluorescence marker so that their viability against the 
ROS could be directly monitored in real-time imaging.  The establishment of the 
Pseudomonase aeruginosa and Staphyloccocus aureus models which meet these criteria 
is described as follows.  P. aeruginosa and S. aureus were selected as the Gram-negative 
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and Gram-positive bacterium models respectively, because (1) they are commonly found 
opportunistic pathogenic bacteria, which produce a number of toxins and extracellular 
virulence factors that enable both formidable pathogens when the host immune system is 
impaired (Dubin, 2002; Jonsson et al., 1985; Pollack, 1984); (2) both are well-adapted in 
various environmental niches and are isolated from the natural estuarine habitat of 
horseshoe crab (Jiang et al, unpublished data), thus making them relevant bacterial 
models for investigating the immune mechanism in horseshoe crab.   
 As mentioned in chapter 1, two best-known extracellular proteases of P. 
aeruginosa are the elastolytic proteases, LasA (stapylolysin or LasA protease) and LasB 
(elastase).  In vitro, the bacteria express elastase at the early exponential stage in a sub-
aerobic culture condition.  In vivo, the expression of elastase is triggered by the oxygen 
stress the bacterium encounters upon entry into the host.  
To determine the specificity of the microbial proteases in driving the activation of 
PPO, the wild type strain of P. aeruginosa, PAO1-Iglewski, which produces both LasA 
and LasB, and PAO-B1A1, the lasB::Ω, and lasA:: Tetr mutant of PAO1-Iglewski, which 
is elastase-deficient were chosen as the Gram-negative bacterial model (Toder et al., 
1994).  For real-time bactericidal observation under fluorescence microscope, PAO1-
Iglewski and PAO-B1A1 were transformed with pDSK-GFP, a Pseudomonas plasmid by 
electroporation.  Figure 3.21 (a) shows the fluorescence of the pDSK-GFP transformed 
PAO1-Iglewski bacteria.  Figure 3.21 (b) shows that the extracellular protease 
production of PAO1-Iglewski and PAO-B1A1 was not affected by the pDSK-GFP 
transformation.  These two strains of P. aeruginosa were later used to examine the 
antimicrobial activity of the PO in vitro.   
 













Figure 3.21: Establishment of the Gram-negative bacterial model for realtime antimicrobial 
observation. pDSk-GFP, a Pseudomonas plasmid carrying GFP reporter, was electrically 
transformed into PAE-producing and non-producing Pseudomonas aeruginosa strains, PAO-
Iglewski (Igle) and PAO-B1A1, respectively. (a) The fluorescence image of the P. aeruginosa. (b) 
The protease producing property of each strain was tested to be unaffected using Azocoll assay.   
 
The extracellular V8 protease is an important Staphylococcal virulence factor of S. 
aureus.   In the wild type laboratory strain 8325-4, V8 expression is repressed by sarA, a 
global regulator of Staphylococcal virulence factor biosynthesis.  Therefore the S. aureus 
strain PC1839, which is the sarA knockout of 8325-4, produces an enhanced level of V8 
protease.  Aureolysin, another S. aureus extracelluar protease is needed for activating the 
V8 proenzyme.  Therefore S. aureus AK3, an aur deletion mutant of PC1839 does not 
produce active V8 protease  (Karlsson et al., 2001).  PC1839 and AK3 strains of S. 
aureus were selected to examine the antimicrobial activity of PO against Gram-positive 
bacteria.  To label the S. aureus strains with green fluorescence protein (GFP), 
pALC1420, an Escherichia coli-S. aureus shuttle vector containing gfpuv were 
transformed into electroporated S. aureus (Cheung et al., 1998).   Figure 3.30 (a) shows 
the fluorescence of the pALC1420 transformed S. aureus PC1839 bacteria. Figure 3.30(b) 
shows that the extracellular protease production of S. aureus PC1839 and AK3 was not 
affected by the pDSK-GFP transformation.  These two strains of S. aureus were later 
used to examine the antimicrobial activity of PO against Gram-positive bacteria. 
b a 































Figure 3.22: Establishment of the Gram-positive bacterial model for real-time antimicrobial 
observation. pALC1420, a Staphylococcal plasmid carrying GFP reporter, was electron-
transformed into V8 protease-producing and non-producing S.aureus strains, PC1839 and AK3 
respectively. (a) The fluorescence image of the P. aeruginosa. (b) The protease producing 
property of each strain was tested to be unaffected using Azocoll assay.   
 
3.3.6 Gram positive bacteria as an ideal model for evaluating the in vivo 
antimicrobial action of the PO-mediated quinone production 
 
To demonstrate the ability of PO in clearing the invading pathogen in vivo, we 
infected horseshoe crabs with protease-producing and non-producing bacteria prepared as 
described above.  Previously, it was reported that HMC/PPO is activated by host 
intracellular factors, such as activated Factor B, and proclotting/clotting enzyme (Nagai 
et al, 2000, 2001).  These factors are released from hemocytes upon LPS-dependent 
degranulation (Ariki et al., 2004; Muta et al., 1995).  In this work, to avoid provocation of 
PPO by such cellular components and to unequivocally demonstrate that the microbial 
factor-activated PPO contributes to the antimicrobial defense, Gram-positive bacteria 
lacking LPS were used to avoid LPS-induced hemocyte lysis.  To this end, the S. aureus 
strains, PC1839 and AK3 were used.  The following morphological and biochemical 
analyses (Figure 3.23) show that amebocytes did not undergo degranulation in contact 
with S. aureus, thus ruling out the involvement of host hemocyte intracellular 
a b 
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components in the in vivo bacterial clearance assay (Jiang et al, 2007), making our 
findings distinctive from that of Nagai et al (2000, 2001).    
For the morphological analysis, the horseshoe crab hemolymph was collected via 
the cardiac chamber under pyrogen-free condition.  Then 1 µl of PC1839, at a density of 
107cfu/ml was mixed with 1 µl hemolymph on a glass slide and the mixture of hemocytes 
and bacteria was immediately examined under bright-field and fluorescence microscopy 
with Zeiss fluorescence microscope.  Time-lapse microscopy images of the hemocytes 
after S. aureus challenge were taken at 30 s intervals for 30 min.  As a positive control of 
host degranulation, morphological observation of hemocyte in contact with P. aeruginosa 
PAO-Iglewski, a Gram-negative bacterium, was performed under the same condition.  
The morphological examination of hemocytes in contact with Gram-positive bacterium S. 
aureus and Gram-negative bacterium P. aeruginosa shows distinctive differences 
(Figure 3.23a).  Gram-positive bacteria caused the hemocyte to protrude pseudopods 
towards the bacteria, but no degranulation was observed.  However, Gram-negative 
bacteria caused immediate and drastic degranulation of the hemocyte, resulting in 
hemocytes devoid of granules within 5 min (Jiang et al, 2007).  
To further validate the absence of hemocyte degranulation or lysis, and hence, 
excluding the involvement of host intracellular factors in the humoral PPO activation, 
biochemical analysis of Factor C activity was performed.  As an intracellular serine 
protease in the hemocyte granules, the Factor C activity is an extremely sensitive 
indicator of LPS-induced hemocyte degranulation or lysis (Ding and Ho, 2001).  Thus, 
aliquots of 500 µl of freshly collected hemolymph contained in pyrogen-free borosilicate 
glass test tubes were incubated with 100 µl of serially diluted bacteria (from108 cfu/ml 




Figure 3.23: Gram-positive bacteria do not cause degranulation of hemocytes, thus ruling 
out the involvement of host hemocyte components in the in vivo bacterial clearance assay. (a) 
Morphological examination of hemocytes in contact with Gram-positive bacterium S. aureus and 
Gram-negative bacterium P. aeruginosa.  One ml hemolymph was applied to a glass slide and 
immediately mixed with 1 ml of 107cfu/ml bacteria under examination.  The hemocytes were 
monitored under bright-field with Zeiss fluorescence microscope.  Time-lapse microscopy image 
of the hemocytes were taken at 30 s intervals for 20 min.  (b) Factor C activity, as an indication of 
hemocyte degranulation, was assayed.  Samples were tested with and without LPS, in case Factor 
C was exocytosed in its inactive precursor form.  The inset shows that after incubation with S. 
aureus, hemocytes aggregated at the bottom of pyrogen-free borosilicate glass tube appearing as a 
dense ring.  In contrast, P. aeruginosa, a Gram-negative bacterium with LPS, caused hemocyte 
degranulation, thus, the absence of such aggregation rings as the hemocytes were degranulated.  
Scale bar, 10 mm in (a). 
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to 105 cfu/ml) at room temperature.  After 90 min, the supernatants were collected and 
the Factor C activity was measured.  Ten µl supernatant was mixed with 90 µl fluorescent 
substrate from the PyroGeneTM Endotoxin Diagnostic Kit (Cambrex Inc., USA), and the 
fluorescence emission at 440 nm was monitored upon excitation at 380 nm.  The 
supernatant samples were also tested with the addition of 10 µg/ml LPS to activate the 
Factor C if any, in case it was exocytosed in its inactive precursor form (Ding et al., 
1993).  For the negative control, pyrogen-free saline was used in place of bacteria. 
Figure 3.23b shows that upon contact with S. aureus up to 108 cfu/ml, there was no 
Factor C released from hemocytes, thus excluding the interference of hemocyte 
components released upon degranulation.  On the contrary, contact with 104 cfu/ml P. 
aeruginosa caused significant Factor C release due to degranulation of the hemocytes.  
The inset of Figure 3.23b shows that after incubation with S. aureus, hemocytes 
aggregated at the bottom of pyrogen-free borosilicate glass tube appearing as a dense 
button.  In contrast, P. aeruginosa, a Gram-negative bacterium with LPS, caused 
hemocyte degranulation, thus, the absence of such aggregation button as the hemocytes 
were degranulated.  Taken together, the morphological observation and the chemical 
analysis both support that in vivo challenge with Gram-positive bacteria does not cause 
hemocyte degranulation thus excluding the involvement of granular components in 
activating the immune response pathways (Jiang et al, 2007).     
In this study, the PTU was used as the PO-specific inhibitor (Nellaiappan and 
Sugumaran, 1996).  However, PTU concentration must be optimized to (1) effectively 
inhibit PO; (2) reduce the antimicrobial effect of PTU alone.  Figure 3.24 shows the 
dependency of the PO inhibitory activity of PTU.                        

















Figure 3.24:  Optimization of the PTU concentration used for inhibit the phenol oxidase 
activity. Knowing that PTU is antimicrobial active by itself, we selected 0.1 mM concentration in 
the later in vitro antimicrobial assay, in order to realize an effective inhibition of PO without 
significant bactericidal effect.   
 
Finally, 0.1mM PTU was selected for the in vitro antimicrobial assay since it can 
inhibit 97% of the PO activity while the bactericidal activity at 0.1 mM PTU alone was 
less than 20% for the model bacteria (Figure 3.25, column 3).  However, when applied in 
the in vivo assay, considering the obvious dilution effect, PTU concentration was 
increased to 5 mM in the injection.  The population of the injected bacteria was not 
affected within the 2 min of pre-injection time.   
 
3.3.7 HMC kills bacteria via its PPO activation: an in vitro demonstration of 
antimicrobial ability 
 
End-point antimicrobial activity assay with Gram-negative bacterial strains 
To examine the functional significance of PPO activation, the antimicrobial effect 
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Figure 3.25:  The in vitro antimicrobial action of the activated PO: the endpoint 
antimicrobial activity assay using PAE-producing and PAE non-producing strains of 
Pseudomonas aeruginosa.  Each strain, at 106 cfu/ml, was incubated with purified HMC/PPO 
and 4ME for 1 h.  PTU at 0.1 mM was used to inhibit PO, if any.  The data represent means ± 
s.e.m. for three experiments, each in triplicate. n.s., non-significant, **P < 0.01 by Student’s t test.  
The antimicrobial activity was attributed to PO seeing that 0.1mM PTU can destroy the 
bactericidal effect. Meanwhile, the significant difference between the antimicrobial activities 
against the protease producing and non-producing strains demonstrate the involvement of 
extracellular microbial protease in triggering the antimicrobial action, thus demonstrating that the 
protease from microbial can trigger a bactericidal PPO production from HMC/PPO.   
 
 PAO-Iglewski and PAO-B1A1, the protease-producing and protease-deficient 
strains of Gram-negative bacterium P. aeruginosa respectively, were tested.  Each strain 
of P. aeruginosa, at 106 cfu/ml, was incubated with purified HMC/PPO and 4-
methylcatehol [a PO substrate, (Nellaiappan and Sugumaran, 1996)], for 1 h and the 
residual bacterial population was enumerated.  Indeed, 66 ± 5% of the PAE-producing P. 
aeruginosa were killed within 1 h, while only 15 ± 7% of the PAE-mutant succumbed 
(Figure 3.25, column 4).  The involvement of PO in this antimicrobial action was 
confirmed by the observation that the addition of PTU as the PO-specific inhibitor, 
significantly retarded the killing of PAE-producing strain but did not affect the PAE-
mutant (Figure 3.25, column 7 compared to column 4). Meanwhile, the significant 
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difference in the antimicrobial activities against the protease-producing and non-
producing strains demonstrate the involvement of extracellular microbial protease in 
triggering the antimicrobial action, thus confirming that the protease of  microbial origin 
can trigger a bactericidal PPO production from HMC/PPO (Jiang et al, 2007).     
Furthermore, supplementation of exogenous PAE to the incubation mixture 
containing PAE-mutant increased the antimicrobial activity dose-dependently (Figure  
3.26), demonstrating the essential role of PAE in realizing the antimicrobial activity.  It is 
known that HMC/PPO harbors precursors of antimicrobial peptide.  However, in our 
study the contribution of the HMC-related antimicrobial peptide appears to be minor 
(Figure 3.25, column 1) because the HMC/PPO alone does not show differential levels 
of antimicrobial activities between the two strains.  Thus, the PO-induced production of 
quinone must be the major contributor of bactericidal activity.  Since 4ME and PTU 
harbors basal level of bactericidal activity, it is inappropriate to perform the interaction 
beyond 1 h.    
 
Figure 3.26:  Supplementation of exogenous PAE increased the antimicrobial activity 
against the PAE non-producing strain, demonstrating that microbial protease is essential in 
the PPO mediated antimicrobial action.  PAO-B1A1, at 106 cfu/ml, was supplemented with 
PAE at indicated amount and incubated with purified HMC/PPO and 4ME for 1 h.  Then the 
residual bacterial population was measured.  The data represent means ± s.e.m. for three 
experiments, each in triplicate. n.s., non-significant, **P < 0.01 by Student’s t test.  
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Real-time antimicrobial activity assay with Gram-negative bacterial strains 
Besides measuring the end-point antimicrobial activity, the real-time bacterial 
clearance was visualized by time lapse microscopy (Figure 3.35).  To this end, the above 
mixture was examined under a Zeiss Fluorescence Microscope (Axiovert 200M) for one 
hour.  Again we observed that 85% of the protease-producing strain was killed within one 
hour, whereas the killing of protease–deficient strain was less than 10%.  Furthermore, 
addition of PTU which inhibits the PO activity, if any, significantly retarded the 
bactericidal effect against protease-producing strain.  These observations again 
demonstrated that the PO activation contributes to the antimicrobial action against PAE-
producing strain, while sparing the PAE-mutant counterpart (Figure 3. 27).   
 
 
Figure 3.27: The real-time observation of the bacterial clearance mediated by the activated 
PO. The bacteria under test were diluted to 107cfu/ml.  One ul of the antimicrobial assay reaction, 
as that set up for endpoint observation, were applied to the fluorescence microscopy. Images were 
taken at intervals of 30 s for 1 h, at magnification of 63 x 1.6, and a movie was made.  (a) the 
image of the bacteria at different time points. (b) bacterial survival rate during the 60 min of 
observation. Seeing that The P. aeruginosa is a motile bacterium. To quantify the bacterial 
survival at a certain time point, we counted the bright bacterial spots in 3 consecutive screens and 
use the mean value for the survival rate calculation.  
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S. aureus, the Gram-positive bacterium was also examined under the same 
conditions and the results, which were consistent with those obtained from P. aeruginosa, 
were shown in Figure 3.28.  Altogether, these results demonstrate that the HMC/PPO 
was specifically activated by the microbial protease to PO which, in the presence of 4-
methylcatechol (4ME), produces quinone to kill the bacteria effectively (Jiang et al, 
2007).  
 
3.3.8 The in vivo antimicrobial action by PO is specifically triggered by the invading 
microbe’s protease  
 
To examine the PO production and to demonstrate the ability of PO in clearing 
the invading pathogen in vivo, we infected horseshoe crabs in the presence or absence of 
PO-specific inhibitor, PTU or kojic acid.  A comparison of the remnant bacterial load 
under these conditions should help to clarify the specific contribution of PO, if any, to the 
antimicrobial activity.   Previously, it was reported that HMC/PPO is activated by host 
intracellular factors released through LPS-dependent degranulation of hemocytes (Muta 
et al., 1995).  To avoid provocation of PPO by such cellular components and to 
unequivocally demonstrate that the microbial factor-activated PPO contributes to the 
antimicrobial defense, Gram-positive bacteria lacking LPS were used to avoid LPS-
induced hemocyte degranulation. As shown in Figure 3.29, when either S. aureus strains 
AK3 (protease V8-inactive) or PC1839 (protease V8-active), at 106 cfu/ml each, was 
injected into the hemolymph of the horseshoe crab, both were cleared rapidly.  At 30 min 
post challenge, less than 500 cfu/ml were retrieved from the host hemolymph, suggesting 
that horseshoe crab harbors other efficient parallel antimicrobial mechanisms against  
 










Figure 3.28: Functional evaluation of the microbial protease-activated PO in in vitro 
antimicrobial action using active V8 protease producing and non-producing strains of S. 
aureus.  (a) The endpoint antimicrobial activity assay.  Each strain, at 106 cfu/ml, was incubated 
with purified HMC/PPO and 4ME for 1 h.  PTU at 0.1 mM was used to inhibit PO, if any.  Data 
represent means ± s.e.m. for three experiments, each in triplicate. n.s., nonsignificant, *P < 0.05 
by Student’s t test.  (b) Supplement of exogenous subtilisin increased the bactericidal activity 
against protease non-producing strain.  (c) The real-time observation of the bacterial clearance 
caused by the activated PO.   ml Each bacterial strain at 107 cfu was mixed with 60 mg HMC and 
100 nmol 4ME in 100 PBS.  One ml of such mixture was examined under the Zeiss Fluorescence 
Microscope (Axiovert 200M).  Images were taken at 30 s intervals for 1 h (magnification: 63 x 
1.6).  (D) The bacterial survival at different time points in the real-time observation was 
calculated by enumerating the bacteria in each time frame.  
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AK3 strain which is protease inacitive and which would have evaded PO-ROS killing if 
not for these PO-independent mechanisms.  Moreover, co-injection of PTU (Figure 
3.29a) or kojic acid (Figure  3.29b) impaired the clearance of the V8 protease-positive 
strain, PC1839, resulting in significantly more bacteria recovered from the host (n=5, 
P<0.01 Student’s t test).   In contrast, the clearance of the V8 protease-negative strain, 
AK3, was unaffected by PTU or kojic acid, indicating that the killing of this strain was 
independent of PO-mediated quinone activity, but possibly, by other co-existing 
extracellular antimicrobial mechanism(s), such as the lectin-mediated complement 
system, which is not susceptible to inhibition by PTU or kojic acid.  Consistent 
observations were made with S. aureus ATCC49775 as well as six other naturally 
occuring Gram-positive bacterial species isolated from the habitat of the horseshoe crab 
(Figure 3.29). 
Further proof that PO activation by the Gram-positive bacteria was independent 
of intracellular components was obtained by confirmation that collateral hemocyte 
degranulation or cell lysis was absent (Figure 3.23).  These observations unambiguously 
support our hypothesis that the PO activity triggered by the invading microbes’ proteases 
contributes to in vivo extracellular clearance of the protease-producing bacteria.  In the in 
vitro antimicrobial activity assay, we have used 4ME as a synthetic substrate for PO upon 
which quinone was produced to kill the microbe. At this juncture, although the 
physiological substrate for PO remains to be identified, the in vivo antimicrobial action 
suggests that such a substrate does exist and that the PO activated by microbial proteases 
forms a powerful defense mechanism (Jiang et al, 2007).   
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In this part of the thesis, the bactericidal effect against Gram-positive and Gram-
negative bacterial models has been tested.  The PO activity triggered by the invading 
microbial components has been demonstrated to contribute to in vitro and in vivo 
clearance of the protease-producing bacteria, thus forming a non-self distinguishing host 
defense mechanism.   The following part will examine the ROS production mechanism in 
mammalian innate immune system.   
 
3.4 ROS production by hemoglobin upon microbial challenge : a host defense in   
mammals  
 
The functional homology between HMC and Hb prompted us to examine the 
existence of a similar ROS-mediated direct antimicrobial mechanism in mammals.  Hb, 
the respiratory proteins of the vertebrates, can produce ROS through a pseudoperoxidase 
cycle initiated by the auto-oxidization of hemoglobin (FeII) to methemoglobion (metHb, 
FeIII) (Alayash, 1999) (Section 1.2.2.1, Figure 1.12).    Under physiological conditions, 
Hb is sequestered in RBC, which harbors various ROS scavengers to quench them and 
avoid the potential damage to the host.  However, recent reports show that microbes can 
produce hemolytic toxins and release hemoglobin from RBC under infection.  S. aureus 
produces hemolysin to lyse RBC, so as to usurp the heme for its nutrient source (Skaar et 
al., 2004).  Under microbial challenge, (i) how is the ROS production regulated by the 
microbial virulence factors during infection and (ii) the significance of ROS-mediated 
antibacterial activity, are not fully understood.  The ensuing sections of this thesis will 
present our findings of the Hb-ROS mediated countermeasure against infection by 
protease-active virulent strains of invading bacteria. 
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3.4.1 Pseudoperoxidase activity of metHb is increased by synergism of the microbial            
         proteases and PAMPs.  
 
In view of the ROS production by metHb, we hypothesized that while the bacteria 
seemingly usurp the iron from hemoglobin via erythrocyte lysis, the hemoglobin 
molecule elicits antimicrobial action in the vicinity of the microbes by a concerted release 
of ROS.  To test this possibility, we first monitored, in vitro, in a cell-free system, the 
release of O2 ˙  by metHb using a specific chemiluminescence indicator, cypridina 
luciferin analog, CLA.  Then we analyzed the effect of the microbial components, 
proteases and PAMPs, on the superoxide production.  In the end, mechanism of how 
these components affect the ROS production by metHb was investigated.  
 
3.4.1.1 CLA chemiluminescence (CLA-CL) indicates the superoxide production by  
metHb  
 
Figure 3.30 shows the chemiluminescence assay using CLA. Indeed, metHb 
catalyzes the production of superoxide ion which can further excite CLA to produce 
quantifiable photons.  The chemiluminescence signal, i.e. the photon density, is 
proportional to the concentration of superoxide ion, which is the catalytic product, in the 
reaction.  Therefore the activity of pseudoperoxidase can be kinetically defined as the 
increment of the product concentration over time (Kawano et al., 2002).   As shown in 
Figure 3.30a, pseudoperoxidase activity is proportional to the amount of metHb in the 
reaction, when excessive substrate was provided.  
Besides metHb, two more protein species, BSA and hemocyanin were tested to 
confirm the specificity of the ROS production from H2O2 substrate.  As shown in Figure 
3.31, under the same condition, only metHb produced superoxide; whereas BSA and 
hemocyanin did not.  This observation verified that the pseudoperoxidase activity was a 
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unique property of hemoglobin, and evolution/speciation has ensured that even the 
ancient respiratory protein counterpart, HMC, did not exhibit pseudoperoxidase function, 
but produces phenoloxidase which culminates in the same antimicrobial effect (Jiang et al, 
2007).  
Figure 3.30:  MetHb catalyzed the production of O2˙, as shown by the chemiluminescence 
(CL) assay. (a) Each reaction included 0.8 nmol cypridina luciferin analog (CLA), 1 µmol H2O2 
and metHb at indicated amounts in 160 µl PBS.  The chemiluminescence was recorded for 60 
seconds.  (b) SOD specifically neutralized the CLA-CL, indicating that the ROS produced by 




Figure 3.31: The pseudoperoxidase activity was specifically induced from metHb.  4 ug of 
each protein under test was first incubated with 20 µg of subtilisin A at 37 ˚C for 10 min.  Then it 
was applied to a substrate mixture containing 0.8 nmol cypridina luciferin analog (CLA), 1 µmol 
H2O2 and in 160 µl PBS.  The chemiluminescence was recorded for 60 seconds.   
 
b 
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3.4.1.2 Microbial proteases and PAMPs synergistically enhance the 
pseudoperoxidase activity of metHb 
 
Further experiment was performed to investigate how microbial proteases might 
affect the ROS production from metHb.  To this end, metHb was incubated with 
subtilisin A for 10 min prior to the CLA-CL assay.   As shown in Figure 3.32, compared 
to non-treated metHb, the subtilisin A treated metHb exhibits 4.5 fold increase in ROS 
production.  However, BSA tested under the same condition did not enhance ROS 
production by metHb.  Furthermore, various proteases, from microbes or mammalian 
hosts were tested to show their potential capacity to enhance ROS production by metHb.   
 
 
Figure 3.32: The pseudoperoxidase activity of metHb was significantly enhanced by 
microbial protease subtilisin A, but not by mammalian digestive protease trypsin.  BSA was 
used as a non-protease control. 4 µg of metHb which was first incubated with 10 µg of the 
proteases or BSA at indicated amounts at 37 ˚C for 10 min. Then it was applied to a substrate 
mixture containing 0.8 nmol cypridina luciferin analog (CLA), 1 µmol H2O2 ad in 160 µl PBS.  
The chemiluminescence was recorded for 60 s.   
 
As shown in Figure 3.33, subtilisin A, proteinase K, type XIV protease, and 
pseudomonas elastase (PAE) could significantly enhance the ROS production by metHb, 
whereas collagenase from microbe, and trypsin from mammalian host could not.  
Furthermore, when subtilisin was inhibited by CrSPI-D2, a 43-mer peptidyl serine 
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protease inhibitor (Thangamani, Jiang et al, unpublished; Chor, 2006), we observed 
significantly reduced ROS production by metHb, which clearly indicates that the 
proteolysis of hemoglobin by microbial proteases is specific and essential to activate the 
metHb. The differential action between subtilisin and trypsin suggests that the 
pseudoperoxidase activity resides in unique peptidyl fragment(s), which remains hitherto 
unidentified.  Moreover, when subtilisin A was inhibited by recombinant CrSPI-D2 (a 
peptidyl serine protease inhibitor specific to subtilisin A, Thangamani, Jiang et al, 





Figure 3.33: The pseudoperoxidase activity of metHb was increased via conditional 
proteolysis by various microbial proteases but not by mammalian trypsin.  Ten µg of metHb 
and 2 µg of each microbial protease were incubated for 10 min prior to CL assay.   For the last 
column, 2 µg of subtilisin A was first incubated with CrSPI-D2 (a 30-mer peptidyl subtilisin-
specific inhibitor), at 1:1.5 molar ratio for 20 min before it was used for treating the metHb.   
 
Furthermore, LPS and LTA were tested for their affect on the ROS production by 
metHb.  To this end, LPS or LTA was added to metHb, and incubated at room 
temperature for 10 min prior to the addition of chemiluminescence substrate.  As shown 
in figure 3.34, LPS from E. coli or from P. aeruginosa, as well as LTA from S. aureus 
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increased the O2 ˙  production by metHb dose-dependently, whereas phosphatidyl lipids 
that are common between the host and the microbe lack such activity indicating a specific 
action of PAMPs on metHb pseudoperoxidase activity.   Further investigation on the 
combination of microbial protease and PAMPs showed a synergistic effect between these 





Figure 3.34: The pseudoperoxidase activity of metHb was increased by PAMPs but not by 
phosphatidyl lipids which are common to the host and the microbe.  POPE, 1-palmitoyl-2-
oleoyl-phosphatidylethanolamine; POPC, 1-palmitoyl-2-oleoyl-sn-glycero--3-phosphocholine. 




Remarkably, consistent with HMC/PPO, when pre-treated with PAE or subtilisin 
A followed by LPS or LTA respectively, the metHb produced 10-fold more superoxide 
ions (Figure 3.35). The consequence of the synergism between these bacterial 
components on the O2 ˙  production strongly suggests that hemoglobin functions in non-
self-recognition by producing deadly ROS in the vicinity of bacteria.  In the following 
section, we will describe the functional significance of the activated metHb regarding the 
antimicrobial activity.   
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 3.4.2 The O2˙ produced by hemoglobin elicits in vitro antimicrobial activity   
To examine the functional significance of the activated metHb, the antimicrobial 
activity was tested in vitro using Gram-positive bacteria S. aureus, PC1839 (V8 protease-
positive) and AK3 (V8 protease–deficient).  Each strain was incubated with human 
metHb, together with a sub-lethal concentration of H2O2 of 30 mM.  GSH, the superoxide 
ion scavenger, at 10 mM was used to eliminate superoxide ions, if any.  The results were 
summarized in Figure 3.36.   
 
 
Figure 3.35: Synergism between microbial proteases and PAMPs in enhancing the 
pseudoperoxidase activity of the metHb. 4 ug of metHb which was first incubated with 
microbial protease at indicated amount at 37 C for 10 min.  Then Pseudomonas LPS or S. aureus 
LTA respectively at indicated amounts were added, immediately before the mixture was applied 
to a substrate solution containing 0.8 nmol cypridina luciferin analog (CLA), 1 µmol H2O2 and in 
160 µl PBS.  The chemiluminescence was recorded for 60 s. 
 
As shown in Figure 3.36,  when incubated with metHb and H2O2, enumeration of the 
residual bacteria showed that 55 ± 8% of the V8-producing S. aureus was killed within 
60 min, while only 20 ± 3% of the V8-negative strain succumbed (Figure 3.36 a, column 
4).  Supplementation of exogenous subtilisin A to the incubation mixture of V8-negative 
strain increased the antimicrobial activity dose-dependently (Figure 3.36 b).  
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Figure 3.36: Functional evaluation of the metHb-mediated ROS production in the in vitro 
antimicrobial action against S. aureus strains.  (a) The combination of H2O2 and metHb killed 
more of the V8 protease-producing strain of S. aureus than that of the active V8 protease-non 
producing strain, demonstrating the involvement of extracellular microbial protease in triggering 
the antimicrobial action. Each strain, at 106 cfu/ml, was incubated for 1 h with 36 µg metHb and 6 
µmol H2O2 in 200 µl PBS.  Two mmol GSH was used to scavenge the superoxide ion, if any, to 
demonstrate the specificity of the oxido-reducing effect.  (b) Supplementation of exogenous 
subtilisin A increased the metHb antimicrobial activity against the active V8 protease-negative 
strain. The data represent means ± s.e.m. for three experiments, each in triplicate. **P < 0.01 by 
Student’s t test.  
 
Finally, addition of GSH significantly retarded the killing of V8-positive S. aureus 
(Figure 3.36 a, column 7 compared to column 4).  Taken together, the O2 ˙  production by 
metHb is enhanced by the microbial protease, thus subverting the pathogen effectively.   
 
3.4.3 Mammalian red blood cells produce bactericidal-ROS when lysed by protease-
positive bacteria 
 
Besides biochemically simulating the bacterial protease-dependent ROS 
production using metHb in a cell-free system, we also examined the function of this 
mechanism using rabbit or human red blood cells (RBC).  We incubated the bacteria with 
RBCs and continuously monitored the: (1) hemolysis, (2) ROS production and (3) 
remnant bacterial population over a period of 30 min.  Both the rabbit and human RBCs 
                                                                                                                                      123           
exhibited similar responses, and the typical profiles from rabbit RBC are shown in 
Figure 3. 37.  
Figure 3.37 shows that the hemolysis caused by S. aureus was observed within 5 
min of the addition of S. aureus strains PC1839 and AK3 (Figure 3.37a).  
Simultaneously, the pseudoperoxidase activity along with the hemolysis was observed 
using the chemiluminescence assay (Figure 3.37b).   Notably, superoxide generation was 
observed in both PC1839 and AK3 lyzed red blood cell, although PC1839 caused more 
rapidly ROS production at higher level.  This is consistent with the result from 
biochemical assays, which showed that both microbial protease and PAMP can enhance 
the ROS production from metHb.  Whether or not the enhanced pseudoperoxidase 




Figure 3.37: Hemolysis caused by S. aureus induces Hb to produce ROS.  The bacteria 
(107cfu/ml) were incubated with RBCs (0.4% v/v) and the hemolysis as well as the ROS 
production were continuously monitored.  (a) The bacteria hemolyzed the RBC within 5 min.  (b) 
CLA-CL assay showed the pseudoperoxidase activity of metHb released from RBC hemolysis.   
PC1839, the protease-positive strain produces higher amount of ROS than AK3, the protease-
deficient strain.   
.  
Figure 3.38 shows the remnant bacterial load in the reaction mixture.  Within 10 
min, >80% of PC1839, the protease-producing S. aureus was killed. However, AK3, the 
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protease-negative strain remained viable.  To dissect the killing factors in the PC1839 
clearance, we added SOD to eliminate superoxide and protease inhibitor Mix G (Server, 
Germany) to stop the microbial proteases.  Both factors had been pre-tested not to 
substantially affect the bacterial growth on their own.  As shown in Figure 3.38, addition 
of either SOD or protease inhibitor to the RBC-PC1839 incubation mixture significantly 
reduced the antibacterial activity against PC1839, resulting in significantly higher 
remnant bacterial load (P<0.01, Student’s t test).  These results confirmed the: (1) 
involvement of superoxide species in the antimicrobial action and (2) necessity of the 
bacterial protease in the ROS production.  This differential effect between PC1839 and 
AK3 suggested that the enhanced pseudoperoxidase activity, resulting from the 
synergism between microbial protease and PAMP, is essential to the antimicrobial action.  
It is conceivable that for AK3, due to the lack of active microbial protease, the PAMPs 
only enhanced the pseudoperoxidase activity marginally, and therefore failed to realize an 















Figure 3.38: Functional evaluation of the metHb-mediated ROS production in RBC by 
various bacteria: antimicrobial activity assay using the S. aureus strains.  Killing assay of the 
two S. aureus strains after addition of the indicated amounts of red blood cells and either 
superoxide dismutase (SOD) or protease inhibitor. n.s., non-significant, *P < 0.05, ** P < 0.01 by 
Student’s t test. The data represent means ± s.e.m. of three independent experiments.  
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To further evaluate the antimicrobial effect of RBC via metHb mediated ROS production, 
we tested naturally occurring clinically important bacterial isolates in the same condition 
(Figure 3.39).  Each bacterial strain, at 106-107 cfu/ml was incubated with 0.4% RBC.  
The extracellular protease-positive strains were killed by the metHb-mediated ROS 
production, and the killing effect was reduced by protease inhibitor.  This is consistent 
with the result from S. aureus PC1839.  However, methicillin resistant S. aureus strains 
MRSA1 and MRSA2, which are hemolytic but extracellular protease-negative, was 
unaffected by the RBC incubation.  This is consistent with the result from S. aureus AK3.  
Furthermore, Enterococcus faecium and Enterococcus faecalis, which are non-hemolytic 
and non-protease producing, were also unaffected.  Notably, two clinical isolates of P. 
aeruginosa, one protease-producing and one non-producing, were unaffected in this in 
vitro assay.  Under the conditions of this assay, neither of these Pseudomonas strains 
caused hemolysis, although they appeared hemolytic on blood agar.  These results 
support that initial hemolysis of the RBC is crucial to the ROS production and subsequent 
killing event.  To recapitulate, these observations suggest that in the mammalian system, 
the hemoglobin released by bacteria-mediated hemolysis of the RBC is activated by the 
microbial protease to produce ROS, which kills the bacteria effectively.  
 
3.5  The actions of the microbial proteases and PAMP in the activation of 
HMC/PPO and Hb into ROS producer.   
 
3.5.1  LTA itself can enhance production of ROS by HMC/PPO and metHb 
In section 3.4, we have described that LPS and LTA both could enhance ROS 
production.  However, it is commonly observed that S. aureus LTA as obtained from  
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Sigma could be heavily contaminated by LPS (Morath et al., 2002).  In order to justify 
that there is an LPS-independent enhancement of the ROS production from HMC/PPO 
and metHb by LTA, we had to use highly purified LPS-free LTA. 
Being aware of this potential contamination, prior to the experiments, the possible 
presence of LPS in various lots of LTA was assayed, using the PyroGene assay (Cambrex 
Inc., USA).   Only those lots of LTA which were uncontaminated were used for 
experiments.  Figure 3.40 shows a typical example of the assay of one batch of S. aureus 
LTA (Sigma Catalogue No. L2515), which was virtually LPS-free (containing < 0.001% 
LPS).    
 
Figure 3.40: Detection of LPS contamination in the S. aureus LTA purchased from Sigma 
(L2515).  The LPS from E. coli strain 055:B5 (Sigma, L4524), which was previously quantified 
and standardized by the PyroGene endotoxin assay was used to calibrate this assay.  Both LTA 
and LPS were 10-fold serially diluted until 10-6 mg/ml using pyrogen-free PBS (pH 7.4).  The 
PyroGene LPS assay was performed according to manufacturer’s instructions.  Whereas 10-6 
mg/ml LPS gave a detectable fluorescence readout, no LPS was detectable in 0.1 mg/ml LTA, 
demonstrating that the LTA is LPS-free.   
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To further confirm that besides LPS enhancement of the ROS production, there is an 
LPS-independent enhancement of the PO-activity of HMC, or of pseudoperoxidase-
activity of metHb by LTA, we used polymyxin B, the LPS specific binding peptide 
(Jerala and Porro, 2004), to selectively neutralize LPS in the LTA sample, if any.  As 
shown in figure 3.41lymyxin B, while such activity triggered by LPS was reduced 
significantly.  Furthermore, we spiked the LTA with various amounts of LPS (1%, 5%, 
and 10%) and measured the resulting PO/pseudoperoxidase activity.  As shown in Figure 
3.41 (b &d), the substitution of LTA with LPS did not cause a significant difference in 
PO/pseudoperoxidase activity.  In other words, even using LTA that may contain up to 
10% LPS contamination, the PO activation was still attributed to LTA.   
 
3.5.2 PAMPs and proteases enhance the pseudoperoxidase activity through causing 
conformational change of metHb   
   
At this juncture, our conjecture on the mechanism of enhancement of 
pseudoperoxidase activity of Hb would be based on what is known in the literature and 
on some of our experimental observations. H2O2 initiates the catalytic cycle between the 
ferric (HbFeIII) and ferryl (HbFeIV) hemes, activating the pseudoperoxidase activity of 
metHb (Refer to section 1.2.3, Figure 1.33.), which eliminates the H2O2, producing the 
superoxide. (Alayash, 1999) Therefore, it is conceivable that any structural change to the 
Hb molecule which is in favor of this cycle (by increasing k1, k2 and/or k3) could result in 
higher pseudoperoxidase activity and therefore increases superoxide production.   
To this end, we first investigated the interaction between hemoglobin and LPS 
and LTA respectively.  As shown in Figure 3.42, both PAMPs bind hemoglobin 
specifically. Furthermore, metHb-LPS interaction was examined by SPR, and the  




Figure 3.41:  LPS-independent enhancement of the PO-activity of HMC or pseudoperoxidase 
activity of metHb by LTA.  (a, b) PO activity of HMC; (c, d) Pseudoperoxidase activity of 
metHb; (a, c) polymyxin B (4 µg) was used to neutralize the LPS contamination, if any, in 50 µg 













Figure 3.42: ELISA shows the direct interaction between Hb and PAMPs.  96 well 
microplates was immobilized with LPS (4µg/ml) or LTA (20 µg/ml) respectively.  Solid line: Hb 
binds to the immobilized PAMP in a dose dependent way.  Dash line: Pre-incubation of Hb with 
increasing amount of PAMP reduced the ELISA signal in a dose-dependent manner, showing the 
specific interaction between Hb and PAMPs.   
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dissociation constant was determined to be 1.02 x 10 -7 M, suggesting that hemoglobin-
LPS interaction is of considerably high affinity. The observation on the specific binding 
of LPS/LTA to metHb provoked us to hypothesize that the binding and cleavage by 
microbial proteases may cause conformational change to the metHb. To verify this, we 
compared the partial proteolysis profile of metHb in the presence and absence of LPS.  
The difference observed, if any, would indicate the conformational change on the 
substrate (metHb) caused by the binding of LPS.  Indeed, we observed that the partial 
proteolytic profiles of metHb in the presence of LPS are significantly different from that 
of Hb alone (Figure 3. 43 a),  which indicates that the presence of LPS changes the 
pattern of cleavage sites of Hb available to subtilisin A, as an evidence of the altered 
tertiary structure of the hemoglobin.   Similarly, the PAE-proteolysis profile of HMC was 
different when LPS was applied in different sequential orders (Figure 3.43 b).   This 
observation, together with that HMC binds LPS specifically (Figure 3.18) clearly 
indicates that the role of LPS in actvating the HMC/PPO to PO is to alter the 
conformation of HMC.  
 
3.5.3  A step-wise model on PO activation by microbial protease and PAMPs 
Microbial protease and PAMPs co-exist on the surface of the invading microbe, at 
the interface of microbe-host interaction.  However, the different sequential orders of 
their action on HMC/PPO may result in different degrees/modes of PO activation.  To 
further understand the orders of event during the activation of PPO by PAMPs and 
protease, we reconstituted the reactions using the microbial proteases and the PAMPs in 
different sequential combinations, and the PO activities obtained are shown in Figure 
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3.44. Here, we observed an 8-fold higher PO activity was induced when the microbial 
protease, subtilisin A, cleaved the HMC/PPO prior to the action of LTA (left column) and 






Figure 3.43:  Partial proteolytic profiles of human metHb cleaved by subtilisin A in the 
presence and absence of LPS (a) and different PAE proteolytic profiles of HMC/PPO were 
obtained when LPS was applied in different sequential combinations (b).  (a) The presence of 
LPS changes the pattern of cleavage sites of Hb available to subtilisin A, providing evidence of 
the altered tertiary structure of the hemoglobin.  72 µg of human metHb was incubated with 90 
µg of LPS, in 180 µl of pH7.4 PBS, at 37 °C for 10 min, followed by the addition of 72 ng (10 
U/mg) of subtilisin in 7.2 µl of PBS.  The control contains subtilisin without LPS. At the 
indicated time points, a 40 µl aliquot of the incubation mixture was collected and the proteolysis 
was stopped with 5 mM PMSF.  15% reducing Tricine-SDS-PAGE was used to examine the 
proteolytic profile.  For each lane, 2 µg of metHb was loaded.  Western analysis was performed 
using polyclonal rabbit anti-human Hb antibody.  * annotates unique bands which occur only in 
the presence of LPS.   (b)  Each lane contained 12 mg of HMC. The arrowheads indicate 
proteolytic intermediates and products of HMC/PPO.  
                
The HMC/PPO-PAMP binding ELISA, as shown in Figure 3.18 clearly show 
that PAMP can bind to HMC/PPO specifically.  This PAMP-HMC interaction, together 
with the differential PO activity induced when microbial protease and PAMPs acted on 
the HMC in different sequential orders, indicate that PAMPs, by specifically binding to  
                        
 
b a 
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Figure 3.44: Higher PO activity was induced when the microbial protease acted on the 
HMC/PPO prior to the application of a PAMP, suggesting a sequential order of the actions 
of protease and PAMPs on PPO activation.  Same amount of protease and PAMP were used to 
reconstitute the PO activation, but in different sequential orders. For the solid bars, HMC/PPO 
was first incubated with protease for 10 min.  Then PAMPs were added immediately before the 
addition of 4ME.  For the void bars, the HMC/PPO were first incubated with PAMPs for 10 min, 
then protease was added and incubated for another 10 min before 4ME was added. A405 readings 
at 5 min after the 4ME addition are presented. 
 
Taken together, our observations suggest two mechanisms of PO activation 











Figure 3.45: A model for the synergistic activation of HMC/PPO by microbial proteases and 
PAMPs. (i) The microbial proteases first proteolyze the HMC/PPO to a partially activated PO 
intermediate, [PO]; then, PAMPs bind the [PO] to produce a fully active PO, PO↑↑ (solid lines) 
and/or (ii) PAMPs interact with HMC/PPO to form an inactive complex which is subsequently 
cleaved by microbial proteases to PO↑, exhibiting only marginal activity (dashed lines).  In vivo, 
these two mechanisms of PPO-activation may co-exist and constitute a refined regulation of host 
immune response: lower PO activity is employed to combat strains which produce less 
extracellular proteases, while higher PO activity is unleashed against the strains which produce 
more extracellular proteases.     
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HMC/PPO, changed the conformation of the protein, and therefore altered the proteolytic 
profile which results in different PO activities.   
Previous studies on the structural basis of the potential PPO activity of HMC 
suggested that in the dormant state, entry to the active site of HMC/PPO is blocked by a 
Phe49  from its
 
α-domain (Decker and Rimke, 1998; Decker et al., 2001).  Such blockage 
must be removed so that phenolic substrates can gain the access to the PO active site.  
From our experimental results, we suggest two step-wise mechanisms of activation of 
HMC/PPO by the microbial proteases and PAMPs, which, albeit co-exist, result in 
different PO activities upon microbial infection.     
As illustrated in Figure 3.45, in one scenario, the microbial protease nicks the 
HMC/PPO, only producing marginal PO activity (indicated as [PO]); subsequently, 
PAMPs bind to the partially activated PO and cause a further conformational change 
which realizes the full PO activity (solid line).  Alternatively, the HMC/PPO molecule is 
pre-occupied by PAMPs and undergoes a conformational change, which exposes 
cleavage sites different from those on the free HMC/PPO.  Further proteolysis upon this 
PAMP-bound HMC/PPO can only achieve a marginal PO activity (dashed line).   
It is not clear which of the mechanisms is predominant in vivo.  In fact, these two 
mechanisms may constitute a refined regulation of PO activation: lower PO activity is 
employed to combat microbe which produces less extracellular proteases, while higher 
PO activity is unleashed against those strains which produce more extracellular 
proteases.  Considering the cytotoxicity of quinone produced by PO, such fine-tuning on 
PPO activation may be crucial to avoid host self-destruction while clearing the invading 
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 CHAPTER 4: DISCUSSION  
 
Having demonstrated how HMC and Hb are converted to ROS producers by 
microbial components to elicit antimicrobial activity, this chapter endeavors to provide 
critical explanations for the mechanisms underlying the ROS production which is crucial 
for immediate host defense against microbial invaders. 
    
4.1 The temporal and spatial regulation of PO-mediated ROS production in 
horseshoe crab is essential for host immune response and homeostasis  
 
4.1.1 PO activation as a non-self differentiation mechanism 
ROS production is a major host defense mechanism.  However, to avoid self-
destruction due to the general cytotoxicity, the ROS production must be well-regulated in 
the host.   By biochemical analysis, we showed that ROS production from the horseshoe 
crab HMC/PPO and human hemoglobin was effectively initiated by microbial proteases 
(Figure 3.11 & Figure 3.14), but not by the host proteases (for example, horseshoe crab 
Factor C).  Furthermore, the ROS production is enhanced by PAMPs from microbial cell 
wall (at a relatively high concentration which is only achievable at the vicinity of the 
microbe itself), but not by phosphatidyl lipids such as POPG or POPC, which are 
common to both the hosts and microbes (Figure 3.15).    
The selectivity/specificity of the activating factors, of microbial origin assures 
that the ROS is only produced in the vicinity of the invading microbes, in particular, 
against the virulent strains which generate extracellular proteases.  Thus, the host 
uncannily averts self-destruction.   
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4.1.2   Low level of phenolic substrate helps prevent undesirable production of 
quinone  
 
Besides the specificity/selectivity of PPO activation by microbial protease and 
PAMPs, the availability of PO substrate could be another checkpoint of the toxic quinon 
production. The total phenolic substrate level in the horseshoe crab plasma remained 
constantly low in all the individuals examined. Moreover, such level was not significantly 
affected by bacterial infection (Figure 3.16).  Considering the extremely high 
concentration of HMC/PPO in the plasma, this low level of the in vivo phenolic substrate 
helps to effectively prevent any undesirable formation of the harmful quinone product.  It 
is conceivable that the production/availability of phenolic substrate is also under tight 
control, although the identity of the endogenous substrate remains unknown.   
 
4.1.3   Endogenous host serine protease inhibitors act as regulatory “on-off” switch 
for the PO activity 
 
Endogenous protease inhibitor, such as CrSPI found in the hemolymph, could 
inhibit subtilisin activated PPO (Figure 3.17).  Since CrSPI undergoes a dynamic profile 
with lowered levels of transcript and protein upon microbial challenge (Thangamani, 
Jiang et al, unpublished), it may form an “on-off” regulatory mechanism of host immune 
responses at the acute phase, including the extracellular PPO activation pathway.   
 
4.1.4 Localization of HMC/PPO on the microbial surface prevents the diffusion of 
PO activity  
 
HMC/PPO is localized at the vicinity of the invading microbe, through either 
direct binding with PAMPs, or indirect interactions through PRR molecules.  This was 
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supported by the recurrent observation that HMC is consistently incorporated in the 
pathogen recognition complex isolated of by affinity elution from the bacterial or PAMP 
beads (Li Yue et al, 2007).   
In summary, to avoid undesirable self-destructive effect caused by the highly 
reactive quinone produced from PPO activation, the host has evolved a fine thread in 
regulating temporal and spatial PPO activation, to kill the invading microbe effectively 
while sparing the host itself.  
 
4.2 The extracellular PO activation represents a novel antimicrobial defense  
Compared to other studies on the PPO activation mechanism in the chelicerate 
immunity, our study is distinct in that we targeted at a different scope of potential PPO 
activator molecules in our experimental model.  In the early studies, probably due to the 
lack of awareness of native PPO activator identities, Decker et al (1998, 2001) tested a 
series of chemicals that do not exist in the host organism.  They found that the detergent 
SDS can elicit PO activity from the horseshoe crab HMC/PPO and proposed that 
conformational change caused by such detergent is necessary for the activation.  Later, in 
order to find the native activating factors in the host organism, Nagai et al (2000, 2001) 
tested several proteins from the hemocyte lysate, including the clotting cascade enzymes 
and the antimicrobial peptides.  They demonstrated that factor B, clotting enzyme from 
large granules and techyplesin from small granules could activate the horseshoe crab PPO.  
Based on these observations, they suggested that the PPO pathway in the chelicerate is 
linked to the clotting pathway by sharing the common hemocyte components as 
activators.  However, in our study, taking into consideration the presence of microbes at 
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the immediate locality of infection, we examined the microbial molecular components, 
including the extracellular proteases and PAMPs, and showed that they are indeed 
functional PPO activators (Jiang et al, 2007).  Hitherto, due to the lack of exact 
quantitative comparisons on the PO activity levels obtained in each study, it is still 
unclear whether the host’s activator dominates those from the microbe, or vice versa in 
the real infection scenario.  However, it is conceivable that our model may represent a 
more direct/prompt PPO activation mechanism.  One can envisage that once the microbe 
enters the host, its microbial proteases and PAMPs are immediately available as the PPO 
activators to the circulating HMC/PPO; by contrast, the host hemocyte components can 
only get access to the HMC/PPO after they are released through the PAMP-triggered 
exocytosis, thus lagging behind the microbial proteases.   
Recent work on the horseshoe crab has revealed that this ancient species harbors 
several parallel immunosurveillance mechanisms in its hymolymph, including an opsonic 
complement system (Zhu et al, 2005), which is mediated by a repertoire of plasma lectins 
(Zhu et al, 2006).  Gram-negative bacteria are effectively eliminated through the LPS-
induced hemocyte degranulation (Muta et al., 1995), whereas Gram-positive bacteria, 
which lack LPS, are mainly cleared by extracellular antimicrobial mechanisms.  This 
thesis describes novel findings of the activation mechanism of the horseshoe crab 
HMC/PPO by microbes at the frontline interface of microbe-host interaction in the 
extracellular milieu.  This mechanism is different from those reported before by other 
researchers (Nagai et al, 2000, 2001).  Instead of relying on intracellular serine proteases 
and/or antimicrobial peptides (which are only accessible upon LPS-dependent lysis of the 
hemocytes and degranulation), to activate the extracellular PPO, we provide evidence for 
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a direct and prompt frontline antimicrobial action, which immediately responds to the 
microbial invader as it gains entry into the host.  Furthermore, the respiratory protein is 
triggered by proteases and PAMPs from both the Gram-positive and Gram-negative 
bacteria, orchestrating an equally effective clearance of both types of bacterial invaders.  
Analysis of the in vivo physiological significance of this mechanism suggested that the 
PO-mediated quinone production is necessary and sufficient to kill protease-producing 
bacteria but is not necessarily the only defense against protease-negative bacteria.  The 
observation that the host exploits different defense mechanisms against different species 
of pathogens recapitulates the notion that the hosts have co-evolved astutely against the 
microbes.   
 
4.3 The existence of a specific PPO-independent of HMC in horseshoe crab 
Arthropod HMC and PPO both belong to the hexamer family.  The alignments of 
all known HMC and PPO sequences show that the homology between HMC and PPO is 
30% for the whole protein, but is higher than 80% for the central copper binding site.  In 
the chelicerate, such as horseshoe crab, HMC/PPO exists as circulating protein in the 
plasma, whereas in most insects, PPO exists as a hemocyte specific protein (Cerenius and 
Soderhall, 2004).   Question has been asked whether or not in chelicerate, PPO is 
exclusively the HMC in the plasma?  If yes, are all the seven subunits equivalent in PO 
activation?  If not, is there an individual specified PPO?  This question is also interesting 
for solving the puzzle about the phylogeny of HMC and PPO: which one occurred first?    
For American horseshoe crab, Decker et al (2000) demonstrated that only two of 
the 7 subunit of HMC show PO activity after being activated by detergent.  However, for 
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the Japanese horseshoe crab, Nagai et al (2000, 2001) showed that all of the different 
subunits displayed similar activity.  We have partially purified the C. rotundicuda 
hemocyanin to different subunits (Figure 3.2 and 3.3) and the PO activity induced from 
the single subunit IV did not vary significantly.  Recent investigation in the lab examined 
the spatial and temporal transcriptional profile of immune response molecules by 
subtractive hybridization (Ding et al, 2005). Surprisingly, hemocyanin subunit 2 was the 
only hemocyanin subunit that was picked up showing two folds up-regulation of 
transcription in the acute phase.    This might indicate that unique property of this subunit, 
probably as a specified PPO.  Whether or not this subunit II is of higher PPO activity than 
other subunits remains unknown. 
 
4.4  From HMC to Hb, and from horseshoe crab to human - functional convergence 
of respiratory proteins in innate immune defense 
 
In this thesis, we have revealed a direct antimicrobial mechanism in the 
invertebrate, elicited by HMC.  The functional analogy between hemocyanin and 
hemoglobin, both as oxygen carriers under physiological condition, prompted us to 
examine the existence of a similar mechanism in humans.  In view of the known ROS 
production by metHb through the pseudoperoxidase cycle (refer to 1.2.3, Figure 1.12), 
we hypothesized that while the bacteria seemingly usurp hemoglobin via erythrocyte 
lysis, the hemoglobin molecule elicits antimicrobial action in the vicinity of the microbial 
invader by a concerted release of ROS.   However, at this juncture, we encounter a 
dilemma of the location of the two respiratory proteins; the intracellular location of Hb vs 
extracellular location of HMC.  HMC exists as a plasma protein in the open circulating 
system of the invertebrates.  Therefore, it is immediately available as a front line 
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antimicrobial factor.  However, Hb is normally sequestered in the protected environment 
within the RBC.  The missing link is how is the Hb released to the front line 
antimicrobial immune response?   Recently, Skaar et al (2004) reported that S. aureus, a 
widespread pathogenic bacterium, has evolved a complete set of virulent factors, to usurp 
heme iron from the host Hb.  Using hemolysin, S. aureus rapidly forms pores on the RBC 
membrane and releases the metHb to immediately contact the invading bacteria.  Our 
finding revealed that the consequent activation of metHb as an ROS producer 
significantly killed the protease V8 producing strains.  In other words, hemolysis to 
release the metHb to the vicinity of bactericidal and the protease positive are the 
conditions necessary for triggering this immediate host immune defense.    
 
4.5   The relevance of the metHb-mediated ROS production to human diseases 
We have demonstrated that hemoglobin from both the rabbit and human RBC, 
when released by hemolytic bacteria, is triggered synergistically by PAMPs and 
microbial proteases to produce antimicrobial ROS, forming a strong innate immune 
defense (Jiang et al, 2007).  At this juncture, whether or not this defense mechanism 
operates in genetic disorders such as chronic granulomatous disease (CGD) remains 
uncertain.  CGD is an intriguing genetic disease associated with a lack of ROS (El-Benna 
et al., 2005; Zekanowski and Skopczynska, 1999); however, this case may not be relevant 
to the met-Hb mechanism we proposed, and the apparent lack of ROS provocation need 
not necessarily rule out the possibility that the antimicrobial mechanism we described is 
important to humans because, firstly, it is well-appreciated that patients with CGD whose 
phagocytes are defective in producing ROS, are prone to infection by peroxidase-
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producing bacteria (eg: Staphylococcus aureus, Salmonella, and Pseudomonas) and fungi 
(eg: Aspergillus), which can quickly destroy the H2O2 produced by the phagocyte burst 
(Zekanowski and Skopczynska 1999; El-Benna, Dang et al. 2005).  However, at this 
juncture, there is no evidence that the CGD patients are not able to activate their met-Hb 
to produce ROS in antimicrobial defense.  Therefore, it is not likely that the clinical 
implications of CGD compromise the significance of the hypothesis.  Secondly, in fact, 
the present study suggested that on entry into the blood, the pathogenic microbes, which 
are hemolytic, can activate the met-Hb and trigger a host defense.  Along these lines of 
reasoning, it is notable that in CGD, the infection is limited to the organs, and 
septicaemia is rare, indicating that the pathogens may be effectively cleared in the 
systemic route, possibly through the metHb-mediated ROS production. Nevertheless, 
further investigation on the contribution of this defense mechanism in vivo may open new 
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CHAPTER 5: GENERAL CONCLUSION AND FUTURE PERSPECTIVES 
 
5.1 General Conclusion 
The main aim of the present study was to examine the roles of respiratory proteins, 
hemocyanin and hemoglobin, in innate immunity, with respect to their potency as ROS 
producers. Previous studies have shown that the invertebrate protein hemocyanin and the 
vertebrate protein (met)hemoglobin can generate reactive oxygen intermediates via 
prophenoloxidase (PPO) and pseudoperoxidase activity, respectively. The present study 
demonstrated that:  
(1) the PPO activity of the hemocyanin and the pseudoperoxidase activity of 
methemoglobin are efficiently triggered by microbial proteases and further enhanced by 
pathogen-derived molecules (PAMPs).  
(2) the in vitro and in vivo antimicrobial assay demonstrated that this ROS 
production play important roles in the host innate immunity.  Thus, both invertebrate and 
vertebrate hosts are capable of exploiting microbial virulence factors for the rapid 
activation of an extracellular antimicrobial effector mechanism that in vertebrates only 
necessitates lysis of erythrocytes, but no prior transcriptional induction or translational 
upregulation is required.  
(3) the ROS-meidated antimicrobial defense is located at the vicinity of the 
invader, through HMC/Hb-PAMP interactions, thus forming an effective antimicrobial 
defense while sparing the host itself. 
The respiratory protein-mediated ROS production represents an antimicrobial 
defense mechanism that is not dependent on specialized cells of the innate or adaptive 
immune system.  The significance of this model is as follows:  
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(i) It is direct (a short-cut) and does not require the string of signaling events from 
extra- to intra- cellular route prior to production of AMP.  Furthermore, due to its local 
activation, this mechanism is likely to achieve destruction of certain bacteria without 
generating negative effects on host tissue.  
 (ii) In terms of its rapid availability the newly described killing mechanism is 
most reminiscent of the activation of NADPH oxidase in vertebrates, which is expressed 
in phagocyte cells and only requires the translocation of cytosolic proteins for the 
immediate release of ROI. However, unlike NADPH oxidase, the hemoglobin-based 
killing of bacteria does not require uptake of the microbes, but is restricted to those 
bacteria that cause hemolysis and express an activating protease. Thus, the mechanisms 
are likely to complement each other with respect to the site of action and the antibacterial 
spectrum.  
To summarize, we have shown that host respiratory proteins can be activated to 
produce ROS, thus forming a strong antimicrobial defense.  Such mechanism, found in 
both the invertebrate and vertebrate, circumvents the need for a chain of events including 
PAMP-recognition and signal transduction prior to antimicrobial actions.  Instead, the 
host directly exploits the invading microbe's virulence factors to convert its own 
respiratory proteins from oxygen carriers to potent ROS producers, thus resulting in a 
localized surge of the cytotoxic free radicals (quinone in the invertebrate or superoxide in 
the vertebrate), which rapidly kills the pathogen in its immediate vicinity, whilst sparing 
the host from self-destruction (Figure 5.1).  Such a seminal shortcut immunosurveillance 
mechanism, which has been entrenched >500 million years ago, probably represents 
another ancient form of innate immunity, being functionally conserved before the split of 
protostomes and deuterostomes.    
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5.2   Future perspectives on the invertebrate PPO system  
 
To isolate and identify the endogenous PO substrate in the invertebrate  
          
Throughout the studies of antimicrobial activity and protease-induced PO activity, an 
exogenous substrate 4ME, which is a well-appreciated synthetic substrate for PO was 
used. Activated PO generates the 4ME cytotoxic quinones, in high enough concentrations, 
leads to microbicidal actions.  Although it has been well-accepted that the endogenous 
substrate of phenoloxidase does exist in vivo (Cerenius and Soderhall, 2004), the 
identification of such endogenous substrate(s) has been severely hampered due to their 
presumably low level and transient existence in the host.  Recently, Zhao et al. (2007) 
demonstrated that the toxicity of quinone to bacteria is likely to depend on what catechol 
is actually present in hemolymph.  Therefore, future work targeting the actual substrate in 
vivo will help provide an even more persuasive set of results to demonstrate the 
importance of microbial proteases in enhancing host anti-microbial defense via the PO 
system.  Bearing in mind that the substrate production might also be under tight temporal 
and spatial regulation, in order to elucidate the substrate, we may establish a model in 
which the HMC/PPO is depleted or inhibited so that the substrate can be accumulated to 
a considerably high level to be identified properly.   
To isolation of the active form of PO derived by the proteolysis of HMC/PPO 
In this study, using biochemically reconstitution, we have demonstrated that 
microbial proteolysis is essential for the conversion from HMC/PPO to PO.   In insects, 
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the active form PO, which is derived by proteolysis of PPO, has been isolated, and a 
consensus of cleavage site has been identified.  In chelicerates, HMC is the functional 
PPO and each subunit of the hexamer harbors the potential to generate PO activity.  
Therefore, it is intriguing to identify the active form of PO derived from individual 
subunits of HMC.  To this end, one can “freeze” the proteolysis in the activating reaction 
with protease inhibitor, and then isolate the active form from the cleavage mixture.  
Another technical avenue is to first examine the possible cleavage site of the microbial 
protease on the target HMC subunit.  Then, after producing the correspondening 
recombinant protein, one can evaluate the PO activity, thus identifying the active form 
accordingly. This information on PO active form will greatly enhance our knowledge of 
the structure-activity relationship to the PO catalytic.   
 
To explore the existence of a specialized PPO in chelicerate 
Both chelicerate HMC and insect PPO are from the hexamerin family. 
Interestingly, in the arthropod crayfish, PPO and HMC co-exist, and share considerable 
homology (38% identity of amino acids) (Lee et al., 2004; Liu et al., 2006). However, a 
specified PPO has not been identified from the chelicerate amebocytes (Cerenius and 
Soderhall, 2004).  For horseshoe crab, the phylogenetic analysis performed in this thesis 
revealed that among the 7 subunits found in the hexamer holoprotein (refer to section 3.1 
and Figure 3.8), subunit II, is of highest homology to insect PPO, suggesting that this 
subunit could be a specific PPO among the HMC subunits in the horseshoe crab.  
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Future study on the temporal and spatial transcriptional profile of individual HMC 
subunit, particularly under microbial challenge condition, will further reveal their actual 
role in host immunity.  This would also provide information to solve the puzzle on the 
evolution of the hexamer family members, the HMC and PPO (Terwilliger, 1998).   
 
To explore the pathogen recognition complex involving HMC and other PRRS   
The interaction between HMC and the major PRR molecules, such as C-reactive 
protein (CRP) and galactose binding protein (GBP) have been systematically examined 
by Ng et al (2007). In this thesis, the dissociation constants determined for GBP:HMC 
and CRP:HMC are at 10-5 M and 10-7 M respectively, suggesting relatively weak to 
medium interactions with HMC.  However, these interaction studies were based on 
recombinant proteins, which might not have been appropriate modified post-
translationally, thereby affecting the PRR:PRR interactions.  It has been observed that 
during infection, the affinity among PRR molecules increases significantly, ending up in 
stable pathogen recognition complex (Ng, et al, 2007), and the serine protease activity is 
essential for this complex formation (Le Saux et al, personal communications).  
Interestingly, more HMC was retrieved from the complex during infection, suggesting 
that the affinity of HMC-PRR interaction also increases which accumulate more HMC 
during infection.   It is conceivable that under normal physiological conditions, HMC 
interacts with GBP and CRP at basal level; upon infection, this interaction is reinforced 
to form a stable and functional antimicrobial module.  Besides the participation of the 
serine protease, phenol oxidation might also provide protein cross-linking through 
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disulfide bond formation.  Future study should address this possibility bearing in mind 
the application of the phenoloxidase inhibitors in the microbial infection model.  
 
To investigate the transcriptional regulation profiles of HMC subunits 
The cDNA sequences of the 7 subunits of HMC holo-molecule have been 
revealed from this thesis.   However, the functional relationship among these individual 
subunits remains unknown.  This issue can be addressed by examining the transcriptional 
and proteomics profile of each subunit upon challenge condition.   
 
5.3 On the metHb-mediated ROS production as a mammalian innate immune 
mechanism   
In this study, we have also demonstrated that hemoglobin, the respiratory protein 
in vertebrates and humans, is a potent ROS producer under microbial challenge.   The 
synergistic action of microbial protease and PAMPs increases the pseudoperoxidase 
activity of metHb, thus resulting in a burst of ROS production at the vicinity of the 
invading microbe.  Although in the biochemical reconstitution, PAMPs alone can 
enhance the pseudoperoxidase activity of metHb, the microbial protease is still necessary 
for sufficient ROS production (figure 3.38).  The specific interaction between 
hemoglobin and LPS/LTA (Section 3.5.2) is important with respect to locating the 
activated metHb to the bacteria, so as to prevent spreading of the destructive power to 
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To further investigate the structural and functional significance of Hb-PAMP 
interaction   
In innate immunity, PAMPs play important roles in triggering host-pathogen 
interaction, causing inflammation reaction, and to the extreme, the septic shock (Berche, 
2003; Liu et al., 1998). It was known that LPS can bind to Hb (Howe et al., 2007; Jurgens 
et al., 2001; Kaca et al., 1994).   In this study, we showed that LTA, the PAMP from 
Gram-positive bacteria also binds Hb specifically.  Upon challenge by pathogens with 
hemolytic activity, hemoglobin is released from red blood cell.  Existing at high level at 
the front line of immune response, Hb-PAMP interaction inevitably modifies the 
structure and function of PAMPs.  To elucidate the functional significance of this Hb-
PAMP interaction, a series of in vitro/ ex vivo assay should be done.  For example, using 
rFc assay (Ding and Ho, 2001) to evaluate the residual endotoxin activity of LPS upon 
hemoglobin binding; or evaluate LPS-triggered chemokine production using the primary 
monocyte model. We can envisage the importance of such studies for future drug design 
aimed at modulating the innate immunity to the host advantages.   
 
From the structural view point, details on HMC/Hb-PAMP interaction are 
important.  Using the purified hemocyanin and PAMP molecules, we have unequivocally 
demonstrated that HMC directly binds the PAMPs during the microbial infection and the 
dissociation constant of HMC or Hb to LPS is 10-8 M, representing a reasonably strong 
interaction.  Referring to the mechanism underlying how spider hemocyanin binds 
ecdysone and 20-OH-ecdysone (Jaenicke et al., 1999),  we predict the LPS binding site 
on the hemocyanin N-terminal alpha domain, involving the hydrophilic and hydrophobic 
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pockets. Future study on detailed structural mechanism of LPS-HMC or LPS-Hb 
interaction should provide information of the minimum LPS binding fragments, which 
could be important for further drug design to neutralize the endotoxin activity of LPS in 
sepsis (Tan et al., 2000a; Tan et al., 2000b).  Possible experimental design could include 
the in silico docking the LPS and Hb to predict the interaction motif from each side.  
Then further site-directed mutagenesis could provide insightful information on the 
interaction mechanism, which will be important for drug lead design.   
 
To further understand the relevance of the metHb-mediated ROS production in 
human disease and immune defense.  
  
Our findings on ROS production via met-Hb suggest that this antimicrobial 
mechanism may be operative in human infections.  However, the well-appreciated 
inherent disease chronic granulomatous disease (CGD) where ROS is deficient, may not 
be relevant to the met-Hb mechanism we proposed.   In future work, it is of high 
importance to systematically study the clinical infection cases and accumulate 
information on the protease-producing property of the pathogen in individual infectious 
disease.  To this end, we can test clinical samples (e.g. blood) of patients with acute or 
chronic infection, regarding the ability of their RBC to produce ROS against pathogenic 
bacteria.  Connection of this assay to the clinical symptom may help evaluate the 
contribution of this defense mechanism in vivo. Such study may open avenues into the 
development of new antibacterial strategies.   
To this end, information on the protease-producing property of the pathogen in 
individual infectious disease needs to be accumulated.  Further investigation on the 
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contribution of this defense mechanism in vivo may open new avenues into the 
development of antibacterial strategies.   
 
To unveil the whole redox network of metHb in the innate immune response and 
homeostasis 
 
It is well known that a complex redox network exists inside RBCs to eliminate the 
deleterious effects of ROS production under physiological condition (Alayash, 1999). 
Under bacterial challenge, when the hemoglobin is released to the extracellular milieu, 
the redox balance is disturbed and cytotoxic ROS is produced.  In this study, we have 
focused on the metHb without examining the other RBC components, such as catalase 
and SOD.  Future study on the regulation of the activity of these molecules could reveal 
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Respiratory protein–generated reactive oxygen species
as an antimicrobial strategy
Naxin Jiang1, Nguan Soon Tan2, Bow Ho3,4 & Jeak Ling Ding1,4
The evolution of the host-pathogen relationship comprises a series of invasive-defensive tactics elicited by both participants.
The stereotype is that the antimicrobial immune response requires multistep processes. Little is known about the primordial
immunosurveillance system, which probably has components that directly link sensors and effectors. Here we found that the
respiratory proteins of both the horseshoe crab and human were directly activated by microbial proteases and were enhanced
by pathogen-associated molecular patterns, resulting in the production of more reactive oxygen species. Hemolytic virulent
pathogens, which produce proteases as invasive factors, are more susceptible to this killing mechanism. This ‘shortcut’
antimicrobial strategy represents a fundamental and universal mode of immunosurveillance, which has been in existence since
before the split of protostomes and deuterostomes and still persists today.
Throughout evolution, pathogenic microbes have developed many
ways to invade the host and simultaneously evade its immune defense.
These tactics include the secretion of virulence factors1,2, the forma-
tion of biofilm3 and the use of molecular mimicry4. Conversely, the
host immune system has developed various countermeasures such as
the release of antimicrobial peptides5, the synthesis of highly toxic
reactive oxygen species (ROS)6 and the formation of the complement-
mediated membrane-attack complex7. It is commonly accepted that
the innate immune responses are multistep processes initiated by the
recognition of pathogen-associated molecular patterns (PAMPs),
followed by successive signal transduction leading to the action of
‘downstream’ antimicrobial effectors8. Over the past two to three
decades, researchers have focused their attention on families of host
receptors and signaling cascades. However, the primordial forms of
immunosurveillance, which might directly link the host’s pathogen
sensors and the antimicrobial effectors, need to be further examined.
ROS-mediated antimicrobial activity is a powerful host defense
mechanism6. Studies have shown that hemocyanin (HMC) and
hemoglobin, the respiratory proteins of invertebrates and vertebrates,
respectively, can produce ROS9,10. However, in both cases, how ROS
production is regulated by the microbial virulence factors during
infection and the importance of ROS-mediated antibacterial activity
are not fully understood.
The horseshoe crab, an ancient protostome that has been dubbed a
‘living fossil’11, has an array of frontline defense molecules12. The
HMC of the horseshoe crab has prophenoloxidase (PPO) potential9,13
(called ‘HMC-PPO’ here). Its activation to phenoloxidase (PO) results
in the production of highly reactive cytotoxic quinone, which is
functionally equivalent to ROS produced by vertebrates14; quinone
kills the microbial intruder effectively. As the toxicity of ROS poses a
dilemma to the host’s own survival, its production must be tightly
controlled. Several host proteases have been shown to catalyze the
conversion of HMC-PPO to PO15–17. However, whether the microbial
proteases can activate HMC-PPO remains unknown.
The vertebrate respiratory protein hemoglobin binds reversibly to
oxygen. When hemoglobin is auto-oxidized to the ferric form,
methemoglobin (metHb), it gains a pseudoperoxidase activity capable
of catalyzing the production of superoxide ion (O2
–)10,18. Although
superoxide ion itself is not considered cytotoxic19, it spawns toxic
derivatives such as hydroxyl radicals and hypohalous acid20. Therefore,
processes that facilitate the generation of O2
– will perpetuate and
potentiate oxygen-dependent microbicidal action20. In physiological
conditions, hemoglobin is sequestered in erythrocytes, where intra-
cellular reductive mechanisms maintain metHb at a low concentra-
tion21, thereby avoiding host self-destruction18. However, research has
shown that virulent bacteria produce cytolytic toxins to hemolyse
erythrocytes and release hemoglobin22. For example, Staphylococcus
aureus uses hemolysin to convert hemoglobin and selectively retrieves
the heme as its ‘preferred’ iron resource for growth22. This raises the
issue of how the hemoglobin molecule counters such a microbial
assault. We reasoned that when the host is challenged into hemolysis,
the released hemoglobin molecule elicits antimicrobial activity
through ROS production in the vicinity of the intruding microbe.
However, whether such bactericidal activity is regulated by microbial
virulence factors after infection remains an enigma.
In addition to cytolytic toxins, microbial intruders have also
developed other virulence factors such as extracellular proteases to
gain entry into and colonize the host23–25. Here we found that the
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PPO activity of invertebrate HMC and the pseudoperoxidase activity
of vertebrate metHb were both triggered by microbial proteases and
were further enhanced by PAMPs. Thus, we have demonstrated a
direct antimicrobial strategy by which the host opportunistically
exploits the invading microbe’s virulence factors to convert its
respiratory proteins into potent ROS producers, which effectively
kill the intruder. This mechanism has probably been in existence for
over 500 million years, before the split of protostomes and deuter-
ostomes, and is particularly potent against virulent bacteria that
produce extracellular proteases.
RESULTS
Microbial activation of HMC-PPO to PO
To test the hypothesis that microbial proteases can trigger the con-
version of HMC-PPO to PO independently of host proteases, we
treated purified HMC-PPO with several microbial proteases and
assessed the resulting PO activity. Subtilisin A and type XIV protease
from Gram-positive bacteria, pseudomonas elastase (PAE) from
Gram-negative bacteria and proteinase K from fungi efficiently
activated HMC-PPO (Fig. 1a). When we inhibited subtilisin A,
proteinase K and type XIV protease with phenylmethyl sulfonyl
fluoride and when we inhibited PAE, a metalloprotease, with 1,10-
phenanthroline monohydrate, we noted less than 20% PO activity
compared with that of their uninhibited counterparts (Fig. 1a),
indicating that proteolysis was specific and was conditional on PPO
activation. However, factor C, a host serine protease that is an effective
lipopolysaccharide (LPS)–recognition receptor, did not activate the
PPO (data not shown), suggesting that the PPO activation contributes
to a non-self type of immune response.
PAMPs are important in triggering the innate immune
response26,27. To understand their contribution to PPO activation,
we tested LPS from Gram-negative bacteria, lipoteichoic acid (LTA)
from Gram-positive bacteria and laminarin from fungi, either
individually or in combination with the corresponding microbial
proteases. None of the PAMPs alone (at concentrations of 0.125–
20 mg/ml) activated HMC-PPO substantially. However, when we
pretreated HMC-PPO with PAE before adding LPS, the resulting
PO activity was enhanced in a dose-dependent way by LPS (Fig. 1b).
We obtained similar results with the LTA–subtilisin A combination
(Fig. 1b) but not with the lamarin–type XIV and lamarin–proteinase
K combinations. The enhancement of the microbial protease–induced
PO activity by PAMPs suggests that HMC-PPO activation is a
sensitive non-self recognition mechanism.
Activation of PPO to PO through proteolysis
To delineate the mechanism of PPO activation by microbial proteases
and PAMPs, we reconstituted the reactions with the microbial
proteases and PAMPs in various sequential orders. When we first
lysed HMC-PPO by proteolysis with microbial proteases followed by
the addition of PAMPs, higher PO activity was achieved (Fig. 1c).
Next, we further examined the proteolytic profile of HMC-PPO by
PAE with the addition of LPS before or after PAE. There were distinct
differences in the proteolytic profiles of HMC-PPO depending on the
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Figure 1 Activation of HMC-PPO to PO by microbial proteases and PAMPs. (a) PO activity after treatment with various microbial proteases with (+) and
without (–) the protease inhibitors phenylmethyl sulfonyl fluoride (1 mM), to inactivate subtilisin A, proteinase K (Prot K) and type XIV protease (Type XIV), or
1,10-phenanthroline monohydrate (1 mM), to inactivate PAE. A405, absorbance at 405 nm. (b) PO activity after the addition of HMC with either subtilisin A
or PAE (concentration, below graph) with or without increasing concentrations of the PAMPs LTA and LPS. (c) PO activity after the addition of microbial
proteases (subtilisin A or PAE) and PAMPs (LTA or LPS) in various sequential order (key). (d) SDS-PAGE of HMC-PPO incubated with PAE and LPS applied
in sequential order: *, PAE before LPS; **, LPS before PAE. Arrowheads indicate proteolytic intermediates and/or proteolytic products of hemocyanine. Each
lane is loaded with 12 mg HMC. kDa, kilodaltons (molecular size markers). (e) ELISA of HMC-LPS after incubation of HMC-PPO and LPS (concentrations,
below graph). (f) Synergistic activation of HMC-PPO by microbial proteases and PAMPs. Microbial proteases first lyse HMC-PPO by proteolysis to a partially
activated PO intermediate ([PO]), then PAMPs bind the partially activated intermediate to produce fully active PO (POmm; solid arrows) and/or PAMPs
interact with HMC-PPO to form an inactive complex that is subsequently cleaved by microbial proteases to PO with only marginal activity (POm; dashed
arrows). Data are representative of three experiments (mean ± s.d., a,b,c,e).
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caused a conformational change that exposed an alternate cleavage site
for PAE. By enzyme-linked immunosorbent assay (ELISA), we found
that HMC-PPO bound LPS specifically (Fig. 1e). These observations
collectively suggest collaborative activity of the microbial virulence
factors, proteases and PAMPs in triggering HMC-PPO and enhancing
the activity of PO.
It has been proposed that in the dormant state, entry to the active
site of HMC-PPO is blocked by an a-domain Phe49 and thus phenolic
substrates cannot be oxidized28. Our data indicated two possible PPO-
activation mechanisms (Fig. 1f). First, after infection, the microbial
protease nicks the HMC-PPO, producing only marginal PO activity;
when PAMPs bind to the partially activated PO, it causes a conforma-
tional change, resulting in a full PO activity (Fig. 1f, solid arrows).
Second, the HMC-PPO molecule preoccupied by PAMPs undergoes a
conformational change and exposes cleavage sites different from those
on the free HMC-PPO, after which microbial protease–mediated
proteolysis can achieve only marginal PO activity (Fig. 1f, dashed
arrows). In vivo, these two mechanisms of PPO activation may coexist
and may constitute a refined regulation of the host immune response:
lower PO activity is used to combat strains that produce less extra-
cellular proteases, whereas higher PO activity is unleashed against the
strains that produce more extracellular pro-
teases. Given the cytotoxicity of quinone
produced by PO14, such fine-tuning of PPO
activation could be crucial for clearing the
invading microbes effectively with different
combating powers while avoiding host
self-destruction.
Activated PO has antimicrobial activity
To examine the functional importance of
PPO activation, we tested the antimicrobial
effect of the PO-catalyzed release of quinone
in vitro. We tested protease-producing and
non-protease-producing strains of the Gram-
negative bacterium Pseudomonas aeruginosa.
The P. aeruginosa strain PAO-Iglewski pro-
duces PAE29, the main extracellular protease
virulence factor24, whereas PAO-B1A1 is a
‘PAE-knockout’ mutant29. We incubated each
strain of P. aeruginosa, at a concentration of
1  106 colony-forming units (CFU) per ml,
for 1 h with purified HMC-PPO and
4-methylcatehol (4ME), a PO substrate. We
counted the residual bacterial population by
plating the reaction mixture on nutrient agar
plate and incubating the plates overnight at
37 1C. We found that 66% ± 5% of the PAE-
producing P. aeruginosa were killed within
60 min, whereas only 15% ± 7% of the PAE-
deficient P. aeruginosa succumbed (Fig. 2a).
Furthermore, supplementation of the incuba-
tion mixture containing PAE-deficient
P. aeruginosa with exogenous PAE in-
creased the antimicrobial activity in a dose-
dependent way (Fig. 2b), demonstrating the
essential function of PAE in achieving
the antimicrobial activity. We confirmed the
involvement of PO in this antimicrobial
action by our finding that adding the PO-
specific inhibitor phenylthiourea (PTU)30
significantly retarded the killing of PAE-producing strain but
did not affect the PAE-deficient strain (Fig. 2a). It is known that
HMC-PPO contains precursors of antimicrobial peptides31; however,
in our study, the contribution of the HMC-related antimicrobial
peptide seemed to be minor, as HMC-PPO alone did not demonstrate
increased antimicrobial activity (Fig. 2a). Thus, the PO-induced
production of quinone must have been the main contributor
of bactericidal activity. In addition to measuring the end-point
antimicrobial activity, we visualized real-time bacterial clearance by
time-lapse microscopy. We labeled P. aeruginosa with green fluorescent
protein, incubated the bacteria with purified HMC-PPO and 4ME
and examined them for 1 h by fluorescence microscopy. Again
we found that more of the PAE-producing strain than the PAE-
deficient counterpart succumbed (Fig. 2c,d and Supplementary
Movies 1–3 online). These results demonstrate that the HMC-PPO
was specifically activated by the microbial protease to PO, which,
in the presence of 4ME, produced quinone to kill the bacteria
effectively. We obtained similar results with the Gram-positive
S. aureus laboratory strains PC1839 and AK3 (Supplementary



































































































Figure 2 In vitro antimicrobial action of activated PO. (a,b) End-point antimicrobial activity of
PAE-producing and PAE-deficient strains of Pseudomonas aeruginosa. (a) Incubation of each strain
(1  106 CFU/ml) for 1 h with purified HMC-PPO and 4ME; PTU (0.1 mM), a PO-specific inhibitor,
was used to inhibit PO. NS, not significant; **, P o 0.01 (Student’s t-test). Data represent the
mean ± s.e.m. of three independent experiments, each done in triplicate. (b) PAE-deficient strain
supplemented with exogenous PAE. Data represent the mean ± s.d. of three independent experiments.
(c) Fluorescence microscopy of the samples in a (time, above images). Original magnification,
63  1.6. (d) Survival of bacteria from c.
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In vivo antimicrobial PO is triggered by microbial protease
To demonstrate the ability of PO to clear the invading pathogen
in vivo, we infected horseshoe crabs in the presence or absence of the
PO-specific inhibitors PTU and kojic acid33. We compared the
remaining bacterial load in those conditions to help clarify the specific
contribution of PO to the antimicrobial activity. It has been reported
that HMC-PPO is activated by host intracellular factors15,16 released
through LPS-dependent degranulation of hemocytes34. To avoid the
elicitation of PPO by such cellular components and to unequivocally
demonstrate that the microbial factor–activated PPO contributes to
the antimicrobial defense, we used Gram-positive bacteria lacking LPS
to avoid LPS-induced lysis of hemocytes. We injected the S. aureus
strains PC1839 and AK3 into the horseshoe crabs. Indeed, at 30 min
after injection, the host had cleared over 90% of both strains (Fig. 3a
and Supplementary Fig. 2 online). However, injection of PTU or kojic
acid together with the bacteria impaired the clearance of the V8
protease–positive strain PC1839, resulting in the recovery of signifi-
cantly more bacteria from the host (n ¼ 5; P o 0.01 (Student’s
t-test)). In contrast, clearance of the V8 protease–negative strain AK3
was unaffected by PTU or kojic acid, indicating that the killing of this
strain was independent of PO-mediated quinone activity. This also
indicated that the killing was possibly mediated by other coexisting
extracellular antimicrobial mechanisms, such as the lectin-mediated
complement system26,35, which is not susceptible to inhibition by PTU
or kojic acid. Notably, we found that the V8 protease–positive strain
PC1839 seemed to be resistant to the coexisting extracellular PO-
independent antimicrobial pathways, although the exact mechanism
remains to be determined. Furthermore, we obtained similar results
with S. aureus ATCC49775 as well as six other naturally occurring
Gram-positive bacteria species isolated from the habitat of the horse-
shoe crab (Fig. 3b). We obtained further evidence that activation of
PO by the Gram-positive bacteria was independent of intracellular
components by confirming that collateral hemocyte degranulation
and cell lysis were absent (Supplementary Fig. 3 online). These
observations unambiguously support our hypothesis that the PO
activity triggered by the invading microbes’ proteases contributes to
in vivo extracellular clearance of the protease-producing bacteria. In
the in vitro antimicrobial activity assay, we used 4ME as a synthetic
substrate for PO on which quinone was produced to kill the microbe.
At this juncture, although the physiological substrate for PO remains
to be identified17, the in vivo antimicrobial action demonstrates that
such a substrate does exist and that the PO activated by microbial
proteases forms a powerful defense mechanism.
Synergistic activity of microbial proteases and PAMPs
The functional homology between HMC and hemoglobin prompted
us to search for a similar direct antimicrobial mechanism in humans.
Given the ROS production by metHb10,18, we hypothesized that
whereas the bacteria seem to usurp hemoglobin through erythrocyte
lysis, the hemoglobin molecule elicits antimicrobial action in the
vicinity of the microbes by concerted release of ROS. To test that
possibility, we monitored the release of ROS by metHb with the
chemiluminescence indicator Cypridina luciferin analog (CLA)10
(Fig. 4a). The chemiluminescence of CLA was substantially inhibited
by superoxide dismutase, indicating that the ROS was O2
– (Supple-
mentary Fig. 4 online). Microbial proteases such as proteinase K, type
XIV protease, PAE and subtilisin A specifically increased the release of
O2
– by metHb (Fig. 4b). Moreover, when subtilisin A was inhibited
by recombinant CrSPI-D2 (a 30–amino acid peptidyl serine protease
inhibitor specific to subtilisin A; S. Thangamani et al., unpublished
data), we noted much less O2
– production, indicating that the
proteolysis of hemoglobin by microbial proteases was specific and
was essential for the activation of metHb (Fig. 4b). Furthermore, LPS
and LTA increased the O2
– production in a dose-dependent way,
whereas the phosphatidyl lipids POPC and POPE, which are common
to both the host and the microbe36, lacked such activity (Fig. 4c),
indicating that the action of PAMPs on metHb is specific. Notably,
consistent with the results obtained with HMC-PPO, when pretreated
with PAE or subtilisin A followed by LPS or LTA, respectively, metHb
produced tenfold more superoxide ions (Fig. 4d). LPS and LTA bound
hemoglobin specifically (Fig. 4e,f), and such interaction caused a
conformational change to metHb (Supplementary Fig. 5 online),
which probably contributed to the increased pseudoperoxidase activ-
ity. The consequence of the synergism between these bacterial
components on the O2
– production suggests that hemoglobin
functions in non-self recognition by producing deadly ROS in the
vicinity of the bacteria. The specific interactions between hemoglobin
and PAMPs suggest a mechanism underlying how metHb is recruited
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Figure 3 PO triggered by microbial protease contributes to in vivo bacterial clearance. Killing assay of bacteria (1  105 to 1  106 CFU bacteria per
100 g horseshoe crab) in the presence (+) or absence (–) of 5 mM PTU, assessed by measurement of the remaining bacterial load in the hemolymph at
30 min after injection. (a) Laboratory S. aureus strains PC1839 (V8 protease positive) and AK3 (V8 protease negative). (b) Naturally occurring S. aureus
strain ATCC49775 (active V8 protease positive), Gram-positive bacteria B. pumilus, B. aquimaris and B. subtilis (extracellular protease positive), and
B. chandigarhensis (B. chand), E. faecium and E. faecalis (extracellular protease negative). *, P o 0.05; **, P o 0.01 (Student’s t-test). Small horizontal
lines indicate median CFU/ml recovered. Data represent five independent experiments, unless otherwise stated (Supplementary Text online).
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ROS produced by metHb kills microbes effectively
To investigate the functional importance of the activated metHb, we
tested the antimicrobial activity against S. aureus PC1839 and AK3
in vitro with a biochemically reconstituted system. We incubated each
strain with human metHb and a sublethal concentration of H2O2
(30 mM). We used the superoxide ion scavenger GSH37 at a con-
centration of 10 mM to eliminate superoxide ions, if any were present.
More of the V8-producing S. aureus than the non-V8-producing
S. aureus was killed within 60 min (Supplementary Fig. 6 online),
whereas supplementation of the incubation mixture of the V8-
negative strain with exogenous subtilisin A increased the antimicrobial
activity in a dose-dependent way (Supplementary Fig. 6b). Finally,
the addition of GSH significantly retarded the killing of V8-positive
but not V8-negative S. aureus (P o0.05 (Student’s t-test); Supple-
mentary Fig. 6a). These results indicate that the O2
– production by
metHb is enhanced by the microbial protease, thus effectively sub-
verting the pathogen.
Mammalian red blood cells produce bactericidal ROS
In addition to biochemically simulating the bacterial protease–
dependent ROS production with metHb, we also examined the
function of this mechanism with rabbit and human red blood cells
(RBCs). We incubated the bacteria with RBCs and continuously
monitored hemolysis, ROS production and the remaining bacterial
populations over a period of 30 min. Both rabbit and human RBCs
showed similar responses (Fig. 5, typical profiles of rabbit RBCs).
There was hemolysis within 5 min of the addition of S. aureus strains
PC1839 and AK3 (Fig. 5a). Simultaneously, we noted pseudoperox-
idase activity in the chemiluminescence assay (Fig. 5b). Within
10 min, over 80% of the protease-producing S. aureus was killed,
whereas the protease-negative strain remained viable (Fig. 5c). The
addition of either superoxide dismutase or protease inhibitor (which
have been shown to not substantially affect bacterial growth on their
own) to the incubation mixture significantly reduced the antibacterial
activity against the protease-producing strains (P o 0.01, Student’s
t-test), confirming the involvement of superoxide species in the
antimicrobial action and the requirement for the bacterial protease
in the ROS production.
We obtained similar results when we tested various naturally
occurring clinically important bacterial isolates (Fig. 5d). Bacillus
subtilis and S. aureus strain ATCC49775, which are hemolytic and
positive for extracellular protease, were killed by metHb-mediated
ROS production, whereas methicillin-resistant S. aureus strains
MRSA1 and MRSA2, as well as Enterococcus faecium and Enterococcus
fecalis, which are either nonhemolytic or do not produce protease,
were unaffected. Notably, two clinical isolates of P. aeruginosa, one
producing protease and one not producing protease, were unaffected
in this in vitro assay. In the conditions of this assay, neither of these
Pseudomonas strains caused hemolysis, although they appeared hemo-
lytic on blood agar (data not shown), thus supporting the idea that
initial hemolysis of the RBC is crucial to the ROS production and
subsequent killing event. In conclusion, these observations suggest
that in the mammalian system, the hemoglobin released by bacteria-
mediated hemolysis of RBCs is activated by the microbial protease to
produce ROS, which kills the bacteria effectively (Supplementary
Fig. 7 online).
DISCUSSION
ROS production is a major host defense mechanism. However, to
avoid self-destruction due to general cytotoxicity, ROS production
must be well regulated in the host17. Here we have shown that ROS
production by horseshoe crab HMC-PPO and human hemoglobin
was effectively enhanced by microbial proteases but not by the host
proteases (such as horseshoe crab factor C or the mammalian digestive
protease-like bovine trypsin). Furthermore, the PAMPs from micro-
bial cell wall but not phosphatidyl lipids such as POPC or POPE,
which are common to both the hosts and microbes36, enhanced the
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Figure 4 Pseudoperoxidase activity of metHb is triggered synergistically by
microbial proteases and PAMPs. (a–d) Chemiluminescence assay of the
pseudoperoxidase activity of metHb. (a) Kinetics of O2
– production
catalyzed by various amounts of metHb (amounts, ends of graph lines).
(b) Pseudoperoxidase activity after the incubation of metHb (10 mg)
for 10 min with microbial proteases (20 mg; horizontal axis); far right (gray
bar), incubation of subtilisin A (20 mg) for 20 min with CrSPI-D2
(subtilisin-specific inhibitor; molar ratio, 1:1.5) before incubation with
metHb. (c) Pseudoperoxidase activity after the incubation of metHb (10 mg)
with PAMPs (LPS and LTA) or with phosphatidyl lipids common to both
host and microbe (POPE and POPC). (d) Pseudoperoxidase activity after the
incubation of metHb (10 mg) with microbial proteases and/or PAMPs. In b–d, an aliquot containing 2 mg metHb was used in each assay; 5 mg subtilisin A
was used in d (in contrast to the 20 mg used in b) to demonstrate the further enhancement by LTA due to the synergism between subtilisin A and LTA.
(e,f) ELISA of mixtures of hemoglobin (Hb) and LPS (e) or hemoglobin and LTA (f). Data represent the mean ± s.d. of three independent experiments.
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factors ensure(s) that ROS are only produced
in the vicinity of the invading microbes, in
particular against the virulent strains that
generate extracellular proteases. Thus, the
host avoids self-destruction.
For invertebrates, work on the horseshoe
crab has shown that this ancient species has
several parallel immunosurveillance mechan-
isms in its hymolymph9, including an opso-
nic complement system26, which is mediated
by a repertoire of plasma lectins35. Gram-
negative bacteria are effectively eliminated
through LPS-induced hemocyte degranula-
tion9,34, whereas Gram-positive bacteria,
which lack LPS, are cleared mainly by extra-
cellular antimicrobial mechanisms. Here we
have demonstrated a previously unknown
activation mechanism of horseshoe crab
HMC-PPO in the extracellular milieu, differ-
ent from the mechanisms reported
before15,16. Instead of intracellular serine pro-
teases and/or antimicrobial peptides (which
are accessible only after LPS-dependent lysis
of the hemocytes and degranulation) to acti-
vate the extracellular PPO, we have provided
evidence here of a direct and prompt front-
line antimicrobial action that immediately
responds to the microbial invader as it
gains entry to the host. Furthermore, the
respiratory protein is triggered by proteases
and PAMPs from both the Gram-positive and
Gram-negative bacteria, orchestrating equally
effective clearance of both types of bacterial
invader. Analysis of the in vivo physiological
importance of this mechanism suggested that PO-mediated quinone
production is necessary and sufficient for killing protease-producing
bacteria but is not necessarily the only defense against protease-
negative bacteria. Other coexisting PO-independent antimicrobial
pathways should also be considered, although in this study we
found that protease-positive bacteria seemed to be resistant to the
PO-independent antimicrobial pathways. It has been noted before that
as virulence factors, microbial proteases enable the bacteria to invade
and break through the host tissues and suppress the host innate
immune mechanism. For example, LasA (staphylolysin or LasA
protease) and LasB (elastase), which are both extracellular zinc
metalloendopeptidases from P. aeruginosa, act synergistically to
degrade elastin and a variety of host proteins, including components
of the immune system, such as complement factors, immunoglobulins
and antimicrobial peptides23,24. It is conceivable that the V8 protease
from S. aureus has similar functions in the PO-independent pathways,
although the exact mechanism for this resistance remains to be
determined. The observation that the host exploits different defense
mechanisms against different species of pathogens recapitulates the
idea that the hosts have astutely coevolved mechanisms against the
microbes.
In vertebrates, the relative importance of adaptive versus innate
immunity depends on the type of infectious agent. However, reports
on the catalytic activity of antibodies20 have apparently shown an
inherent link between the innate and adaptive immune mechanisms as
well as the importance of innate immunity to the adaptive back-
ground. Here we have demonstrated that hemoglobin from both
rabbit and human RBCs, when released by hemolytic bacteria, was
triggered synergistically by PAMPs and microbial proteases to produce
antimicrobial ROS, forming a strong innate immune response. At this
juncture, whether this defense mechanism operates in genetic
disorders, such as chronic granulomatous disease, remains uncertain.
Patients with chronic granulomatous disease, whose phagocytes are
defective in producing ROS because of the lack of the NADPH
oxidase, are prone to infection by peroxidase-positive bacteria
(such as staphylococcus, salmonella and pseudomonas) and fungi
(such as aspergillus)38. Notably, the infection of chronic granuloma-
tous disease is limited to the organs and septicemia is rare, suggesting
that the pathogens may be effectively cleared by the systemic route,
possibly through metHb-mediated ROS production. Neverthe-
less, further investigation on the contribution of this defense mechan-
ism in vivo may open new avenues into the development of
antibacterial strategies.
In conclusion, we have shown here that host respiratory
proteins can be activated to produce ROS, thus forming a strong
antimicrobial defense. Such a mechanism, found in both inverte-
brates and vertebrates, circumvents the need for a chain of events,
including PAMP recognition and signal transduction, before
antimicrobial action. Instead, the host directly exploits the invading
microbe’s virulence factors to convert its own respiratory proteins
from oxygen carriers to potent ROS producers, thus resulting
in a localized surge in cytotoxic free radicals (quinone in invertebrates
and superoxide in vertebrates), which rapidly kill the pathogen
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Figure 5 Functional evaluation of the metHb-mediated ROS production in RBC by various bacteria.
(a) Hemolysis assay of RBCs incubated with S. aureus laboratory strains PC1839 (V8 producing) and
AK3 (V8 nonproducing). (b) Chemiluminescence assay of ROS production after the incubation of RBCs
with S. aureus strains PC1839 and AK3. (c) Killing assay of S. aureus strains PC1839 and AK3 after
the addition of RBCs plus superoxide dismutase (SOD) or protease inhibitor. (d) Killing assay of
naturally occurring and/or clinical bacterial isolates with (+) or without (–) hemolytic activity and
extracellular protease activity. Small horizantal lines indicate median remaining CFU/ml. *, P o 0.05;
**, P o 0.01 (Student’s t-test). Data represent the mean ± s.d. of three independent experiments.
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self-destruction. Such a seminal ‘shortcut’ immunosurveillance
mechanism, which was entrenched over 500 million year ago,
probably represents another ancient form of innate immunity
functionally conserved since before the split of protostomes
and deuterostomes.
METHODS
Hemoglobin. Human hemoglobin obtained used in a lyophilized form
(Sigma). The purity of the protein was analyzed by SDS-PAGE to confirm its
purity of about 98% (Supplementary Fig. 8 online). The PyroGene Endotoxin
Diagnostic Kit (Lonza), which detects LPS to a concentration of as low as
0.05 EU/ml (equivalent to about 10 pg/ml) showed no detectable LPS in
the hemoglobin.
Purified horseshoe crab HMC-PPO. Horseshoe crabs (Carcinoscorpius rotun-
dicauda) were collected from the Kranji estuary in Singapore. Hemolymph was
collected in pyrogen-free tubes by cardiac puncture. Only plasma samples from
crabs with sterile hemolymph were used for further HMC-PPO purification.
Hemocytes were removed by centrifugation for 10 min at 150g. Supernatants
were further clarified at for 10 min at 9,000g, and the resultant second
supernatants (called ‘plasma’ here) were ‘quick-frozen’ in liquid nitrogen and
were stored at –80 1C until further use.
All HMC-PPO purification procedures were done at 4 1C as described42,43
with modifications. Plasma was centrifuged twice (3 h each) at 40,000g. Pellets
containing enriched HMC-PPO were resuspended in 0.5 M pyrogen-free NaCl
and were further dialyzed at 4 1C against a buffer of 0.1 M Tris-HCl, pH 8.0,
5 mM CaCl2 and 5 mM MgCl2. Then these were further purified by gel
filtration through Superdex S200 with elution buffer containing 0.1 M Tris-
HCl, pH 8.0, 5 mM CaCl2 and 5 mM MgCl2. Three fractions were collected; the
large leading peak contained purified HMC (Supplementary Fig. 9a online).
The concentration of the HMC-PPO was determined by the Bradford
method39 with bovine serum albumin (fraction V; Sigma) as the standard.
The purity of the protein was analyzed by SDS-PAGE to be over 98%
(Supplementary Fig. 9b).
Proteases. PAE of P. aeruginosa, chromatographically purified to over 90%
purity from a pathogenic strain, with a specific activity of 261 U per mg
protein, was from Elastin Product Company. Proteinase K of Tritirachium
album, type XIV protease of Streptomyces griseus, subtilisin A of Bacillus
licheniformis, trypsin of bovine pancrease and collagenase of Clostridium
histolyticum were from Sigma-Aldrich. Factor C was expressed recombinantly
and was further activated by LPS40,41.
PAMPs and phosphatidyl lipids. LPS of P. aeruginosa and of Escherichia coli
055:B5, both of gel-filtration chromatography grade, LTA of S. aureus and
laminarin of Laminaria digitata were from Sigma. The synthetic phosphatidyl
lipids POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPE
(1-palmitoyl-2-oleoyl-phosphatidyl-ethanolamine) were from Avanti Polar
Lipids. To rule out the possibility of LPS contamination of the non-LPS PAMP
products such as LTA, we assayed for LPS with PyroGene Kit and used
only LPS-free PAMPs (Supplementary Fig. 10 online). Other reagents are
described in the Supplementary Methods online.
Bacterial strains. For determination of microbial protease specificity in driving
PPO activation, the wild-type strain of P. aeruginosa (PAO-Iglewski), which
produces extracellular PAE, and the mutant strain PAO-B1A1 (mutations of
LasA and LasB), which does not produce PAE, were used29. A Gram-positive
S. aureus bacterium lacking LPS was used to preclude the possibility of any
LPS-mediated hemocyte degranulation and consequential contribution of
intracellular components to PPO activation. S. aureus strain PC1839 (a SarA
mutant of wild-type 8325-4), which produces active V8 protease, and S. aureus
strain AK3 (an Aur mutant of PC1839), which does not produce active V8
protease32, were used to confirm the specificity of bacterial protease action on
HMC-PPO activation and to examine the specific contribution of the extra-
cellular PPO activation to in vivo antibacterial action. Kanamycin (50 mg/ml)
was used for maintenance of S. aureus strains PC1839 and AK3, and
erythromycin (10 mg/ml) was used for culture of S. aureus strain AK3. Six
naturally occurring Gram-positive bacterial species, Bacillus pumilus, Bacillus
aquimaris, Bacillus subtilis, Bacillus chandigarhensis, E. faecium and E. faecalis,
isolated from the horseshoe crab habitat, as well as S. aureus ATCC49775, were
also used in the in vivo antimicrobial test with horseshoe crabs. For analysis of
the antimicrobial activity of metHb-mediated ROS production in RBCs,
methicillin-resistant S. aureus strains from the National University Hospital
(Singapore) were also tested, as well as the naturally occurring bacillus and
enterococcus species. The isolation and identification of naturally occurring
Gram-positive bacteria from the habitat of the horseshoe crab is described in
the Supplementary Methods.
PO activity. PO activity was measured as described44 with modifications.
In a reaction volume of 125 ml, purified HMC-PPO was incubated for 10 min
at 20 1C with proteases in 50 mM Tris-HCl, pH 8.3, containing 0.05 M NaCl,
followed by the addition of the PAMP dissolved in the same buffer.
Then, 1 mM 4ME in 0.1 M potassium phosphate, pH 6.0, was added as
substrate. The absorbance at 405 nm was monitored continuously with
a microplate reader (Molecular Devices). PO activity is presented as the
absorbance at 405 nm at 5 min after the addition of substrate (Supplementary
Fig. 11a,b online).
Detection of O2
– production by chemiluminescence and pseudoperoxidase
activity of metHb. The generation of O2
– by metHb was monitored by the
chemiluminescence of CLA as described10, with modifications, with the Sirius
luminometer (Berthold Detection Systems). The chemiluminescence of CLA,
expressed as relative luminescence units per second (RLU/s), specifically
indicates the generation of O2
– but not of ozone, H2O2 or hydroxyl radicals
10.
For this analysis, 2.0 mg metHb was added to a substrate mixture containing
5.3 mM CLA and 3.3 mM H2O2 in 150 ml PBS, pH 7.4. Chemiluminescence was
measured beginning immediately after the metHb was added and was con-
tinuously monitored for 1 min at a rate of one ‘reading’ per second. The
pseudoperoxidase activity of the metHb is presented as the maximum speed of
O2
– production in the presence of excess H2O2 and CLA. To prove that the
ROS indicated by the chemiluminescence of CLA were superoxide anions,
superoxide dismutase was applied to specifically quench superoxide anions.
Enhancement of pseudoperoxidase activity by LTA alone is described in
Supplementary Figure 11c,d. Analysis of the auto-oxidation of hemoglobin
to metHb is described in the Supplementary Methods.
Bacterial culture for antimicrobial assays. Single colonies of P. aeruginosa
and S. aureus were inoculated into 10 ml Luria-Bertani broth and 10 ml
tryptone soy broth, respectively, and were shaken at 200 r.p.m for 16 h at
37 1C. For the induction of extracellular protease production (if any occurred),
overnight cultures of PAO-Iglewski and PAO-B1A1 were diluted in
Luria-Bertani broth to a concentration of 1  103 CFU/ml and were incubated
for 48 h at 37 1C as standing cultures29. For S. aureus, overnight cultures
of PC1839, AK3, ATCC49775, MRSA1 and MRSA2 were diluted in tryptone
soy broth until the absorbance at 600 nm reached 1.0 and then were shaken
at 220 r.p.m. for 4 h at 37 1C (ref. 32). For the naturally occurring
bacillus species, overnight cultures were diluted with marine broth until
the absorbance at 600 nm reached 0.5 and then were shaken at 220 r.p.m.
for 2 h at 37 1C. Bacterial cultures were collected by centrifugation for
10 min at 8,000g. At this point, extracellular proteases were quantified
by the Azocoll protease assay (Sigma) as described in the Supple-
mentary Methods.
For exclusion of the possibility of the presence of LPS in Gram-positive
bacterial cultures, every precaution was taken to prepare culture media with
pyrogen-free water and containers. Bottles made pyrogen-free by being
baked for 4 h at 200 1C were used. After sterilization of the media,
LPS was assayed with the PyroGene kit, and medium was used only when
the LPS was negligible. Gram-positive bacteria were further tested for
their inability to cause degranulation of the hemocytes to ensure that the
bacteria that were collected lacked LPS. Only pyrogen-free cultures were used
for in vitro and in vivo antimicrobial assays to confirm that the HMC-PPO
activation was truly attributable to extracellular factors. Analysis of horseshoe
crab hemocyte degranulation and examination of exocytosis are described in
the Supplementary Methods.
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In vitro antimicrobial assay with the chemically reconstituted system. The
end-point measurement of the ROS-mediated antimicrobial activity was done
with an initial bacterial population of 1  106 CFU/ml. For metHb analysis,
bacteria were incubated for 1 h at 37 1C with 36 mg metHb and 1.6 mmol H2O2
in 200 ml PBS. The remaining bacterial population in each reaction mixture was
counted by plating of 100 ml of serially diluted samples on nutrient agar plates
followed by overnight incubation at 37 1C. To further prove that the
antibacterial activity was indeed attributable to ROS, superoxide ions were
quenched with 2 mmol GSH. Controls comprised incubation of bacteria with
metHb, H2O2 and GSH separately or in combination. For HMC-PPO analysis,
bacteria were incubated for 1 h at 37 1C with 60 mg purified HMC plus
100 nmol 4ME in 100 ml PBS. For analysis of the effect of PO activity, 10 nmol
PTU was added to the reactions described above. Controls comprised incuba-
tion of bacteria with HMC-PPO or 4ME or PTU separately or in combination.
Each condition was tested in triplicate.
Real-time imaging of bacterial clearance elicited by PO-catalyzed production
of quinone was done with PAE-producing and PAE-deficient strains of
P. aeruginosa. Each bacterial strain (1  107 CFU) was mixed with
60 mg HMC-PPO and 100 nmol 4ME in 100 ml PBS. An aliquot of 1 ml
of the mixture was examined by fluorescence microscopy. Images were
obtained at intervals of 30 s for 1 h, at a magnification of 63 (lens objective)
 1.6 (eye piece objective) and movies were made.
In vitro antimicrobial assay with mammalian RBCs. The metHb-mediated
antimicrobial activity was also evaluated with mammalian RBCs. Both rabbit
and human RBCs were collected into heparinized tubes, were washed with
pyrogen-free saline (0.9% (vol/vol) NaCl) and were diluted to 0.4% (vol/vol);
then bacteria were incubated with the washed RBCs. Pyrogen-free saline was
used as a negative control. The bacterial population was monitored for up to
30 min. Protease Inhibitor Mix G (Serva Chemical) was used to investigate the
requirement for microbial protease in triggering the ROS production (if
any were required). Superoxide dismutase from bovine erythrocytes
(4,733 units/ml; Sigma) was used to determine the specificity of ROS in
the antimicrobial action. Measurement of RBC lysis is described in the
Supplementary Methods.
In vivo antimicrobial activity assay. Gram-positive bacteria at a sublethal dose
(1  105 to 1  106 CFU per 100 g body weight) were injected into horseshoe
crabs. At 30 min after injection, cell-free hemolymph was collected from the
crabs as described39. The residual bacterial load was counted by plating of
100 ml of serial dilutions of the cell-free hemolymph on nutrient agar
plates, followed by overnight incubation at 37 1C. To confirm the contribution
of PO activity to the bacterial clearance, 5 mM PTU or 5 mM kojic acid
was injected along with the bacteria to block in vivo PO activity (if any
were present).
ELISA-based protein-PAMP interaction and factor C activity. These assays
are described in the Supplementary Methods.
Note: Supplementary information is available on the Nature Immunology website.
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